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Abstract 
Antibiotics are administered to livestock at subtherapeutic levels to maintain animal health. 
Many of the antibiotics used are analogues or the same as those used in human medicine, raising 
the possibility that genes conferring resistance arise within agricultural production systems with 
implications for human health. In beef cattle, macrolides are administered for the control of 
bovine respiratory disease and liver abscesses and have been identified by the World Health 
Organization as critically important antibiotics for which management strategies are required to 
prevent resistance development. Enterococci are present in the gastrointestinal tract of humans 
and cattle and are also associated with nosocomial infections in humans. They are an indicator 
bacterium that can be used to monitor macrolide resistance. This thesis examined antibiotic 
resistance in the Canadian beef feedlot industry. Real-time, quantitative PCR was used to 
examine differences in the relative abundance of eighteen resistance genes across five antibiotic 
families including sulfonamides [sul1 and sul2], tetracyclines [tet(A), tet(B), tet(M), tet(O), 
tet(Q) and tet(W)], macrolides [erm(A), erm(B), erm(C), erm(F) and mef(A)], fluoroquinolones 
[qnrS and oqxB] and β-lactams [blaSHV, blaTEM1 and blaCTX-M] from feedlot cattle faeces and 
urban environments. The effect of in-feed administration and withdrawal of tylosin phosphate on 
macrolide resistance was examined using enterococci as an indicator bacterium. Resistant 
enterococci (n=21) were selected for whole-genome sequencing and comparative genomics. 
Results presented here show that the relative abundance of resistance genes differs between 
cattle feedlots and urban environments, likely a reflection of differences in antibiotic use. 
Sulfonamide, fluoroquinolone and β-lactam resistance genes predominated in urban wastewater, 
whilst tetracycline resistance genes were more prevalent in cattle faeces. The inclusion of tylosin 
in the diet of cattle at subtherapeutic levels increased the proportion of erythromycin- and 
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tylosin-resistant enterococci. However, withdrawal of tylosin from the diet appeared to 
contribute to a reduction in macrolide resistant enterococci. Comparative genomics revealed 
resistance to macrolides was present on mobile genetic elements, specifically the Tn917 
transposon harbouring erm(B). This transposon was identified in both Enterococcus hirae and 
Enterococcus faecium, suggesting inter-species transfer of resistance genes may occur in the 
bovine gastrointestinal tract. Furthermore, the integrative conjugative elements (ICEs) Tn916 
and Tn5801, both conferring tetracycline resistance, were identified in E. faecium. As the cost of 
genomic sequencing continues to decrease, further investigation of ICEs using whole genome 
sequencing will help determine if there are linkages between enterococci isolates from bovine 
environmental and human clinical sources and whether bovine enterococci represent a source of 
dissemination and spread of antibiotic resistance. Although macrolide resistance in enterococci 
decreased following the withdrawal of macrolides from cattle feed, this is not a reason to become 
complacent with the use of macrolides in cattle production. Investigating alternatives to 
macrolides for the control of bovine respiratory disease and liver abscesses, such as vaccines and 
plant bioactives, is becoming increasingly important. Furthermore, implementation of 
management practices by cattle producers that reduce the likelihood of disease spread is also 
essential to reduce the need to use antibiotics to control infectious diseases. 
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Chapter 1 – General Introduction 
Antimicrobial resistance is a prominent issue in today’s society. Multi-drug resistant 
pathogens such as carbapenem-resistant and extended spectrum β-lactamase (ESBLs) producing 
Enterobacteriaceae (e.g. New Delhi Metallo-beta-lactamase-1 [NDM-1] Klebsiella pneumoniae 
and ESBL Escherichia coli), vancomycin-resistant enterococci (VRE) and methicillin-resistant 
Staphylococcus aureus (MRSA) represent some of the current antibiotic resistant threats to 
public health (Centers for Disease Control and Prevention, 2013).  
Antibiotics are frequently used for therapy and prophylaxis in both humans and animals, 
therefore exposing not only pathogenic and zoonotic bacteria, but also commensal bacteria to 
these compounds (Van den Bogaard and Stobberingh, 2000). A consequence of this is the 
emergence and spread of resistant bacteria. This has made it increasingly difficult to successfully 
treat infections that were in the past easily controlled by antibiotics. Resistant bacteria can be 
transferred among humans in health care settings or resistant bacteria of animal origin can be 
transferred to humans through direct contact with animals, or through the consumption of animal 
products contaminated with resistant bacteria (Centers for Disease Control and Prevention, 
2013). Contamination of the environment with residual antibiotics entering the ecosystem 
through sewage, application of livestock and poultry manure to land, or from surface water run-
off from farms also contributes to the spread of antibiotic resistance and can lead to selection of 
resistance in bacterial communities residing in these environments (Centers for Disease Control 
and Prevention, 2013). Some of the potential routes of transmission of antibiotic resistant 
bacteria to humans are summarised in Figure 1.1.  
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Figure 1.1. Potential routes of transmission of antibiotic resistant bacteria to humans. Figure 
adapted from Centers for Disease Control and Prevention (2013). 
 Compared to the pre-1970’s, modern livestock and poultry production systems have 
intensified, with animals being housed at high densities (Silbergeld et al., 2008; Thornton, 2010). 
Consequently, infectious diseases are more easily spread (Otte et al., 2007) and antimicrobials 
are administered at sub-therapeutic levels in livestock and poultry feed to control and prevent 
disease (Marshall and Levy, 2011; Silbergeld et al., 2008), raising the possibility that genes 
conferring resistance arise within agricultural production systems. Many of the antimicrobials 
used are analogues or the same as antimicrobials used in human medicine.  
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Beef production is the third largest meat industry after swine and poultry production with 
>65 million tonnes of beef produced globally (Food and Agricultural Organization, 2015). 
Feedlots are used in the United States, Canada and Australia for intensive beef cattle production 
(Australian Lot Feeders Association, 2015; Galyean et al., 2011). They are generally used to 
‘finish’ cattle before slaughter after these cattle have initially been raised on pasture. Most cattle 
are finished using a high-grain diet over a period of 100 to 120 days. Feeding cattle in this 
manner ensures that growth is maximised over the duration they are housed in the feedlot. 
However, the nature of this type of production means that disease can become a significant issue, 
in particular bovine respiratory disease (BRD) and liver abscesses.  
BRD represents the primary disease of young calves and feedlot cattle in North America, 
accounting for >70% and >40% of feedlot morbidity and mortality, respectively (Hilton, 2014). 
The disease is multifactorial, involving a number of pathogens of both viral and bacterial origin, 
and arises when cattle are exposed to risk factors promoting stress, many of which are commonly 
experienced in the feedlot environment. The feeding of high-grain diets to cattle can cause 
acidosis, leading to ruminal lesions. This predisposes cattle to invasion by Fusobacterium 
necrophorum, the primary etiological agent involved in the formation of liver abscesses 
(Nagaraja and Chengappa, 1998). Cattle with liver abscesses experience reduced productivity 
caused by reduced feed intake and weight gain. In North America, macrolide antibiotics are 
frequently administered to cattle to prevent and treat these diseases (Pagel and Gautier, 2012). 
Tylosin phosphate is a common in-feed macrolide used to reduce the incidence of liver abscesses 
by inhibiting F. necrophorum, whilst tilmicosin, tulathromycin and gamithromycin are injectable 
macrolides used in the treatment of BRD (DeDonder and Apley, 2015; Nagaraja and Chengappa, 
1998).  
	
	
4	
Commensal bacteria, such as Escherichia coli and enterococci, are considered suitable 
indicators to study selection pressure exerted on bacterial populations due to antibiotic use (Van 
den Bogaard and Stobberingh, 2000). They are also useful indicators of faecal contamination. In 
the case of macrolides, enterococci represent a more suitable candidate as E. coli is intrinsically 
resistant to this antibiotic class (Mao and Putterman, 1968). As enterococci are present in a 
number of environments, including the bovine and human gastrointestinal tract (Chenoweth and 
Schaberg, 1990; Devriese et al., 1992; Noble, 1978), they represent a potential source of 
resistance genes that could be transferred to other bacteria including pathogenic bacteria. 
It is almost inevitable that bacteria that are exposed to antibiotics will develop resistance 
making it important that responsible stewardship be employed in their use. Surveillance and 
monitoring indicator bacteria such as enterococci for antibiotic resistance can provide 
information on the development of antibiotic resistance within the feedlot environment. As such, 
this thesis aims to provide insight on how antibiotic use in the Canadian beef feedlot industry 
contributes to resistance development by quantifying resistance genes using real-time, 
quantitative PCR (qPCR). Further, enterococci were selected as an indicator bacterium to 
investigate the effects of macrolide use, specifically tylosin phosphate, on the development of 
antibiotic resistance. Select isolates were further analysed using whole genome sequencing and 
comparative genomics to provide further insight into the genus Enterococcus.   
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Chapter 2 – Literature Review 
2.1. Antimicrobials 
Antimicrobials are defined by the World Organisation for Animal Health as a ‘naturally 
occurring, semi-synthetic or synthetic substances that exhibit antimicrobial activity by killing or 
inhibiting the growth of micro-organisms’ (World Organisation for Animal Health, 2013). This 
definition encompasses agents active against bacteria, viruses, protozoa and fungi. The term 
‘antibiotic’ is used in this document to describe antimicrobial agents which are active against 
bacteria. Many classes of antibiotics are available for use in human and animal medicine with 
each class representing a group of structurally related antibiotics. The penicillin, cephalosporin, 
carbapenem and monobactam classes are grouped collectively as the beta-lactam (β-lactam) 
antibiotics and represent the largest group of antibiotics. Other classes of antibiotics include the 
aminoglycosides, tetracyclines, macrolides, quinolones, sulfonamides, chloramphenicals, 
oxazolidinones, ansamycins, streptogramins, lipopeptides and glycopeptides. Many of the 
antibiotics used in animal husbandry are from the same antibiotic class as those used in human 
medicine (Table 2.1; Marshall and Levy, 2011). 
 
2.1.1. Ranking of antibiotics according to importance 
In 2005, the World Health Organization (WHO) held ‘the Canberra meeting’ to develop a 
list ranking antimicrobial agents according to their importance in human medicine. In 2007, this 
list and rankings were reviewed at ‘the Copenhagen meeting’. Since then, it has been revised 
twice, with the latest revision occurring in Oslo, Norway in 2011 (World Health Organization, 
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2012a). The WHO list represents the first international consensus to rank antimicrobials 
according to their importance in human medicine. In doing so, this list provides an important 
guideline with regard to which antimicrobials used in food animal production are most likely to 
compromise the treatment of infectious diseases in humans (Collignon et al., 2009). 
In the WHO list, antimicrobials were placed into one of three categories based on two 
criteria. The first criteria addressed if the antimicrobial was the sole or one of a few alternative 
therapies available to treat serious infectious disease in humans. The second criteria addressed 
whether the antimicrobial was used to treat diseases caused by organisms that may be zoonotic 
or the extent to which they may acquire resistance genes from zoonotic sources (World Health 
Organization, 2012a). Based on these two criteria, antimicrobials meeting both were categorised 
as critically important, those meeting either were categorised as highly important and those 
satisfying neither criteria as important (Table 2.2; World Health Organistion, 2012a). 
Antimicrobials within the critically important category were further prioritised to identify 
agents where management strategies were urgently needed to reduce the development of 
antimicrobial resistance. Selection was based on a number of guidelines, including if the 
antimicrobial was the sole or one of the few alternative therapies used to treat diseases affecting 
a significant portion of the human population, if the antimicrobial was frequently used and if it 
was used to treat diseases caused by organisms showing evidence of transmission from non-
human sources to humans or able to acquire resistance genes from non-human sources. 
Following these guidelines, fluoroquinolones, third- and fourth-generation cephalosporins, 
macrolides and glycopeptides were given highest priority for risk management (World Health 
Organization, 2012a). 
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2.1.2. Antibiotic use in humans 
Antibiotics have been used extensively in the treatment of infections in humans. Their 
use has revolutionised human medicine and can be credited with the control of many potentially 
fatal infections. Penicillin, discovered in 1928, was one of the first antibiotics used to treat 
clinical infections in humans and its use became widespread in 1941 (Shaban et al., 2014; Zaffiri 
et al., 2012). Since the discovery of penicillin, additional antibiotics have been discovered and 
developed (Figure 2.1). This development pipeline has in part been driven by the need to 
discover new antibiotics effective against resistant bacteria. Bacterial resistance to penicillin was 
documented shortly after its discovery. Finland et al. (1950) demonstrated a clear difference in 
penicillin sensitivity in staphylococci strains isolated from hospitalised patients before 1946 to 
those in later years, highlighting emerging resistance to penicillin following its widespread use 
(Finland et al., 1950). This pattern of emerging resistance following discovery and use is also 
apparent with other antibiotics (Figure 2.1; Centers for Disease Control and Prevention, 2013; 
Zaffiri et al., 2012; Zaffiri et al., 2013).  
Inappropriate use of antibiotics in human medicine has contributed to the development of 
antibiotic resistant bacteria. In a bacterial population, both susceptible and resistant bacteria are 
present. Resistant bacteria may be intrinsically resistant to an antibiotic or may acquire resistance 
through mutation or horizontal gene transfer (HGT). Incorrect use of antibiotics such as 
inadequate treatment duration, too low of a dose, or selection of an antibiotic inappropriate for 
the target bacteria results in selective pressure enabling resistant bacteria to survive. Without 
competition, resistant bacteria proliferate and after a period of time replace susceptible bacteria, 
dominating the population (Figure 2.2; Rosenblatt-Farrell, 2009).  
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Figure 2.1. Timeline of antibiotic discovery and development of antibiotic resistance. Figure adapted from Centers for Disease 
Control and Prevention (2013); Zaffiri et al. (2012) and Zaffiri et al. (2013). 
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Figure 2.2. Selective pressure and antibiotic resistance development. (A) Bacterial population 
consists of a mixture of susceptible and resistant bacteria; (B) Antibiotics provide selective 
pressure, eliminating susceptible bacteria whilst resistant bacteria survive; (C) Resistant bacteria 
predominant the population. Figure adapted from Centers for Disease Control and Prevention 
(2013) and Rosenblatt-Farrell (2009). 
2.1.3. Antibiotic use in food producing animals 
Antibiotic use in food producing animals is also suggested to contribute to the emergence 
of resistant bacteria. There is growing concern resistant bacteria can be transmitted from animals 
to humans via the food chain. Antibiotic use in animal production can be separated into four 
different categories: therapeutic use in the treatment of disease, prophylactic use to prevent the 
development of disease, metaphylactic use for the control of disease, and for growth promotion 
(Australian Commission on Safety and Quality in Health Care, 2013; European Platform for the 
Responsible Use of Medicines in Animals, 2013). The USA, Canada, Australia and Europe have 
different regulatory laws regarding the use of antibiotics in livestock and each has their own 
governing body responsible for the regulation of antibiotics. The antibiotics listed include those 
approved for use in growth promotion as well as those approved for therapeutic and prophylactic 
use (Table 2.1.). 
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Concerns surrounding the use of antibiotics in food producing animals were evident in 
1969 following the release of the Swann report by the Joint Committee on the use of Antibiotics 
in Animal Husbandry and Veterinary Medicine. This report provided recommendations on the 
use of antibiotics in food animals and suggested only antibiotics which have little or no 
application as therapeutic drugs in either humans or animals should be allowed for use as growth 
promoters. Subsequently, it was recommended that the antibiotics chlortetracycline, 
oxytetracycline, penicillin, tylosin and the sulphonamides no longer be used for growth 
promotion (House of Lords, 1998).  
The Swann Report was one of the first reports to promote changes in the use of 
antibiotics in food producing animals. Some of these changes included the removal of antibiotics 
(such as penicillin) from animal feeds in the UK, Australia and several other countries, but this 
policy was not implemented in the USA (Barton, 2010).  
Concern over the use of antibiotics for growth promotion continued, and in the 1990s it 
was demonstrated the use of the glycopeptide growth promotant, avoparcin, was selecting for 
vancomycin-resistant Enterococcus faecium in livestock and poultry (Bager et al., 1997). 
Vancomycin is used as an alternative to ampicillin in patients allergic to β-lactam antibiotics or 
to treat infections caused by penicillin resistant pathogens, in particular methicillin-resistant 
Staphylococcus aureus (MRSA) and penicillin-resistant Streptococcus pneumoniae (Arias and 
Murray, 2012; Levine, 2006). Widespread vancomycin-resistance is of concern as it would 
reduce the effectiveness of this last resort antibiotic, particularly with regard to vancomycin-
resistant enterococci, increasing treatment failure. Consequently, this prompted the European 
Union (EU) to ban the use of antibiotics for growth promotion of livestock in 2006 (European 
Food Safety Authority, 2015a).  
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2.1.4. Monitoring and surveillance schemes for antimicrobial resistance 
It was reported by the WHO Advisory Group on Integrated Surveillance of Antimicrobial 
Resistance (AGISAR) that ‘the rate of antimicrobial resistance in bacteria causing serious and 
life-threatening infections is rising’ (World Health Organization, 2012b). Human medicine has 
played a big part in this increase, but the use of antibiotics in agriculture is also a contributor. It 
has therefore become increasingly important for surveillance schemes to be in place to assess the 
impact of antibiotic use on the development of antibiotic resistance. The USA, Canada and 
Europe have implemented monitoring and surveillance schemes with Australia in the process of 
establishing one (Table 2.3.; Shaban et al., 2014).   
In the USA, the Centers for Disease Control and Prevention (CDC) established the 
National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS) in 1996. 
Collaboration between the US CDC, the US Food and Drug Administration (FDA), the US 
Department of Agriculture (USDA) and state and local health departments established a system 
to monitor antimicrobial resistance within enteric bacteria. Three main sources of antimicrobial 
resistant bacteria are monitored; humans (CDC), retail meat (FDA) and food animals (USDA), 
with each department responsible for its specific source. Enteric bacteria collected from these 
sources undergo antimicrobial susceptibility testing and genetic analysis to determine the extent 
of resistance development. Information obtained from these isolates identifies emerging trends of 
resistance and links enteric illnesses to specific sources and possible risk factors. The molecular 
portion of the study provides information on the underlying genetic mechanisms of resistance 
and their possible spread amongst enteric bacteria. The program characterises enteric disease 
outbreaks, aides in the development of recommendations for the judicious use of antimicrobial 
agents and educates consumers on food safety and about foodborne antimicrobial resistance 
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threats. Information from NARMS is provided in an annual report, published on their website 
and in scientific articles (Centers for Disease Control and Prevention, 2015).  
In Canada, the Canadian Integrated Program for Antimicrobial Resistance Surveillance 
(CIPARS) was established in 2002. It is a coordinated approach involving the Laboratory for 
Foodborne Zoonoses (LFZ), the Foodborne, Waterborne and Zoonotic Infections Division 
(FWZID), the National Microbiology Laboratory (NML), the Canadian Food Inspection Agency 
(CFIA), and provincial health and agricultural ministries. Together they monitor trends in 
resistance development in selected bacterial organisms collected from human, animal and food 
sources throughout Canada. Information obtained allows decisions to be made about policies to 
control antimicrobial use in hospital, community and agricultural settings and to identify 
measures to manage the emergence and spread of resistant bacteria (Public Health Agency of 
Canada, 2007).  
Europe has extensive surveillance systems in place for monitoring antimicrobial 
resistance. National surveillance systems exist in many European countries including Denmark 
(DANMAP), Norway (NORM/NORMVET), France (ONERBA), Finland (FINRES-VET), the 
Netherlands (NETHMAP/MARAN), Sweden (SWEDRES/SVARM) and Italy (ITAVARM) 
(World Health Organization, 2014). These programs collect isolates from both animal and 
human sources. In addition to these programs, the European Food Safety Authority (EFSA), an 
independent European agency funded by the EU, reports on isolates collected from food-
producing animals and products across 26 EU member states (European Food Safety Authority, 
2012; European Food Safety Authority, 2015b). More recently, reports have included a section 
entitled ‘Farm-to-Fork Analysis’ including data on human isolates alongside the data of animal 
isolates, encompassing a ‘one health’ perspective (European Food Safety Authority, 2012).  
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Presently, Australia has no nationally coordinated veterinary or agricultural antimicrobial 
resistance monitoring and surveillance program in place. A number of pilot studies have been 
conducted and in 2013 the Australian Antimicrobial Resistance Prevention and Containment 
(AMRPC) Steering Group was established. The Steering Group is chaired by the Department of 
Health and Aging (DoHA) and the Department of Agriculture and Water Resources (previously 
the Department of Agriculture, Fisheries and Forestry; DAFF) with aims of establishing a 
comprehensive National Antimicrobial Resistance Prevention and Containment Strategy for 
Australia (Australian Commission on Safety and Quality in Health Care, 2013). In 2015, the 
Australian Government announced Australia’s first National antimicrobial resistance strategy to 
be implemented (Australian Government, 2015). Presently, a strategy implementation plan is 
being developed in consultation with stakeholders (Department of Health, 2016).  
 
2.2. Antibiotic Resistance 
2.2.1. Development of antibiotic resistant bacteria 
Antibiotics have various mechanisms of inhibiting and killing bacteria as summarised in 
Table 2.4. Bacteria have evolved five main mechanisms to counteract the activity of antibiotics 
through resistance. Resistance genes encode for enzymes which degrade or modify the target 
antibiotic, rendering it inactive. Alternatively, antibiotic-efflux pumps can pump the antibiotic 
out of the bacterial cell before it is able to cause damage. Other adaptations include modification 
of the bacterial cell surface to reduce uptake of the antibiotic through a reduction in cell wall or 
cell membrane permeability, the production of an alternative metabolic pathway bypassing the 
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action of the antibiotic, and alteration of the intracellular target of the antibiotic so it no longer 
has an effect on its target (Tenover, 2006).  
Antibiotic resistance in bacteria can be intrinsic or acquired. Intrinsic (or innate) 
resistance is a term used to describe resistance to antibiotics whereby the general physiology or 
anatomy of the microorganism confers resistance (Rosenblatt-Farrell, 2009). Examples of this 
include the target for the antimicrobial agent being absent in the microorganism, the cell 
envelope being impermeable to the antimicrobial, or the natural presence of an enzyme or 
enzymes that degrade the antibiotic or remove it from the cell (Rosenblatt-Farrell, 2009).  
Acquired resistance arises through spontaneous mutations or acquisition of new genetic 
material through gene transfer (Federation of Veterinarians of Europe, 2002). Spontaneous 
mutations in the bacterial chromosomal DNA can alter the target of an antibiotic leading to 
resistance. Such an event is rare, happening at a frequency of about 1 per 107−1010 bacteria 
(Mulvey and Simor, 2009). However, these types of changes are vertically transmissible and the 
exponential growth rate of bacteria can lead to a substantial increase in the number of resistant 
bacteria in a population within a short period of time.  
 
2.2.2. Spread of resistance  
In addition to treating the pathogen of interest, administering antibiotics to humans or 
animals also exposes commensal bacteria, leading to the elimination of susceptible organisms 
and selection for resistant strains. Bacteria carrying resistance genes can then disseminate into 
the environment or be acquired by other hosts where they may serve as a reservoir of resistance 
genes. Once disseminated, these bacteria can potentially transfer their resistance genes to 
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pathogenic bacteria or to other commensals facilitating the spread of resistance genes within the 
bacterial community (Shaban et al., 2014). 
Metagenomic analysis of 30,000 year old DNA identified resistance genes to β-lactam, 
tetracycline and glycopeptide antibiotics (D’Costa et al., 2011). This phenomenon is not 
surprising considering the majority of antimicrobial classes originated from naturally occurring 
substances produced by fungi and bacteria within the environment (Shaban et al., 2014). 
Antibiotic use in any setting, whether in humans, animals or agriculture can select for antibiotic 
resistant bacteria. Selection of resistant strains occurs at both lethal and sub-lethal concentrations 
of the antibiotic (Figure 2.3.). At lethal concentrations, bacteria conferring high resistance are 
usually selected whilst at sub-lethal concentrations bacteria with low resistance are selected. 
Sub-lethal concentrations are likely to select for bacteria conferring high resistance with a low 
fitness cost. However, this scenario is rare because high-level resistance usually is accompanied 
by a high fitness cost. Consequently, sub-lethal concentrations of antibiotics are more likely to 
select for highly fit resistant bacteria (Andersson and Hughes, 2012). This scenario is particularly 
concerning in cases where residual antibiotics enter and contaminate the environment providing 
selection pressure at sub-lethal concentrations. It highlights the importance of appropriate dosing 
and length of exposure when using antibiotics to treat individuals, whether animal or human. 
 
2.2.3. Horizontal gene transfer 
Horizontal gene transfer (HGT) involves the transfer of antibiotic resistance genes on 
mobile segments of DNA such as plasmids, transposons or integrons (Mulvey and Simor, 2009). 
It can greatly accelerate the spread of antibiotic resistance because it can occur amongst strains 
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of the same species or between genera occupying the same ecological niche (De Niederhausern 
et al., 2004; Sparo et al., 2011; Vignaroli et al., 2011). Most concerning from a public health 
perspective, is the transfer of resistance genes from non-pathogenic to pathogenic bacteria, 
especially if they infect humans. Horizontal gene transfer occurs through three main 
mechanisms: conjugation, transformation and transduction.  
 
Figure 2.3. Schematic demonstrating how different concentrations of antibiotics influence the 
characteristics of resistant mutants in terms of their fitness and level of resistance.              At 
high (lethal) antibiotic concentrations, highly resistant mutants are selected, with either a high or 
low fitness cost.                    At low (sub-lethal) antibiotic concentrations, mutants with a low 
fitness cost are selected that are either highly resistant or low level resistant. At both high or low 
antibiotic concentrations, highly resistant mutants with a low fitness cost can be selected, 
indicated by the blue shaded box. Figure adapted from Andersson and Hughes (2012).  
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Conjugation 
Conjugation is the most common mechanism of HGT. It involves the transmission of 
plasmids (extrachromosomal circular fragments of DNA which can replicate semi-
autonomously) between bacteria (Thomas, 2004). For plasmids to be transmissible, they require 
two key genes; the tra genes which encode the membrane proteins allowing the bacterium to 
form a mating pair, and the origin of transfer (oriT) genes, which initiate replication of the 
plasmid and its transfer. A conjugative plasmid contains both of these genes and is thus, self-
transmissible. Mobilisable plasmids lack the tra genes, but can still be transferred provided the 
bacterium also contains a conjugative plasmid containing the tra genes (Kaiser and Suchman, 
2014).  
In Gram-negative bacteria, transmission of plasmids occurs through a pilus that extends 
from the donor to the recipient bacterium. The recipient bacterium has a receptor for the pilus, 
with bridges or pores being formed between the donor and recipient cell. A copy of the plasmid 
then passes through the bridge from the donor to the recipient cell. In contrast, Gram-positive 
bacteria do not form pili during conjugation and instead rely on chemical signalling to promote 
plasmid transfer. Little is understood about this mechanism of plasmid transfer. However, it is 
believed it involves a variety of cell surface components and the formation of mating aggregates 
(Andrup, 1998; Kaiser and Suchman, 2014). 
Pheromone-responsive plasmids in enterococci are the most studied conjugal transfer 
system in Gram-positive bacteria. They are a unique type of plasmid transfer system first 
described in enterococci by Dunny et al. (1978). Short peptide pheromones are secreted by 
potential recipient cells, signalling donors carrying the respective plasmids to synthesise an 
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adhesion that aides in the formation of mating aggregates among recipients. Each pheromone 
produced corresponds to a particular plasmid and once the recipient has acquired this plasmid, 
the production of the corresponding pheromone ceases whilst the production of pheromones 
specific for other plasmids continues (Clewell et al., 2000). The production of pheromones 
mediates high-frequency plasmid transfer. 
 
Transformation 
Transformation involves the uptake of free DNA (“naked DNA”) from the environment 
(Alanis, 2005). Transformation can be a natural or an artificial process with natural 
transformation only described in a limited number of bacterial species (reviewed in Chen and 
Dubnau, 2004; and Lorenz and Wackernagel, 1994). Artificial transformation involves the 
uptake of DNA by physical, chemical or enzymatic treatment and has been exploited by 
scientists for many years for use in molecular biology.  
 
Transduction 
Transduction is a form of gene transfer which involves the use of viral vectors known as 
bacteriophages to transfer genetic material amongst bacteria (Alanis, 2005). When 
bacteriophages undergo their replicative cycle inside bacterial cells, sometimes they incorporate 
the host’s cell DNA into their capsids. When the bacteriophage infects a new host, this DNA can 
then be integrated into the new host’s DNA. If the DNA carried by the bacteriophage happens to 
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contain antibiotic resistance genes then the new host has the potential to become antibiotic 
resistant (Griffiths et al., 2000). 
 
2.2.4. Mobile genetic elements 
Mobile genetic elements (MGEs) are segments of DNA containing the ‘machinery’ 
(enzymes and other proteins) required to facilitate their movement within genomes (intracellular 
movement) or between bacterial cells (intercellular movement) (Frost et al., 2005). Many 
resistance genes are located on MGEs, therefore, they play a significant role in HGT. A number 
of MGEs have been identified including transposons, integrons, plasmids and bacteriophages. Of 
these, transposons and plasmids are the most extensively studied, whilst the role of 
bacteriophages in the transfer of resistance genes is still under investigation.  
 
Transposons 
Transposons are mobile fragments of DNA with the ability to carry multiple resistance 
genes. They are not self-replicating, but have the ability to move within the genome, for example 
from chromosome to plasmid (Capita and Alonso-Calleja, 2013). Three different types of 
transposons have been identified. These are composite transposons, Tn3 family of transposons 
and integrative conjugative elements (ICEs) (Weaver et al., 2002).  
Composite transposons are composed of a segment of DNA flanked by two insertion 
sequences (ISs) of the same family, which encode enzymes to promote transposition (Werner et 
al., 2013). Several families of ISs exist, grouped based on their genetic organisation (Siguier et 
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al., 2006). Not only do these IS elements allow for mobility of resistance genes, they are also 
responsible for co-integration of plasmids with other plasmids and with the bacterial 
chromosome (Hollenbeck and Rice, 2012).  
The Tn3 family of transposons are identified by the presence of a transposase (TnpA) and 
the replicative mechanism, resolvase (TnpR), which allows them to transpose intracellularly 
within or between different replicons (Hegstad et al., 2010).  
Integrative conjugative elements (ICEs), also known as conjugative transposons, are self-
transmissible elements that typically contain three modules ensuring maintenance, dissemination 
and regulation. Maintenance modules are responsible for integration and excision of ICEs. ICEs 
integrate into a replicon of their host ensuring vertical inheritance. Dissemination modules 
contain an array of genes encoding ‘mating machinery’ which enables the transfer of ICEs via 
conjugation. Finally, regulation modules encode the genes and the mechanisms responsible for 
the regulation of ICE transfer (Burrus and Waldor, 2004; Werner et al., 2013). ICEs have been 
identified in both Gram-positive and Gram-negative bacteria, including Proteobacteria, 
Actinobacteria and Firmicutes (Roberts and Mullany, 2009; Wozniak and Waldor, 2010). As 
more information about ICEs is generated, it has become apparent they play a greater 
evolutionary role than just conferring resistance to antibiotics. ICEs often carry genes that code 
for other beneficial properties, including resistance to heavy-metals, virulence factors, biofilm 
formation, nitrogen fixation and metabolic adaptation (Bi et al., 2012; Wozniak and Waldor, 
2010).  
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Integrons 
Integrons are genetic units that capture small mobile elements known as gene cassettes 
(Hall, 2012). Integrons are not in themselves mobile, but are often found within transposons or 
plasmids (Rice, 2002; Werner et al., 2013). The defining features of an integron include an 
integrase gene (intI), a recombination site (attI site) where gene cassettes are inserted, and a 
promoter (Pc) that directs expression of the genes encoded by the cassette (Hall et al., 1999). 
Gene cassettes usually include only one gene or open reading frame and an attC recombination 
site. This recombination site is recognised by the integrase gene, enabling splicing of the 
cassettes into the attI site of the integron. This process can occur repeatedly, resulting in a string 
of gene cassettes. Thus, integrons are capable of containing a few to hundreds of cassettes (Hall, 
2012). Although gene cassettes carry only one gene, a pool of more than 130 different cassettes 
within integrons has been identified with many of these genes coding for antibiotic resistance 
(Partridge et al., 2009).  
Two types of integrons have been identified, mobile and chromosomal (reviewed by 
Cambray et al., 2010; and Mazel, 2006). Mobile integrons (MI) mostly carry gene cassettes that 
code for antibiotic resistance genes. These types of integrons are associated with MGEs, 
enabling their dissemination between bacteria of the same or different species. Within this group, 
five different classes have been identified and it is likely new classes will be discovered in the 
future. The different classes are grouped based on the sequence of the encoded integrase. The 
first three classes are typically involved in the spread of multi-resistance phenotypes, with class 1 
integrons being the most ubiquitous. However, all five have been associated with antibiotic 
resistance determinants. In contrast, chromosomal integrons (CI) are non-mobile with a subset of 
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integrons within this group being termed superintegrons, as they contain large cassette arrays that 
contain more than 20 genes.  
As gene cassettes are typically promoterless, they rely on the promoter within integrons 
to regulate their expression (Cambray et al., 2010). Gene cassettes in close proximity to the 
promoter are highly expressed, with this expression declining as the distance of gene cassettes 
from the promoter increases. Recombination events, such as excision and integration of 
cassettes, can displace cassettes to distal positions from the promoter, ultimately silencing them 
(Guerin et al., 2009).  
It has been demonstrated that induction of the SOS response increases integrase 
expression 4.5-fold in E. coli and 37-fold in Vibrio cholerae (Guerin et al., 2009). The SOS 
response is an inducible, widespread regulatory network, allowing bacteria to survive sudden 
increases in DNA damage. The SOS response is regulated by two main proteins, LexA, a 
repressor that binds to the “SOS box” and prevents the expression of SOS genes, and RecA, an 
inducer which binds to single stranded DNA (ssDNA) forming a multimeric nucleoprotein 
filament that induces the self-cleavage of LexA. When bacteria undergo DNA damage, the 
presence of ssDNA increases in the cell, activating the RecA protein and subsequent cleavage of 
LexA. This leads to the expression of the SOS genes and subsequent DNA repair (Michel, 2005; 
Sutton, 2000). Under normal conditions, SOS repression inhibits the expression of the integrase 
gene, thus maintaining cassette arrays in their designated order. Certain antibiotics, such as 
fluoroquinolones, trimethoprim and β-lactams, can induce the SOS response and increase the 
expression of integrase (Erill et al., 2007; Kelley, 2006). This promotes recombination events 
which reorder gene cassette positioning, reactivating silenced cassettes or incorporating new 
cassettes from the surrounding bacterial communities (Guerin et al., 2009).  
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Resistance mechanisms are usually costly to bacterial fitness, so in the absence of 
selection by antibiotic exposure they are usually lost. However, the ability to silence these 
mechanisms when incorporated into cassette arrays ensures they impose no biological cost until 
they are required. Thus, in this sense, the SOS response ensures the persistence of resistance 
genes in bacteria whilst also influencing their regulation and expression (Guerin et al., 2009). 
Induction of the SOS response has also been shown to promote mobilisation of some ICE 
(Beaber et al., 2004) and transposons (Aleshkin et al., 1998). Induction of an SOS response 
therefore plays an important role in antibiotic resistance spread by promoting horizontal gene 
transfer.  
 
Plasmids 
Plasmids are extrachromosomal genetic elements which can replicate semi-autonomously 
(Thomas, 2004). They play a key role in bacterial evolution and horizontal gene transfer 
(Norman, 2009). Plasmids are classified based on a number of criteria such as mode of 
replication (rolling-circle, theta or strand displacement replication) and on incompatibility (Inc) 
which is based on groups of plasmids that fail to co-reside in the same cell (Del Solar, 1998; 
Novick, 1987). Pheromone responsive plasmids are a unique group of plasmids associated with 
enterococci which are transferred in response to the excretion of short peptide pheromones 
(Clewell et al., 2000; Dunny et al., 1978).   
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Bacteriophages 
The role of bacteriophage in the transfer of antimicrobial resistance genes has been 
investigated with examples of bacteriophage mobilising resistance genes present in the literature. 
Lytic bacteriophages from the family Siphoviridae have been studied in enterococci and transfer 
of resistance genes by transduction has been demonstrated (Mazaheri Nezhad Fard et al., 2011; 
Yasmin et al., 2010). Yasmin et al. (2010) investigated transduction in Enterococcus faecalis. 
The genomes of eight representative phages were pyrosequenced with four distinct groups of 
phages identified. Transduction experiments were performed with generalised transduction 
occurring in each of the eight phages analysed (Yasmin et al., 2010). Mazaheri Nezhad Fard et 
al. (2011) was able to demonstrate the transfer of genes coding for resistance to tetracycline and 
gentamicin through transduction using bacteriophages obtained from strains of Enterococcus 
gallinarum and E. faecalis isolated from swine. Not only did this study demonstrate transduction 
in enterococci, it also demonstrated interspecies transduction: from E. faecalis to E. faecium, 
Enterococcus hirae/durans to Enterococcus casseliflavus; and from E. gallinarum to E. faecalis 
(Mazaheri Nezhad Fard et al., 2011). Despite these findings, further research is still required to 
determine the role of bacteriophages in transferring genes conferring antibiotic resistance. 
 
2.3. Enterococci 
2.3.1. Taxonomy  
The genus Enterococcus includes more than 33 species and belongs to the phylum of 
bacteria known as the Firmicutes (Garrity et al., 2007). They are part of the lactic acid bacteria 
(LAB) group, identified by a low G+C (guanine plus cytosine) content of <50 mol% (Holzapfel 
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and Wood, 1995). This group consists of several other genera of bacteria including 
Lactobacillus, Lactococcus, Weissella, Tetragenococcus, Streptococcus, Pediococcus, 
Leuconostoc and Carnobacterium (Klein et al., 1998). Lactic acid bacteria share a number of 
similar characteristics including being Gram-positive, catalase negative, non-spore forming with 
an ability to grow in microaerobic/anaerobic conditions (Klein, 2003). 
 
2.3.2. Physiology 
Enterococci are Gram-positive bacteria that occur as cocci, both singly and as chains. 
They are facultative anaerobes, with the ability to grow in both aerobic and anaerobic conditions. 
Enterococci can grow over a broad range of temperatures (10 – 45°C) and pH (4.6 to 9.9) as well 
as in the presence of 40% (w/v) bile salts, a trait used in the formulation of selective media 
(reviewed in Fisher and Phillips, 2009; and Vu and Carvalho, 2011). 
Enterococci are difficult to distinguish from Streptococcus spp. and were originally 
classified as Group D streptococci because both groups possess the Group D cell wall antigen. In 
1984, enterococci were reclassified into the single genus, Enterococcus (Murray, 1990). 
Enterococci can be distinguished from streptococci by their ability to survive and grow at high 
salt concentrations (6.5% NaCl) and under highly alkaline conditions (Schleifer and Kilpper-
Balz, 1984). 
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2.3.3. Distribution 
Enterococci can be found in a range of habitats including soil, on plants, in fresh and salt 
water, sewage and in the gastrointestinal tract of animals (including mammals, birds, fish, 
reptiles and insects) and humans (Franz et al., 2011). They are often isolated from foods of 
animal origin due to their presence within the gastrointestinal tract. Enterococci have been 
isolated from meat, cheese, fish, sausages and ground meat, with E. faecalis and E. faecium 
being the predominant species identified (Aslam et al., 2012; Devriese et al., 1995; Peters et al., 
2003). This differs from enterococci isolated from plants, where Enterococcus mundtii and E. 
casseliflavus are the most common species isolated (Klein, 2003; Micallef et al., 2013). 
Enterococci make up an essential part of the gastrointestinal flora of both humans and 
animals. In humans, E. faecalis is the predominant species of enterococci isolated, but E. faecium 
also occurs in high numbers. Counts of E. faecalis and E. faecium in human faeces range from 
105−107 CFU/g and 104−105 CFU/g, respectively (Chenoweth and Schaberg, 1990; Noble, 
1978). The species of enterococci within the gastrointestinal tract tends to be host specific. In 
poultry, E. faecium, E. faecalis and Enterococcus cecorum are regularly isolated. The species of 
enterococci in the gastrointestinal tract of poultry also varies with the age of the host. Devriese et 
al. (1991) reported E. faecium and E. faecalis were dominant enterococci species in day old 
chicks whereas E. faecium was more common in the gastrointestinal tract of 3−4 week old 
broilers. E. cecorum was the dominate species isolated from mature poultry (Devriese et al., 
1991). The species distribution of enterococci also varies with maturity in cattle. Enterococcus 
avium, E. cecorum, E. durans, E. faecalis, E. faecium and E. hirae have been isolated from 
suckling calves with E. faecalis making up the greatest proportion. In mature dairy cows, the 
enterococci population is less diverse with E. faecalis, E. hirae and E. casseliflavus being the 
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principal species isolated (Devriese et al., 1992). Finally, in pigs it has been reported E. faecalis, 
E. faecium, E. cecorum and E. hirae are the most common species isolated (Devriese et al., 
1994). It is likely that the species distribution varies with age in pigs, as it does with poultry and 
cattle, a possibility that has yet to be investigated. 
 
2.3.4. Role of enterococci in food, silage and health 
Enterococci play an important role in the fermentation and spoilage of food. They are 
desirable components of the microflora of many traditional European cheeses where they play a 
role in the ripening and development of desirable aromas. Enterococci are also associated with 
the fermentation of sausages and vegetables, including table olives, sauerkraut, kimichi, tomato 
juice, fruit beans, caper berries and cereal-based products (Foulquie Moreno et al., 2006; M`hir 
et al., 2012), and the production of silage (Acosta Aragón et al., 2012; Weinberg and Muck, 
1996). Not only do enterococci play a role in fermentation, they have also been shown to 
produce bacteriocins which protect against spoilage or pathogenic bacteria, such as Listeria 
monocytogenes. Known as enterocins in enterococci, they are ribosomally synthesised 
antimicrobial peptides with activity against closely related Gram-positive bacteria (Khan et al., 
2010).  
In addition to their role in food and silage production, certain strains of enterococci have 
been utilised as probiotics to improve human and animal health. They have been used to treat 
diseases such as irritable bowel syndrome (Enck et al. 2008; Gade and Thorn, 1989), diarrhoea 
or antibiotic associated diarrhoea (Wunderlich et al., 1989), or improve health through lowering 
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cholesterol levels (Agerholm-Larsen et al., 2000) and stimulating the immune system 
(Habermann et al., 2002; Stockert et al., 2007). 
 
2.3.5. Pathogenesis 
Although part of the normal microflora of humans, enterococci are often responsible for 
nosocomial and community-acquired infections, particularly targeting individuals that are 
immunocompromised or elderly. There are number of virulence factors that contribute to their 
pathogenicity including aggregation surface adhesin proteins, enterococcal surface protein (Esp), 
cytolysin, gelatinase and microbial surface components recognising adhesive matrix molecules 
(MSCRAMMs). 
Aggregation substance is a surface adhesion protein, encoded by pheromone responsive 
plasmids and expression is stimulated by short peptide pheromones secreted by plasmid-free 
recipient cells (Olmsted et al., 1991; Yagi et al., 1983). Studies have demonstrated aggregation 
substance increases binding to cultured renal tubular cells (Kreft et al., 1992), promotes 
adherence and intercellular survival in human macrophages (Sußmuth et al., 2000) and affects 
the pathogenesis of experimental endocarditis (Schlievert et al., 1998). It is therefore believed to 
play an important role in enterococcal virulence by facilitating adherence and infection of host 
cells.  
Enterococcal surface protein (Esp) is a cell wall associated protein identified in both E. 
faecalis (Tendolkar et al., 2004) and E. faecium (Heikens et al., 2007). It is believed to promote 
the adhesion, colonisation and evasion of the immune system and increased innate resistance to 
antibiotics through the formation of biofilms. The ability to form biofilms can also facilitate the 
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attachment to abiotic surfaces such as intrauterine devices and catheters, aiding in transmission 
and spread of hospital acquired infections (Donlan, 2002). 
Cytolysin is a two-peptide lytic toxin that exhibits both haemolytic and bacteriocin 
activity and is usually encoded by pheromone-responsive plasmids (Clewell, 2007; Ike et al., 
1990) or pathogenicity islands (Shankar et al., 2002) in strains of E. faecalis (Cox et al., 2005). 
Its bacteriocin activity is believed to assist in its growth and persistence by inhibiting the growth 
of other Gram-positive bacteria (Brock et al., 1963; Jett and Gilmore, 1990), whilst its 
haemolytic properties can lyse macrophages and neutrophils enabling it to circumvent immune 
responses (Miyazaki et al., 1993).  
Gelatinase is a bacterial protease produced by E. faecalis. This enzyme hydrolyses 
gelatin, collagen, casein and haemoglobin (Su et al., 1991). Secretion of gelatinase is controlled 
by the two-component fsr system comprised of the genes fsrA, fsrB, fsrC and fsrD. This system 
plays a role in the expression of the protease genes, gelE and spreE, which encode for gelatinase 
and serine protease, respectively (Nakayama et al., 2006; Qin et al., 2000). The production of 
gelatinase is also suggested to play a role in biofilm formation in E. faecalis (Hancock and 
Perego, 2004).  
Microbial surface components recognising adhesive matrix molecules (MSCRAMMs) 
are important in the establishment of infections. They facilitate adherence to the host’s 
extracellular matrix (ECM). Two well-studied MSCRAMMs in enterococci are Ace in E. 
faecalis and Acm in E. faecium. Ace is conditionally expressed in the presence of collagen or 
serum, binding to the ECM components collagen type I (CI), collagen type IV (CIV) and lamina 
(LN) (Nallapareddy et al., 2000; Nallapareddy and Murray, 2006), whilst Acm binds to CI 
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(Nallapareddy et al., 2003). Under normal conditions, epithelial or endothelial cells cover ECMs 
and prevent binding. However, following trauma or damage to the host tissues it can result in 
ECMs becoming exposed, allowing enterococci to colonise and cause infection (Nallapareddy et 
al., 2000). 
 
2.3.6. Clinical infections, epidemiology and VRE 
Despite their usual commensal nature, enterococci are becoming increasingly important 
as pathogens. Their increased involvement in the development of clinical infections is in part due 
to their intrinsic resistance to certain antibiotics including clindamycin, cephalosporins and 
aminoglycosides, but also their ability to acquire resistance to antibiotics such as vancomycin. 
Resistance to vancomycin is of particular concern as it is a last resort antibiotic in the treatment 
of penicillin resistant pathogens such as MRSA, and an important alternative to ampicillin for 
patients allergic to β-lactam antibiotics (Arias and Murray, 2012; Levine, 2006).  
In humans, enterococci are associated with urinary tract infections, hepatobiliary sepsis, 
endocarditis, surgical wound infections, bacteraemia and neonatal sepsis (Agudelo Higuita and 
Huycke, 2014; Poh et al., 2006). Healthcare-associated enterococcal infections are 
predominantly caused by E. faecalis and E. faecium (Sivert et al., 2013). E. avium, E. 
casseliflavus, E. durans, E. gallinarum, E. hirae, Enterococcus raffinosus and E. mundtii have 
also been known to cause clinical infections, but far less frequently than E. faecalis and E. 
faecium (De Perio et al., 2006; Gordon et al., 1992).  
Increased use of vancomycin and broad-spectrum antibiotics has contributed to emerging 
resistance in enterococci and has changed the epidemiology of enterococcal infections. In the 
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past, E. faecalis was the predominant species isolated from clinical infections, but more recently 
E. faecium has been more frequently isolated (Deshpande et al., 2007; Mutnick et al., 2003). This 
trend follows the increase in VRE, as E. faecium is ten times more likely to be resistant to 
vancomycin than E. faecalis (Iwen et al., 1997). In the United States, the incidence of 
hospitalisations with VRE infections more than doubled between 2000 and 2006 (Ramsey and 
Zilberberg, 2009). VRE are now widely distributed having been isolated from patients in the 
United Kingdom, France, Belgium, Denmark, Germany, Italy, The Netherlands, Spain, Sweden, 
USA, Canada, Malaysia and Australia (Cetinkaya et al., 2000). 
 
2.3.7. Antibiotic resistance in enterococci  
Intrinsic resistance 
β-lactams 
The cell wall of Gram-positive bacteria consists of an outer thick peptidoglycan layer, 
with attached accessory molecules including teichoic acids, teichuronic acids, polyphosphates or 
carbohydrates. Assembly of the cell wall is catalysed by penicillin binding proteins (PBPs), such 
as transpeptidases and carboxypeptidases, which are the target of β-lactam antibiotics (Navarre 
and Schneewind, 1999). β-lactams bind covalently to PBPs and thereby inhibit cell wall 
synthesis (Zapun et al., 2008). Penicillin binding proteins produced by enterococci have a low-
affinity for β-lactam antibiotics resulting in an inherent low-level of resistance (Fontana et al., 
1983; Fontana et al., 1985). Overproduction of PBPs has also been attributed to increased 
resistance (Fontana et al., 1994). The minimum inhibitory concentration for 90 percent of strains 
(MIC90) to penicillin for E. faecalis and E. faecium is 4 µg/mL and >64 µg/mL, respectively, 
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much higher than reported for streptococci and other related Gram-positive organisms (Murray, 
1990; Weinstein, 2001). 
 
Aminoglycosides 
Enterococci have intrinsic resistance to low to moderate levels of aminoglycosides, such 
as streptomycin and gentamicin. This low to moderate level of resistance is attributed to a 
decreased uptake of these antibiotics (Kristich et al., 2014). This is generally overcome with the 
synergistic use of cell-wall active antibiotics such as β-lactams and glycopeptides, which 
increase the uptake of these molecules (Moellering and Weinberg, 1971). This therapeutic 
approach can be negated by the acquisition of high-level aminoglycoside resistance (Kristich et 
al., 2014). 
 
Lincosamides and streptogramins 
E. faecalis is intrinsically resistant to clindamycin (a lincosamide), quinupristin (a 
streptogramin B class) and dalpfopristin (a streptogramin A class). Resistance is conferred by the 
expression of the resistance gene lsa, believed to be responsible for encoding an ATP-binding 
cassette (ABC)-efflux pump targeted at these antibiotics (Singh et al., 2002).  
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Trimethoprim-sulfamethoxazole 
Trimethoprim-sulfamethoxazole inhibits folate synthesis by targeting steps in the 
tetrahydrofolate synthesis pathway responsible for folate synthesis. Many bacteria rely on this 
pathway for the production of folate, as they lack the ability to acquire it from the environment. 
Without folate, bacteria cannot produce nucleic acids and therefore are killed by the activity of 
these antibiotics (Hollenbeck and Rice, 2012). Enterococci are intrinsically resistant to this 
combination of antibiotics as they have the ability to absorb folate from the environment, 
rendering trimethoprim-sulfamethoxazole ineffective (Zervos and Schaberg, 1985).  
 
Acquired resistance 
Glycopeptides 
Glycopeptide resistance is well documented in enterococci (Clark et al., 1993; Liassine et 
al., 1998; Mascini and Bonten, 2005). High-level resistance to vancomycin, a critically important 
glycopeptide, has been increasingly reported in nosocomial infections (Ramsey and Zilberberg, 
2009). This is important because of the ability of enterococci to transfer resistance not only to 
antibiotic-susceptible enterococci, but also potentially to other pathogens. Vancomycin is an 
essential antibiotic used in the treatment of infections caused by methicillin-resistant 
Staphylococcus aureus (MRSA) (Mascini and Bonten, 2005). Transfer of vancomycin resistance 
from VRE to MRSA has been documented (Centers for Disease Control and Prevention, 2002; 
Centers for Disease Control and Prevention, 2004; Chang et al., 2003). 
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Nine distinct gene clusters have been associated with glycopeptide resistance and 
described in enterococci. The most common among clinical isolates are the VanA and VanB 
types which have been studied in the greatest detail (Kristich et al., 2014). These two gene 
clusters are acquired and confer moderate to high-level glycopeptide resistance. Intrinsic 
resistance, conferred by the VanC operon, provides low levels of vancomycin resistance. It is 
chromosomally located and non-transferrable. Three species of enterococci have been shown to 
harbour the VanC operon, namely E. gallinarum, E. casseliflavus and Enterococcus flavescens. 
Each species has a unique set of genes contained in this operon which encode the ligase-related 
proteins; vanC-1 for E. gallinarum, vanC-2 for E. casseliflavus and vanC-3 for E. flavescens 
(Leclercq et al., 1992; Navarro and Courvalin, 1994).  
In peptidoglycan synthesis, glycan chains composed of a repeating disaccharide, N-
acetylmuramic acid-(β1-4)-N-acetyleglycosamine (MurNAc-GlcNAc), are linked by cross bridge 
peptides that connect short wall peptides (consisting of three to five amino acids) that branch off 
the MurNAc segment of the glycan chain (Navarre and Schneewind, 1999). These peptidoglycan 
precursors (glycan chain with branching chain of peptides) typically end with a D-alanine-D-
alanine (D-Ala-D-Ala) dipeptide. Glycopeptides act to inhibit cell wall synthesis by binding to 
the D-Ala-D-Ala terminus of the peptidoglycan precursor thus preventing peptidoglycan 
synthesis (Kristich et al., 2014). 
Glycopeptide resistance is achieved through the synergistic action of two pathways. The 
first pathway involves replacement of the terminal D-Ala in a peptidoglycan precursor with D-
lactate (D-Lac) or D-serine (D-Ser) and the second is prevention of the synthesis or destruction 
of peptidoglycan precursors which end in D-Ala-D-Ala by action of specific D,D-
carboxypeptidases. The production of modified peptidoglycan precursors and destruction of 
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those ending with D-Ala-D-Ala is achieved by the production of enzymes encoded by the 
glycopeptide gene clusters (Kristich et al., 2014). Replacement of D-Ala with D-Lac or D-Ser 
reduces the binding affinity of glycopeptides to peptidoglycan precursors, effectively reducing 
their ability to inhibit cell wall synthesis. In the case of D-Lac, the binding affinity is reduced 
1,000 fold conferring high-level glycopeptide resistance while with D-Ser the reduction in 
affinity is less pronounced (approximately 7 fold), thus conferring low-level glycopeptide 
resistance (Billot-Klein et al., 1994; Bugg et al., 1991). The intrinsic VanC operon leads to the 
replacement of D-Ala with D-Ser, whilst VanA and VanB operons replace D-Ala with D-Lac 
(Arthur et al., 1996).  
The VanA and VanB operons are acquired by enterococci through the transfer of 
transposons or plasmids, specifically, the Tn1546 transposon for VanA and Tn1549 and/or 
Tn5382 for VanB (Arthur et al., 1993; Carias et al., 1998; Garnier et al., 2000). The VanA 
operon contains seven genes (vanR, vanS, vanH, vanA, vanX, vanY and vanZ) and confers 
inducible resistance to high levels of vancomycin and teicoplanin (Arthur et al., 1996). The 
VanB operon is organised and functions in a similar manner to the VanA operon. However, 
unlike VanA, resistance is induced by vancomycin but not teicoplanin (Ribeiro et al., 2011). The 
genes of the VanB operon consist of vanRB, vanSB, vanHB, vanB, vanXB, vanYB, vanW and vanV 
(Evers and Courvalin, 1996; Ribeiro et al., 2011). The vanR/vanRB and vanS/vanSB genes encode 
a two-component regulatory system that regulates the expression of glycopeptide resistance 
genes. The vanH/vanHB and vanA/vanB genes are involved in the synthesis of depsipeptide D-
alanyl-D-lactate and vanX/vanXB and vanY/vanYB are responsible for the hydrolysis of 
peptidoglycan precursors containing the D-Ala-D-Ala dipeptide (Arthur et al., 1996). The vanZ 
gene confers low-level teicoplanin resistance through an unknown mechanism (Evers and 
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Courvalin, 1996). The function of the vanW and vanV genes of the VanB operon is also 
unknown, with vanV gene not found in all VanB operons (Ribeiro et al., 2011). 
	
Aminoglycosides 
As described above, enterococci have inherent resistance to low to moderate levels of 
aminoglycosides, and can acquire high-level resistance to all aminoglycosides, including 
gentamicin and streptomycin. High-level resistance to gentamicin and streptomycin is of 
particular concern because these antibiotics are used synergistically in the treatment of serious 
enterococcal infections (Chow, 2000).  
Aminoglycosides bind to prokaryotic ribosomes thus disrupting protein synthesis. Genes 
conferring high-level aminoglycoside resistance are usually encoded on plasmids, but are also 
associated with transposons (Hodel-Christian and Murray, 1992; Simjee et al., 2000). High-level 
resistance to all aminoglycosides, except for streptomycin, is encoded by the bi-functional 
aminoglycoside-modifying enzyme AAC(6’)-Ie-APH(2’’)-Ia. High-level resistance to 
streptomycin arises from ribosomal mutations altering the S12 ribosomal protein or by the 
acquisition of a gene coding for a nucleotidyltransferases, ANT(3’’)-Ia or ANT(6’)-Ia, which 
inactivates this aminoglycoside (Chow, 2000). The binding affinity of aminoglycoside antibiotics 
to the bacterial ribosome is reduced by the action of these aminoglycoside-modifying enzymes 
which catalyse the covalent modification of amino and hydroxyl groups within the 
aminoglycoside molecule (Mingeot-Leclercq et al., 1999).  
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Oxazolidinones 
Linezolid is an oxazolidinone used in the treatment of infections caused by VRE. 
Resistance is most often due to point mutations of the 23S ribosomal RNA ribosome-binding site 
or through acquisition of the cfr gene (Long et al, 2006; Prystowsky et al., 2001). Resistance to 
linezolid is still rare in enterococci, but has been documented in enterococci isolated from 
humans (Patel et al., 2013). The first report of the cfr gene in an E. faecalis strain isolated from 
cattle was from China in 2011 (Liu et al., 2012). This gene encodes for resistance to phenicols, 
lincosamides, oxazolidinones, pleuromutilins and streptogramin A (Long et al., 2006). Liu et al. 
(2012) reported cfr to be located on a plasmid (pEF-01) in E. faecalis EF-01. The transferability 
of pEF-01 from E. faecalis EF-01 was assessed through conjugation and transformation assays. 
Transfer of pEF-01 from E. faecalis EF-01 to E. faecalis JH2-2 through conjugation was 
unsuccessful. However, successful transformation of pEF-01 to E. faecalis JH2-2 and S. aureus 
RN4220 by electrotransformation was demonstrated (Liu et al., 2012). The pEF-01 plasmid was 
functional in both E. faecalis JH2-2 and S. aureus RN4220 following transformation, suggesting 
dissemination of the cfr gene through plasmid transfer may occur. The cfr gene has also been 
recently identified in a human clinical isolate of E. faecium (Patel et al., 2013). This is a 
significant finding because even though linezolid resistance is rare, dissemination of the cfr gene 
may increase the prevalence of resistant enterococci.  
 
Lipopeptides 
Daptomycin is a lipopeptide that has bactericidal activity against enterococci (Akins and 
Rybak, 2001; Jorgensen et al., 2003). The mechanism of daptomycin resistance in enterococci is 
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not fully understood, but recent comparative whole-genome sequencing of a daptomycin-
resistant E. faecalis suggested mutations that alter the ultrastructure of the cell membrane and 
cell wall may contribute to resistance (Arias et al., 2011). This study identified three genes with 
in-frame deletions in the daptomycin-resistant strain of E. faecalis that were absent in susceptible 
strains. Two genes encoded for the putative enzymes, glycerophosphoryl diester 
phosphodiesterase (GdpD) and cardiolipin synthase (Cls), which are believed to be involved in 
phospholipid metabolism. The third gene encoded for a putative membrane protein, lipid II 
cycle-interfering antibiotic protein (LiaF) believed to be a member of a three-component 
regulatory system (LiaFSR). This system is involved in the stress-sensing response to antibiotics 
by the cell envelope (Arias et al., 2011). It was determined mutations in LiaF and GdpD were 
necessary for enterococci to be resistant to daptomycin (Arias et al., 2011). In another study, 
genomic data obtained from the multidrug-resistant E. faecalis strain V583 identified seven 
proteins with mutations associated with daptomycin resistance, including Cls. They further 
confirmed the role of the cls mutant allele in daptomycin resistance through transfer studies. 
However, additional daptomycin-resistant mutants lacking the cls mutation were also observed 
suggesting alternative pathways to daptomycin resistance may also exist (Palmer et al., 2011). 
  
Macrolide, lincosamide and streptogramins  
The macrolide-lincosamide-streptogramin B (MLSB) superfamily is a group of 
structurally unrelated antibiotics which act to bind the 50S ribosomal subunit in bacteria. Binding 
blocks peptide bond formation and translation thus inhibiting protein synthesis (Roberts et al, 
1999; Roberts, 2008).  
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A number of resistance genes have been identified in enterococci which confer MLSB 
resistance (Table 2.5.). Ribosomal methylation is a major mechanism of resistance, encoded by 
erm genes. The product of these genes (rRNA methylases) alter the binding site for antibiotics of 
the MLSB superfamily resulting in resistance (Weisblum, 1995). Other mechanisms of resistance 
also exist, however these confer resistance to only one or two antibiotic classes of the MLSB 
superfamily. These include efflux proteins and inactivating enzymes including esterases, lysases, 
transferases and phosphorylases (Roberts et al., 1999; Roberts, 2008). 
Macrolides used in animal production are not the same as those used in human medicine. 
However, the ability of erm genes to confer resistance to multiple antibiotics in the MLSB 
superfamily, including those used in human medicine such as erythromycin, is concerning. 
Macrolide resistance genes are often found linked with resistance genes conferring resistance to 
other antimicrobials, such as glycopeptides and tetracyclines. They are also often found located 
on MGEs such as plasmids and transposons suggesting the use of macrolides in animal 
production could also be co-selecting for resistance to antibiotics other than macrolides.  
Examples of MGEs conferring MLSB resistance include pheromone-responsive 
conjugative plasmids such as the one found in E. faecalis isolated from a chicken, described 
carrying five drug resistance determinants including vanA, erm(B), aph(3’), aph(6’) and 
aac(6’)/aph(2’), encoding for resistance to vancomycin, erythromycin, kanamycin, streptomycin 
and gentamicin/kanamycin, respectively (Lim et al., 2006). Plasmid co-localisation of tet(O) 
with erm(B) has also been described in E. faecalis isolates from poultry, and tet(M) with erm(B) 
in E. faecalis isolates from pigs (Tremblay et al., 2011; Tremblay et al., 2012). Transposons 
identified in enterococci carrying resistance to MLSB antibiotics include the composite 
transposons Tn5384 (Bonafede et al., 1997) and Tn5385 (Rice and Carias, 1998; Rice, 2002) 
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both linked to the transfer of erm(B), Tn3 family of transposons including Tn917 and Tn3871 
(Banai and LeBlanc, 1984; Shaw and Clewell, 1985) and ICEs including Tn1545 and variants 
(De Leener et al., 2004). 
 
2.4. Implications of Horizontal Gene Transfer  
One of the biggest concerns surrounding resistance development in enterococci is the 
horizontal transfer of resistance genes from non-pathogenic to pathogenic bacteria that cause 
infections in humans. It is hypothesised that human intestinal bacteria may serve as a reservoir of 
resistance genes, with transfer occurring among naturally residing intestinal bacteria or to 
ingested bacteria, including pathogenic bacteria that may contaminate food. Commensal bacteria, 
many of which are opportunistic pathogens, have the potential to cause post-surgical infections 
with acquisition of resistance genes increasing the difficulty of successful therapy (Salyers et al., 
2004). This phenomenon is difficult to study in humans. However, a number of in vitro and in 
vivo studies have been conducted investigating the transfer of resistance genes in enterococci 
(Tables 2.6. and 2.7.). These studies demonstrated intra- and inter-species transfer of resistance 
genes in enterococci, transfer between enterococci and other bacterial genera and transfer 
between enterococci strains isolated from humans and livestock.  
Despite the difficulty of studying horizontal gene transfer in humans, transient transfer of 
resistance genes has been demonstrated. Human volunteers were used to assess if a strain of E. 
faecium from chickens that contained vanA, erm(B) and vat(E) could transfer resistance to E. 
faecium colonising the gut of the participants in the study. Transfer of vanA was demonstrated in 
three out of the six humans participating in the study. Even though colonisation was transient, 
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this study demonstrated transfer of resistance genes between bacteria originating from chickens 
to bacteria from humans could occur within the human intestinal tract (Lester et al., 2006). If 
colonisation of the human gastrointestinal tract with antibiotic resistant bacteria was to occur, 
this could lead to further dissemination of resistance genes or hinder the effectiveness of 
antibiotics in the treatment of opportunistic infections. Thus, transmission of antibiotic resistant 
enterococci from animals to humans through direct contact, the environment or food represents a 
public health risk. 
 
2.5. Comparative Genomics of Enterococci  
The advancement of next-generation technologies has reduced the time and cost 
associated with sequencing bacterial genomes (Loman et al., 2012; Stahl and Lundeberg, 2012). 
Consequently, more and more genomes have been sequenced revolutionising the way we study 
bacteria. Comparative genomics is a technique used to compare the genomes of multiple 
bacteria, allowing identification of similarities and differences among organisms. 
The first enterococcal genome sequenced was E. faecalis V583, published in 2003 
(Paulsen et al., 2003). Since then, hundreds of enterococci have been sequenced with complete 
and draft genome sequences available (http://www.ncbi.nlm.nih.gov/genome). E. faecium and E. 
faecalis make up the bulk of genome sequences available, due to their association and 
importance as nosocomial and community-acquired infections in humans. Examination of 
enterococcal genomes has expanded our knowledge of their population structure, evolutionary 
history and basic biology. 
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Multilocus sequence typing (MLST) has been used to describe the genetic relatedness 
between strains of E. faecium and E. faecalis in order to define their evolutionary history (Ruiz-
Garbajosa et al., 2006; Willems et al., 2005). MLST involves the sequencing and analysis of 
housekeeping genes present in different locations on a chromosome. A limitation of this 
technique is the limited number of alleles assessed, only seven for E. faecium and E. faecalis 
(Homan et al., 2002; Ruiz-Garbajosa et al., 2006). Despite this limitation, MLST analysis has 
assisted in the understanding of population structure and evolution of E. faecium and E. faecalis 
and has assisted in the selection of isolates for whole genome sequencing (Ruiz-Garbajosa et al., 
2006; Willems et al., 2005; Willems et al., 2012). 	
Comparison of whole genome sequences can be used to overcome the limitations 
associated with MLST analysis and has been used to study the population structure and evolution 
of E. faecium and E. faecalis. Initial investigation of E. faecium population structure using 
MLST analysis revealed a major split in the E. faecium population (Willems et al., 2012). This 
split was confirmed following analysis of 6 E. faecium genomes which identified two clades 
designated as clade A and clade B (Palmer et al., 2012). A more recent study examined 51 newly 
sequenced E. faecium genomes and found evidence of a second split within clade A, designated 
clade A1 and A2 (Lebreton et al., 2013). Clade A and B separate hospital-associated and human 
commensal isolates, whilst clade A1 distinguishes clinical isolates from most animal-derived 
strains in A2. Mutation rates were also used to estimate the time of divergence between clades, 
with the split between clade A and B estimated to have occurred 3,000 years ago and the split 
between clade A1 and A2 occurring only 75 years ago (Lebreton et al., 2013). In this study, a 
commensal strain was found to cluster in clade A and an infecting hospital strain was found to 
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cluster in clade B, suggesting the ecological distinction between clades is not absolute. In 
contrast to E. faecium, E. faecalis shows little phylogenetic divergence (Palmer et al., 2012).  
Comparative genomic analysis has been used to study the basic biology of enterococci 
and has identified important structures contributing to virulence, including pathogenicity islands 
in E. faecalis (Shankar et al., 2002) and E. faecium (Lam et al, 2012; van Schaik et al., 2010). It 
has been useful in the identification of plasmids and MGEs associated with antibiotic resistance 
(Hegstad et al, 2010; Palmer et al., 2010) and has provided insight into genome plasticity. 
Clustered, regularly interspaced short palindromic repeats (CRISPR) with CRISPR-associated 
(cas) genes are a system used by prokaryotes as a type of immune defence against the invasion 
of viruses and plasmids (Wiedenheft et al., 2012). Examination of E. faecium and E. faecalis 
genomes has revealed an inverse relationship between CRISPR-cas and antibiotic resistance, 
suggesting antibiotic use selects for enterococci with a compromised genome defence system, 
making them susceptible to the acquisition of antibiotic resistance genes (Palmer and Gilmore, 
2010). Pan-genome analysis is used to estimate the total size of the gene pool accessible to a 
single species and investigate genomic diversity. The E. faecium pan-genome is considered open, 
meaning E. faecium can acquire and incorporate novel DNA into its gene pool contributing to the 
high genomic diversity between strains and enabling this species to adapt to different 
environments through the acquisition of new genes (Van Schaik et al., 2010). Investigation of the 
pan-genomes of other enterococci species has yet to be conducted.   
There has been an increase in the number of genomes of other enterococci species that 
have been characterised. Investigation of these genomes is important in understanding the 
diversity of the genus Enterococcus. Already studies have provided insight into the genetic basis 
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for motility and pigmentation as seen in E. casseliflavus and E. gallinarum, and differences in 
metabolism that discriminate different enterococcal species (Palmer et al., 2012).   
Comparative genomic analysis of enterococci is still in its infancy. A number of areas 
still need to be addressed for further advancements in this field. Firstly, available E. faecium and 
E. faecalis genomes are mostly isolates originating from human infection or from hospitalized 
patients colonized by antibiotic resistant strains. There is a poor representation of strains isolated 
from healthy humans and non-human sources as well as an overrepresentation of strains from 
Europe and North America (Palmer et al., 2014).  Furthermore, there is a lack of sequence data 
available for species other than E. faecium and E. faecalis. As more sequences become available, 
comparative genomics offers a new way to search for traits unique to each species. 
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Tables 
Table 2.1. Antimicrobials registered for use in animals 
Antibiotic class Antibiotic USA Canada Australia 
Aminoglycosides Amikacin D, H H - 
Apramycin Sw Sw C 
Gentamicin D, Ca, H, P, Sw, C C, Sw, P, H, Ca, D H 
Neomycin Ca, D, H, G, Sh, Sw, P C, D, Ca, Sw, H, Sh, P C, Sw, Sh, P 
Spectinomycin P, Sw, D Sw, P, Ca, D Sw 
Streptomycin P, C, D, H, Sw C, Sw, P C, Sw, Sh 
 
Cephalosporins Cefadroxil Ca, D Ca, D - 
Ceftiofur C, H, Sw, P, H, G, Sh, D C, Sw, H, Sh, D C, H 
Cephapirin C C - 
 
Chloramphenicol and 
Congeners 
Chloramphenicol D, Ca Ca, D - 
Florfenicol C, Sw, Fi Fi, C, Sw, P - 
 
Fluoroquinolones Enrofloxacin Ca, D, C, Sw Ca, D, C, Sw - 
Marbofloxacin D, Ca D, Ca - 
Orbifloxacin Ca, D Ca, D - 
 
Glycopeptides Avoparcin - - P, Sw, C 
 
Lincosamides Clindamycin D, Ca D, Ca - 
Lincomycin hydrochloride Ca, D, Sw, P, Bees Sw, P, Ca, D C, Sw, P 
Pirlimycin C C - 
 
Macrolides Erythromycin C, P, Ca, D, Sw C, Sw, Sh, P C, Sw, P, Sh 
Tilimicosin C, Sh, Sw C, Sh C, Sw 
Tildipirosin C C - 
Tulthromycin C, Sw C, Sw - 
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Table 2.1. Continued 
	
Antibiotic class Antibiotic USA Canada Australia 
 Tylosin C, P, Sw, Ca, D, Bees C, Sw, P C, Sw, P, Sh 
 
Nitrofurans Nitrofurantoin - H, Ca, D - 
 Nitrofurazone Ca, D, H H, D, C, Sw, G, Sh, Ca - 
 Amoxicillin D, Sw, Ca, C Ca, D C, Sw, Sh, P 
 
Penicillins Amoxicillin, Clavulanic 
acid 
- D, Ca - 
Ampicillin C, D, Ca, Sw, H C, Sw, Ca, D C, Sw 
Cloxacillin D, C C C 
Penicillin G benzathine C, D, H C, Sw, H, Ca, Sh, D Sh, C 
Penicillin G potassium P, Ca, D Ca, Sw, P - 
Penicillin G procaine Sw, P, C, H, Sh, D, Ca Sw, C, H, Ca, Sh, D, P C, Sw, Sh 
 Polymixin B Ca, C, D, H, Sh C - 
 Virginiamycin P, Sw Sw, P C, Sh, Sw 
 
Polymixin Chlortetracycline Sw, C, P, Sh C, Sw, P, Sh, C, Sw, Sh, P 
 
Streptogramins Oxytetracycline Ca, D, C, Bees, P, Fi, Sh, 
Sw, H 
C, Sw, Sh, P, Fi, Bees C, Sw, Sh, P, H, 
Bees 
 
Tetracyclines Tetracycline 
hydrochloride 
D, C, Ca, P C, Sw, P, Sh - 
Doxycycline D D - 
Tiamulin Sw Sw - 
Sulfadiazine D, H D, Ca, H, Fi - 
 
Pleuromutilins Sulfadimethoxine Ca, D, C, P, H, Fi Fi, Ca, D - 
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Table 2.1. Continued 
Abbreviations: P, poultry; C, cattle; Ca, cat; D, dog; Fi, fish; Sw, swine; Sh, sheep; H, horse.
Antibiotic class Antibiotic USA Canada Australia 
Sulfonamides Sulfaguanidine - C, Sw, H, Sh, D, Ca - 
Sulfamethazine C, P, Sw, H C, Sw, Sh, H, Ca, D, G, P - 
Trimethoprim D, H C, Sw, Ca, D, Fi, H H 
Ormetoprim P, D, Fi Fi - 
 
Diaminopyrimidines Lasolocid sodium C, P, Sh C, P C 
Maduramicin P P - 
 
Ionophores Monensin P, C, G C, P C 
 Narasin P, Sw P, Sw C 
 Salinomycin sodium P P, C, Sw Sw, C 
 Arsanilic acid P, Sw P, Sw - 
 Bacitracin P, C, Sw Sw, P, Ca, D P 
 
Miscellaneous drugs Bambermycins P, Sw, C P Sw, P, C 
 
Bacitracins Olaquinodox - - Sw 
 
Bambermycins Carbadox Sw - - 
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Table 2.2. Ranking of antimicrobials by the World Health Organization (WHO) 
Classification Antimicrobial class Antimicrobial(s) Criteria 1a Criteria 2b 
Critically 
important 
Aminoglycosides Amikacin, arbekacin, bekanamycin, dibekacin, 
dihydrostreptomycin, gentamicin, isepamicin, 
kanamycin, neomycin, netilmicin, ribostamycin, 
sisomicin, streptoduocin, streptomycin, tobramycin 
(Veterinary use only: apramycin, framycetin) 
 
Yes Yes 
 Carbapenems and other 
penems 
Biapenem, doripenem, ertapenem, faropenem, imipenem, 
meropenem, panipenem 
 
Yes Yes 
 Cephalosporins, third and 
fourth generation 
Cefcapene, cefdinir, cefditoren, cefepime, cefetamet, 
cefixime, cefmenoxime, cefodizime, cefoperazone, 
cefoselis, cefotaxime, cefozopran, cefpiramide, 
cefpirome, cefpodoxime, cefsulodin, ceftraoline, 
ceftazidime, ceftizoxime, ceftobiprole, ceftibuten, 
ceftriazone, latamoxef (Veterinary use only: cefovecin, 
cefquinome, ceftiofur) 
 
Yes Yes 
 Cyclic esters Fosfomycin Yes Yes 
 
 Fluoro- and other 
quinolones 
Cinoxacin, ciprofloxacin, enoxacin, fleroxacin, 
flumequine, garenoxacin, gatifloxacin, gemifloxacin, 
grepafloxacin, levofloxacin, lomefloxacin, moxifloxacin, 
nalidixic acid, norfloxacin, ofloxacin, oxolinic acid, 
pazufloxacin, pefloxacin, pipemidic acid, piromidic acid, 
prulifloxacin, rosoxacin, rufloxacin, sitafloxacin, 
sparfloxacin, temafloxacin, trovafloxacin (Veterinary use 
only: danofloxacin, difloxacin, enrofloxacin, ibafloxacin, 
marbofloxacin, orbifloxacin) 
 
Yes Yes 
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Table 2.2. Continued 
Classification Antimicrobial class Antimicrobial(s) Criteria 1a Criteria 2b 
 Glycopeptides Dalbavancin, oritavancin, teicoplanin, telavancin, 
vancomycine (Veterinary use only: Avoparcin) 
 
Yes Yes 
 Glycylcyclines Tigecycline Yes Yes 
 
 Lipopeptides Daptomycin Yes Yes 
 
 Macrolides and ketolides Azithromycin, clarithromycin, erythromycin, 
dirithromycin, flurithromycin, josamycin, midecamycin, 
miocamycin, oleandomycin, rokitamycin, roxithromycin, 
spiramycin, telithromycin, trolandomycin (Veterinary 
use only: gamithromycin, kitasamycin, tildipirosin, 
tilmicosin, tulathromycin, tylosin, tylvalosin) 
 
Yes Yes 
 Monobactams Aztreonam, carumonam Yes Yes 
 
Oxazolidinones Linezolid Yes Yes 
 
 Penicillins, including 
natural penicillins, 
aminopenicillins, and 
antipseudomonals 
Amoxicillin, ampicillin, azidocillin, azlocillin, 
bacampicillin, carbenicillin, carindacillin, clometocillin, 
epicillin, hetacillin, metampicillin, meticillin, 
mexlocillin, penamecillin, penicillin G, penicillin V, 
pheneticillin, piperacillin, pivampicillin, propicillin, 
sulbenicillin, sultamicillin, talampicillin, temocillin, 
ticarcillin (Veterinary use only: penethamate 
hydroiodide) 
 
Yes Yes 
 Polymyxins Colistin and polymyxin B Yes Yes 
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Table 2.2. Continued	
Classification Antimicrobial class Antimicrobial(s) Criteria 1a Criteria 2b 
 Rifamycins Rifabutin, rifampicin, rifaximin, rifapentine, rifamycin Yes Yes 
 
 Drugs solely to treat 
tuberculosis or other 
mycobacterial diseases 
Calcium aminosalicylate, capreomycin, cycloserine, 
ethambutol, ethionamide, isoniazid, morinamide, para-
aminosalicyclic acid, protionamide, pyrazinamide, 
sodium aminosalicylate, terizidone, tiocarlide 
 
Yes Yes 
Highly important Amdinopenicillins Mecillinam, pivmecillinam No Yes 
 
 Amphenicols Chloramphenicol, thiamphenicol (Veterinary use only: 
florfenicol) 
 
No Yes 
 
 Cephalosporins (first and 
second generations) and 
cephamycins 
Cefaclor, cefacetrile, cefadroxil, cefaloridine, cefalexin, 
cefalotin, cefamandole, cefapirin, cefatrizine, 
cefazedone, cefazolin, cefbuperazone, cefmetazole, 
cefminox, cefonicid, ceforanide, cefotetan, cefotiam, 
cefoxitin, cefprozil, cefradine, cefroxadine, ceftezole, 
cefuroxime, flomoxef, loracarbef (Veterinary use only: 
cefalonium) 
 
No Yes 
 Lincosamides Clindamycin, lincomycin (Veterinary use only: 
pirlimycin) 
 
No Yes 
 Penicillins 
(Antistaphylococcal) 
Cloxacillin, dicloxacillin, flucloxacillin, oxacillin, 
nafcillin 
 
No Yes 
 Pleuromutilins Retapamulin No Yes 
 
 Pseudomonic acids Mupirocin No Yes 
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Table 2.2. Continued	
Classification Antimicrobial class Antimicrobial(s) Criteria 1a Criteria 2b 
 Riminofenazines Clofazimine Yes No 
 
 Steroid antibacterials Fusidic acid No Yes 
 
 Streptogramins Quinupristin-dalfopristin, pristinamycin (Veterinary use 
only: virginiamycin) 
 
No Yes 
 Sulfonamides, 
dihydrofolate reductase 
inhibitors, and 
combinations 
Brodimoprim, iclaprim, pyrimethamine, sulfadiazine, 
sulfadimethoxine, sulfadimidine, sulfafurazole, 
sulfaisodimidine, sulfalene, sulfamazone, sulfamerazine, 
sulfamethizole, sulfamethoxazole, 
sulfamthoxypyridazine, sulfametomidine, 
sulfametoxydiazine, sulfametrole, sulfamoxole, 
subtherapeutic, sulfaperin, sulfaphenazole, sulfapyridine, 
sulfathiazole, sulfathiourea, tetroxoprim, trimethoprim 
(Veterinary use only: ormosulfathiazole, 
phthalylsulfathiazole) 
 
No Yes 
 Sulfones Dapsone, aldesulfone Yes No 
 
 Tetracyclines Chlortetracyline, clomocycline, demeclocycline, 
doxycycline, lymecycline, metacycline, minocycline, 
penimepicycline, rolitetracycline, oxytetracycline, 
tetracycline 
 
Yes No 
Important Aminocyclitols Spectinomycin No No 
 
 Cyclic polypeptides Bacitracin No No 
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Table 2.2. Continued	
Classification Antimicrobial class Antimicrobial(s) Criteria 1a Criteria 2b 
 Nitrofurantoins Furazolidone, nitrofurantoin, nifurtoinol, nitrofural 
(Veterinary use only: furaltadone) 
 
No No 
 Nitroimidazoles Metronidazole, tinidazole, ornidazole No No 
 
Adapted from World Health Organization (2012a) 
aCriteria 1: antimicrobial sole therapy or one of few alternatives available to treat serious human disease 
bCriteria 2: antimicrobial used to treat diseases caused by organisms that may be transmitted via nonhuman sources or the diseases 
caused by organisms may acquire resistance genes from nonhuman sources 
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Table 2.3. Summary of surveillance programs and indicator bacteria in the USA, Canada and Europe 
Surveillance 
program 
Country Indicator bacteria Sample source Participants References 
NARMS USA Salmonella, Campylobacter, 
Shigella, Escherichia coli O157 
and Vibrio 
 
Human clinical 
isolates 
Centers for Disease 
Control and 
Prevention (CDC) 
Centers for 
Disease Control 
and Prevention, 
(2015). 
Salmonella, Campylobacter, 
Enterococcus and Escherichia coli 
Retail meat samples 
including chicken, 
ground turkey, ground 
beef and pork chops 
 
US Food and Drug 
Administration (FDA) 
Salmonella, Campylobacter, 
Enterococcus and Escherichia coli 
 
Food-producing 
animal specimens 
US Department of 
Agriculture (USDA) 
CIPARS Canada Salmonella Human isolates National 
Microbiology 
Laboratory (NML) 
 
Government of 
Canada, (2013). 
Salmonella, Campylobacter and 
Escherichia coli 
 
Animal and food 
samples 
Laboratory for 
Foodborne Zoonoses 
(LFZ) 
 
EFSA Europe Salmonella and Campylobacter 
spp. (mandatory), Escherichia coli 
and Enterococcus (voluntary) 
Isolates from humans, 
food of animal origin 
and food-producing 
animals 
26 European Union 
(EU) Member States 
European Food 
Safety Authority 
& European 
Centre for 
Disease 
Prevention and 
Control, (2013). 
 
Abbreviations: NARMS, National Antimicrobial Resistance Monitoring System for Enteric Bacteria; CIPARS, Canadian Integrated 
Program for Antimicrobial Resistance Surveillance; EFSA, European Food Safety Authority 
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Table 2.4. Mode of action of major antibiotic classes 
Mode of action Antibiotic class 
Inhibition of cell wall synthesis β-lactams (penicillins, cephaplosporins, carbapenems, 
monobactams); glycocpeptides; cyclic lipopeptides 
(daptomycin) 
  
Inhibition of protein synthesis Tetracyclines; aminoglycosides; oxazolidonones 
(linezolid); streptogramins (quinupristin-dalfopristin); 
ketolides; macrolides; lincosamides 
  
Inhibition of DNA synthesis Fluroquinolones 
  
Inhibition of RNA synthesis Rifampin 
  
Competitive inhibition of folic acid 
synthesis inhibition 
Sulfonamides; trimethoprim 
  
Membrane disorganising agents Polymyxins (Polymixin-B, Colistin) 
  
Other Metronidazole 
 
Adapted from Alanis et al. (2005) and Levy and Marshall (2004)
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Table 2.5. MLSB resistance genes identified in Enterococcus spp. 
Resistance mechanism Resistance genes 
rRNA methylases erm(A) 
erm(B) 
ermI 
erm(F) 
erm(T) 
  
Efflux genes msr(A) 
msrI 
msr(D) 
lsa(A) 
lsa(E) 
vga(B) 
vga(D) 
mef(A) 
  
Inactivating genes 
 
 
Lysases vgb(A) 
 
Transferases lnu(B) 
vat(B) 
vat(D) 
vat(E) 
vat(H) 
 
Adapted from Roberts (2008); Werner et al. (2013); 
http://faculty.washington.edu/marilynr/ermweb4.pdf 
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Table 2.6. In vitro transfer of resistance genes in Enterococcus spp. 
Donor Recipient Transferred genes Reference 
E. faecalis (food of animal origin) E. faecalis HLGR Sparo et al., 2011a 
 
E. faecalis S. aureus vanA De Niederhausern et al., 
2011 
 
E. faecium L. monocytogenes vanA De Niederhausern et al., 
2011 
 
E. hirae E. faecalis vanA Robredo et al., 1999 
 
E. faecalis E. faecalis tet(M) and tet(L) Hummel et al., 2007 
 
E. faecalis E. faecalis, Lactoccus lactis 
and Listeria innocua 
pRE25 – KM, NE, STR, CM, LI, 
AZ, CH, EM, RO, TYL, CL, NU 
 
Schwarz et al., 2001 
E. faecalis E. faecalis and E. faecium 70-kb plasmid – vat(E) – 
streptogramin 
 
Simjee et al., 2002 
E. faecium and E. durans (pig) E. faecium vanA and erm(B) Vignaroli et al., 2011a 
 
Lactobacillus spp.  E. faecalis tet(M) Gevers et al., 2003 
 
Abbreviations: HLRG, high-level gentamicin resistance; KM, kanamycin; NE, neomycin; STR, streptomycin; CM, clindamycin; LI, 
lincomycin; AZ, azithromycin; CH, clarithromycin; RO, roxithromycin; TYL, tylosin; CL, chloramphenicol; NU, nourseothricin 
sulphate 
atransfer of resistance genes between animal and human strains 
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Table 2.7. Transfer of resistance genes in Enterococcus spp. using in vivo models 
Donor Recipient Model Transferred genes Reference 
E. faecium (pig) E. faecium Germfree C3H mice tet(M), vanA, 
erm(B) 
Moubareck et al., 
2003a 
 
E. faecalis E. faecalis Streptomycin-treated mini-pigs pCF10 [tet(M)] Licht et al., 2002 
 
L. plantarum E. faecalis Gnotobiotic rats tet(M), erm(B) Jacobsen et al., 2007 
 
E. faecalis E. faecalis Ceftriazxone-treated BALB/c 
mice 
 
HLGR Sparo et al., 2011 
E. faecium (chicken) E. faecium (HA) Cefuroxime-treated NMRI mice vanA Lester and 
Hammerum, 2010a 
 
E. faecium (poultry or pig) E. faecium Germ-free NMRI mice vanA, vanB Dahl et al., 2007a 
 
E. faecium L. monocytogenes Germ-free C3H mice Tn1545 Doucet-Populaire et 
al., 1991 
 
E. faecium (poultry) E. faecalis Germ-free C3H mice vanA Bourgeois-Nicolaos et 
al., 2006a 
 
Abbreviations: HLGR, high-level gentamicin resistance; HA, hospital acquired 
atransfer of resistance genes between animal and human strains
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Chapter 3 – Objectives 
This thesis aims to provide insight on the contribution of the beef feedlot industry to 
antibiotic resistance, with a focus on macrolide resistance and using enterococci as an indicator 
bacterium.  
The objective of the first study was to use real-time, quantitative PCR to determine the 
resistance gene profile of Canadian beef feedlots by quantifying resistance genes across five 
antibiotic classes (sulfonamides, tetracyclines, macrolides, fluoroquinolones and β-lactams) and 
comparing this to resistance genes found in catch basins, a surrounding waterway and urban 
wastewater treatment plants.  
The objective of study two was to examine the effect of in-feed administration and 
withdrawal of tylosin phosphate on the prevalence of macrolide resistant enterococci isolated 
from feedlot steers, and to characterise the enterococci recovered through species identification, 
antimicrobial susceptibility testing, identification of resistance determinants and pulsed-field gel 
electrophoresis (PFGE) profiling.  
The objective of study three was to announce the submission of the first draft genome 
sequence of Enterococcus thailandicus isolated from the faeces of feedlot cattle in Southern 
Alberta. A summary of the genome was provided to highlight key findings of this newly 
sequenced genome.  
The objective of the fourth and final study was to perform whole-genome sequencing on 
twenty-one isolates of Enterococcus spp. isolated from bovine faeces and to perform a 
comparative genomic analysis. 
	
	
89	
Chapter 4 
 
 
Antimicrobial resistance genes within feedlots and urban wastewater1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1This chapter has been submitted and is under review: Beukers, A.G., Zaheer, R., Cook, S.R., 
Chaves, A.V., Ward, M.P., Tymensen, L., Morley, P.S., Hannon, S., Booker, C.W., Read, 
R.R., and McAllister, T.A. Antimicrobial resistance genes within feedlots and urban 
wastewater. PLoS One. (Submitted). 
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4.1. Abstract 
The use of antibiotics in livestock production in North America and possible association with 
elevated abundance of detectable antimicrobial resistance genes (ARGs) is a growing concern. 
Real-time, quantitative PCR (qPCR) was used to determine the relative abundance and diversity 
of ARGs in faecal and catch basin samples from four beef feedlots in Alberta. Samples from a 
surrounding waterway and municipal wastewater treatment plants were also included to compare 
the ARG profile of urban environments and fresh water with that of feedlots. The relative 
abundance of eighteen resistance genes across five antibiotic families including sulfonamides, 
tetracyclines, macrolides, fluoroquinolones and β-lactams were examined. Sulfonamide, 
fluoroquinolone and β-lactam resistance genes predominated in human samples, while 
tetracycline resistance genes predominated in cattle faecal samples. These differences appear to 
reflect differences in antibiotic use in cattle versus humans however other factors such as co-
selection of ARGs and differences in bacterial community diversity and distribution may also 
play a role. Antibiotic resistance is a complex issue with multiple factors influencing the 
selection and persistence of ARGs. 
 
Key words: antibiotic resistance, cattle, wastewater, quantitative real-time PCR, Alberta 
 
4.2. Introduction 
The acquisition of antimicrobial resistance genes (ARGs) by bacterial pathogens is a 
serious concern that can impede the successful treatment of infectious diseases (Centers for 
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Disease Control and Prevention, 2013). Antibiotics used in livestock production are often 
analogues or the same as those used in human medicine, raising the possibility that genes 
conferring resistance arise within agricultural production systems. Consequently, ARGs entering 
the environment through runoff or via the food chain could be transferred to pathogenic bacteria 
reducing the effectiveness of antibiotics currently used for human medicine.  
Canada is one of the largest beef-exporting nations in the world, with the industry 
contributing more than $20 billion each year to the Canadian economy (Canada Beef, 2012). A 
number of antimicrobials are approved for administration to cattle as feed additives or in 
drinking water, including aminoglycosides, macrolides, tetracyclines and sulfonamides 
(Silbergel et al., 2008). Commensal bacteria residing in the bovine gastrointestinal tract may 
become resistant to these antibiotics and once disseminated into the environment, transfer these 
genes to pathogenic bacteria (Andremont 2003; Harrison et al., 2013; Marshall et al., 2009). 
Furthermore, residual antibiotics may enter the environment through runoff or application of 
manure to land, exposing bacteria in these environments to antibiotics and possibly applying 
selective pressure for resistance development (Campagnolo et al., 2002; Heuer et al., 2011).  
Real-time, quantitative PCR (qPCR) has been used to study the levels of ARGs in 
livestock and poultry systems (He et al., 2014; Mu et al., 2014; Zhu et al., 2013) and in 
wastewater from urban environments (Marti et al., 2013; Negreanu et al., 2012). It is a useful 
tool that can provide an approximation of the abundance of ARGs in the environment 
(Berendonk et al., 2015). The objective of this study was to use qPCR to compare the types and 
relative abundance of ARGs present in feedlot cattle faeces to those in feedlot catch basins, a 
surrounding waterway and municipal wastewater treatment plants in Alberta. 
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4.3. Materials and Methods 
4.3.1. Study area and sample collection 
Sample collection occurred from April to October 2014. Four beef feedlots (designated A 
to D) and two municipal (human) wastewater treatment plants located in Alberta were selected 
for this study (Appendix 1 Table S4.1.). Antibiotic usage in all feedlots was recorded (Appendix 
1 Table S4.2.). In feedlots A, B and C, conventional production pens associated with the catch 
basins of interest at each feedlot were identified and 20 pens in each feedlot were randomly 
selected. At Feedlot D, pens were stratified by production type with 15 Conventional pens (Dc) 
and 5 Natural pens (Dn) randomly selected. Conventional pens contained cattle routinely 
administered antibiotics while natural pens contained cattle that were not receiving any 
antibiotics. Twenty fresh faecal pats were sampled from each pen and composited to provide one 
faecal sample per pen per feedlot. Three composite samples were then arbitrarily chosen from 
each feedlot (or within each production strata for feedlot D) for real-time qPCR. After collection, 
faecal samples were transported to the lab on ice, flash-frozen in liquid nitrogen within 24 h and 
stored at -80°C for DNA extraction. The research study was reviewed and approved by the 
Lethbridge Research Centre Animal Care Committee, an evaluation body that is accredited by 
the Canadian Council of Animal Care. 
Catch basins, which received runoff from the cattle pens, were also sampled once at each 
feedlot. Sewage influent and effluent samples were collected from wastewater treatment plants 
located at two different municipal centres. Surface water was collected from an ephemeral creek 
that was adjacent to feedlot C, which drains land that receives regular manure application. Based 
on turbidity, catch basin, sewage treatment and surface water samples were processed by 
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centrifugation (30 mL for catch basin and 80 mL for sewage influent; 15,500 × g) or filtration 
(sewage effluent and surface water) through a 0.45 µm nitrocellulose filter membrane (until the 
filter was saturated) within 24 h of collection. The filter membrane or pellet from centrifugation 
was stored at -80°C for later DNA extraction. 
 
4.3.2. DNA extraction 
Total DNA was extracted from individual water samples (pellet or filter) and faecal 
composite samples (approximately 350 mg). Each 100 mg of sample was resuspended in 300 µL 
of resuspension buffer [600 mM NaCl, 120 mM Tris-HCl, 60 mM EDTA, 200 mM Guanidine 
isothyocynate] or 800 µL for filter samples. Aliquots (1 mL) of the resuspended faecal sample or 
pellet were transferred to 2 mL microfuge tubes containing 0.4 g of sterile zirconia beads (0.3 g 
of 0.1 mm and 0.1 g of 0.5 mm). For filtered samples, beads were added directly to the vial 
containing the filter paper. β-Mercaptoethanol (5 µL) and 200 µL pre-heated (70°C) 10% sodium 
lauryl sulfate (SDS) were sequentially added to the tubes and gently mixed. Cell lysis was 
carried out for 3 min at maximum speed (setting=30) using a Qiagen TissueLyser (Germantown, 
MD, USA) or for filter samples using an Omni Bead Ruptor (3.25 m/s for 5 min; Omni 
International, Kennesaw, GA, USA). Samples were then incubated at 70°C for 15 min, with 
gentle shaking. The filter paper was removed and all samples were centrifuged at 4°C for 5 min 
at 16,000 × g, with the supernatant transferred to a new 2 mL microfuge tube. The pellet was 
resuspended in 800 µL of resuspension buffer and the bead-beating process repeated. Duplicate 
lysates were subject to isopropanol precipitation of nucleic acid and the pellet was resuspended 
in 100 µL Tris-EDTA, pH 7.4 (TE). Nucleic acids in TE were pretreated with 2 µL of Dnase-free 
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Rnase (10 mg/mL) per 200 µL of sample and incubated at 37°C for 15 min. The resulting DNA 
was further purified using a QIAamp DNA Stool Mini Kit (Qiagen) with inclusion of proteinase 
K (Kit handbook), and the final elution accomplished using nuclease-free water. Extracted DNA 
was assessed for PCR inhibitors using 16S primers (Appendix 1 Table S4.3.) and where 
inhibition was indicated by the absence or low yield of a PCR product, an additional sepharose 
purification step was undertaken as described by Miller et al. (2001) using sepharose 2B resin. 
Purity of the DNA was determined using a NanoDrop 2000 spectrophotometer (Thermo 
Scientific, Waltham, MA, USA) to ensure that the 260/280 absorbance ratio was approximately 
1.8 and the DNA was quantified using the Quant-iT PicoGreen dsDNA Assay Kit with a 
Nanodrop 3300 fluorospectrometer (Thermo Scientific).   
 
4.3.3. Quantification of antimicrobial resistance genes 
Real-time, quantitative PCR (qPCR) was used to estimate the copy numbers of 18 
resistance genes across five antibiotic families including sulfonamides [sul1 and sul2], 
tetracyclines [tet(A), tet(B), tet(M), tet(O), tet(Q) and tet(W)], macrolides [erm(A), erm(B), 
erm(C), erm(F) and mef(A)], fluoroquinolones [qnrS and oqxB] and β-lactams [blaSHV, blaTEM1 
and blaCTX-M]. Primers for the 16S-ribosomal RNA (rRNA) gene were also included to estimate 
the total amount of bacteria associated with each sample and to normalise the abundance of 
ARGs in collected samples. All qPCR assays were performed on an Applied Biosystems 7500 
Fast Real-Time PCR System (Applied Biosystems, Foster City, CA, USA) using primers and 
conditions as described in Appendix 1 Table S4.3. For primers that were not from published 
information, available sequences encoding each respective antibiotic resistance gene were 
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downloaded from the GenBank Database (http://www.ncbi.nlm.nih.gov/) and aligned in 
Geneious (version 8.1.) to determine a consensus sequence that could be used for primer design. 
Using the primer design tool, forward and reverse primers that would anneal to regions of the 
consensus sequence were identified and the specificity of each primer pair verified using the 
BLAST alignment tool (http://www.ncbi.nlm.nih.gov/blast/).  
Each reaction was carried out in a total volume of 25 µL, containing 2 µL of template, 
0.2 µM of each primer and 1 × iQ SYBR Green Supermix (Bio-Rad, Saint-Laurent, QC, 
Canada). All qPCR reactions included an initial step of 95°C for 3 min, followed by the 
respective number of cycles, with denaturation at 95°C for 15 s, annealing at the respective 
temperature for 30 s, and an extension at 72°C for 30 s, except blaTEM1 which was extended for 
40 s. Melt curve (55 to 95°C) analysis was performed to verify the uniformity of the amplicons.    
Standard curves generated using known quantities of cloned or synthesised target genes 
were used to quantify gene copy numbers. Standards for tet(A), qnrS, oqxB and blaSHV were 
synthesised by Eurofins Scientific (Lancaster, PA) whilst tet(W), blaTEM1 and blaCTX-M were 
synthesised by Integrated DNA Technologies (San Diego, CA). The remaining standards were 
cloned in our laboratory and the presence of the target gene was verified by sequencing. 
Dilutions of cloned target genes at concentrations 108,107, 106, 105, 104, 103, 100 and 50 copies 
per reaction were amplified in duplicate to generate standard curves for each qPCR assay. All 
qPCR reactions were performed in triplicate for DNA samples with raw values averaged.  
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4.3.4. Statistical analysis 
For each resistance gene, averaged raw values for each DNA sample were normalised by 
dividing each by 16S-rRNA values, providing the relative abundance (copies of ARGs/copies of 
16S-rRNA). Using the Shapiro-Wilk test, it was determined that a natural log (ln) transformation 
on normalised data was required to achieve normal distribution. Statistical analyses were 
performed using SAS version 2.0.4 (SAS Institute Inc., Cary, NC). Natural log (ln) transformed 
data were analysed using the MIXED procedure of SAS with feedlot considered as a random 
effect. The model consisted of sample type (feedlot=A, B, C, DC, DN, catch basin=CB, sewage 
influent=Influent, sewage effluent=Effluent and creek=Ephemeral creek) as a fixed effect and 
the relative abundance of each ARG (ln transformed) as the dependant variable. The LSMEANS 
statement was used to separate means with statistical significance declared at a p-value ≤ 0.05. 
Samples that were unable to be detected/outside the standard curve range were arbitrarily 
assigned a value of zero for statistical analysis. The means and standard deviation of means of 
untransformed normalised data were used for figures. 
 
4.4. Results 
Antibiotics from the tetracycline, macrolide, phenicol, cephalosporin, fluoroquinolone 
and sulfonamide families as well as ionophores were used at feedlots A, B, C and DC (Appendix 
1 Table S4.2.). Antimicrobials administered to study animals were approved for use in cattle in 
Canada by the Veterinary Drugs Directorate, Health Canada and used under veterinary 
prescription issued by a licensed veterinarian with a valid veterinary-client-patient relationship. 
At the time of sampling, the majority of cattle from all feedlots were receiving chlortetracycline 
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for the control of liver abscesses and monensin for the control of bloat and coccidiosis. 
Sulfonamides were not being administered at the time of sampling, but parenteral or oral bolus 
sulfonamides had been administered to clinically ill cattle at all feedlots in the past. Tylosin, a 
commonly used macrolide, was only being administered in one pen of cattle from feedlot DC for 
the control of liver abscesses. 
Among the 18 target resistance genes, all genes with the exception of those associated 
with fluoroquinolone (qnrS and oqxB) and β-lactam resistance (blaSHV and blaCTX-M) were 
detected in faecal and catch basin water samples. Both the sewage influent and effluent samples 
possessed all genes except erm(A) and blaSHV, which code for macrolide and β-lactam resistance, 
respectively. Only eight (sul1, sul2, tet(O), tet(Q), tet(W), erm(C), mef(A) and blaTEM1) of the 
eighteen resistance genes were detected in water from the creek.  
The relative abundance of sul1 and sul2 differed (P < 0.0001) among sample types, but 
were similar in faecal samples collected from the four feedlots (Figure 4.1.). The relative 
abundance of both sul1 and sul2 was greater (P < 0.05) in the catch basin and the sewage 
samples compared to the faecal and creek samples. There was no difference (P > 0.05) between 
the conventional and natural production systems for either sul1 or sul2. Error bars for the catch 
basin sample for both sul1 and sul2 were large, indicating variability among individual samples.  
The relative abundance of tet genes also differed among sample types (P < 0.001), except 
tet(A) and tet(B) (P = 0.5 and P = 0.1, respectively) (Figure 4.2.). Sewage influent and effluent 
samples were both lower (P < 0.05) in relative abundance for tet(M) than faecal and catch basin 
samples, but did not differ from each other (P > 0.05). For tet(O), tet(Q) and tet(W), the catch 
basin, sewage influent, sewage effluent and creek samples were all lower (P < 0.05) in relative
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Figure 4.1. Relative abundance (copies of ARGs/copies of 16S-rRNA) of sulfonamide resistance 
genes. (a) sul1 and (b) sul2. Error bars represent standard deviation of the means. A = feedlot A, 
B = feedlot B, C = feedlot C, DC = feedlot D (conventional production), DN = feedlot D (natural 
production), CB = catch basin, Influent = sewage influent, Effluent = sewage effluent, and Creek 
= Ephemeral creek. Means with different letters significantly differ (P ≤ 0.05). 
abundance than the faecal samples. The sewage influent did not differ (P > 0.05) in the relative 
abundance of tet(Q) and tet(W) from the catch basin sample, but were greater (P < 0.05) in 
relative abundance of tet(O). All three tet genes in sewage influent samples were greater (P < 
0.05) in relative abundance than in sewage effluent and creek samples. The creek sample was
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Figure 4.2. Relative abundance (copies of ARGs/copies of 16S-rRNA) of tetracycline resistance 
genes. (a) tet(A), (b) tet(B), (c) tet(M), (d) tet(O), (e) tet(Q) and (f) tet(W). Error bars represent 
standard deviation of the means. A = feedlot A, B = feedlot B, C = feedlot C, DC = feedlot D 
(conventional production), DN = feedlot D (natural production), CB = catch basin, Influent = 
sewage influent, Effluent = sewage effluent, and Creek = Ephemeral creek. Means with different 
letters significantly differ (P ≤ 0.05). w - unable to be detected/outside standard curve range. 
lower (P < 0.05) in relative abundance of tet(O), tet(Q) and tet(W) than samples from all other 
environments. There was no difference (P > 0.05) between faecal samples collected from cattle 
raised in conventional versus natural production systems for tet(M), tet(Q) and tet(W). However, 
faecal samples from the conventional system had greater (P < 0.05) relative abundance of tet(O) 
than the natural system.  
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There was no difference (P > 0.05) in the relative abundance of macrolide resistance 
genes in faecal samples collected from conventional versus natural production systems (Figure 
4.3.). The relative abundance of erm(B) was greater (P < 0.05) in catch basin samples than the 
faecal samples, whereas mef(A) was lower (P < 0.05). The relative abundance of erm(B) was 
greater (P < 0.05) in the sewage influent sample than in faecal, catch basin or sewage effluent 
samples. The relative abundance of mef(A) in the catch basin, sewage influent and effluent and 
creek samples were all lower (P < 0.05) than faecal samples. 
Figure 4.3. Relative abundance (copies of ARGs/copies of 16S-rRNA) of macrolide resistance 
genes. (a) erm(A), (b) erm(B), (c) erm(C), (d) erm(F) and (e) mef(A). Error bars represent 
standard deviation of the means. A = feedlot A, B = feedlot B, C = feedlot C, DC = feedlot D 
(conventional production), DN = feedlot D (natural production), CB = catch basin, Influent = 
sewage influent, Effluent = sewage effluent, and Creek = Ephemeral creek. Means with different 
letters significantly differ (P ≤ 0.05). w - unable to be detected/outside standard curve range. 
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The fluoroquinolone resistance genes (qnrS and oqxB) were only detected in the sewage 
samples (Figure 4.4.). Comparison of the relative gene abundances indicated that there was no 
difference (P = 0.2) for qnrS whilst oqxB was greater (P < 0.05) in relative abundance for 
influent than effluent sewage samples.  
Figure 4.4. Relative abundance (copies of ARGs/copies of 16S-rRNA) of fluoroquinolone 
resistance genes. (a) qnrS and (b) oqxB. Error bars represent standard deviation of the means. A 
= feedlot A, B = feedlot B, C = feedlot C, DC = feedlot D (conventional production), DN = 
feedlot D (natural production), CB = catch basin, Influent = sewage influent, Effluent = sewage 
effluent, and Creek = Ephemeral creek. Means with different letters significantly differ (P ≤ 
0.05). w - unable to be detected/outside standard curve range. 
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The β-lactam resistance gene blaSHV was detected in both sewage influent and effluent 
samples, but the copy number was below the range of the standard curve for effluent samples 
and as a result not included in our analysis. Of the bla genes, blaCTX-M was the only one detected 
in the sewage treatment samples with no difference (P = 0.1) observed between influent and 
effluent samples, whereas blaTEM1 was detected in all samples (Figure 4.5.). Among sample 
types, the relative abundance of blaTEM1 was greater (P < 0.05) in sewage influent than in faecal, 
catch basin or creek samples, but did not differ (P > 0.05) from the sewage effluent sample.  
 
4.5. Discussion 
Real-time, quantitative PCR has been used to examine the abundance and distribution of 
ARGs in beef cattle faeces (Alexander et al., 2011; Yu et al., 2005), feedlot wastewater lagoons 
(McKinney et al. 2010; Peak et al. 2007; Zhang et al. 2009), urban wastewater (Gao et al., 2012; 
Lachmayr et al., 2009) and fresh water samples from a flowing river (Pei et al., 2006). Most of 
these studies have focused on one or two antibiotic families or on one type of environmental 
source. In contrast, this study aimed to examine the abundance and distribution of ARGs across 
five antibiotic families and over a range of environments including from beef cattle faeces, water 
catch basins at feedlots, municipal sewage samples and surface water from a creek, all collected 
within the same temporal period.  
There were obvious differences in the relative abundance of ARGs among sample types, 
with some ARGs clearly predominant in certain environments. For example, the fluoroquinolone 
and β-lactam resistance genes were abundant in the human sewage treatment samples and the 
tetracycline resistance genes were abundant in the cattle faecal samples. 
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Figure 4.5. Relative abundance (copies of ARGs/copies of 16S-rRNA) of β-lactam resistance 
genes. (a) blaSHV, (b) blaCTX-M and (c) blaTEM1. Error bars represent standard deviation of the 
means. A = feedlot A, B = feedlot B, C = feedlot C, DC = feedlot D (conventional production), 
DN = feedlot D (natural production), CB = catch basin, Influent = sewage influent, Effluent = 
sewage effluent, and Creek = Ephemeral creek. Means with different letters significantly differ 
(P ≤ 0.05). w - unable to be detected/outside standard curve range. 
Studies have demonstrated that administration of antibiotics can increase the abundance 
of ARGs, including in beef cattle faeces (Alexander et al., 2008; Alexander et al., 2011; Peak et 
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al., 2007). Consequently, antibiotic use in humans and in livestock production could play a role 
in the abundance and distribution of ARGs among environments. An aspect of this study was the 
collection of data related to antibiotic use from the feedlots sampled (Appendix 1 Table S4.2.). 
As such, inferences between the use of antibiotics in the feedlot environment and the distribution 
and abundance of ARGs could be made.   
Sulfonamides were not being administered to cattle at feedlots A, B, C and D at the time 
of sampling, but they had been used to treat clinically ill cattle at all feedlots in the past 
(Appendix 1 Table S4.2.). Compared to other antibiotics used in feedlots, sulfonamides are more 
hydrophilic and this property combined with their low sorption to soil makes them among the 
most mobile of antibiotics (Chee-Sanford et al., 2009). Therefore, it is possible that sulfonamides 
flowed from the feedlot and accumulated within the catch basin. This would provide selective 
pressure for sulfonamide resistance and may explain the greater relative abundance of the sul 
genes in catch basin samples as compared to faecal samples, where limited use would have led to 
low selective pressure. The relative stability of sulfonamides in water may also explain the 
greater relative abundance of these genes in the sewage treatment samples as sulfonamides are 
excreted in the urine and faeces of humans and enter the environment through sewage (Yang et 
al., 2005). Testing samples for sulfonamide residues would help elucidate if this is the case. The 
relative abundance of sul genes was low in the creek sample suggesting that despite its close 
proximity to one of the feedlots, residual sulfonamides were contained within the catch basin and 
were not being transferred to the broader environment.  
A large proportion of tetracycline resistance genes encode for efflux proteins which 
export tetracycline out of bacterial cells and are the most common tet genes found in Gram-
negative bacteria (Roberts, 2005). In this study, the tetracycline resistance genes encoding for 
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efflux proteins (tet(A) and tet(B)) were present in all environments at similar levels, with the 
exception of the creek sample where tet(A) and tet(B) were not detected. In contrast, the genes 
encoding for ribosomal protection proteins (tet(M), tet(O), tet(Q) and tet(W)) were dominant in 
the faecal samples as compared to other sample types. In general, the relative abundance of 
ribosomal protection proteins was also much greater (3 orders of magnitude) compared to the 
genes encoding for efflux proteins. The ribosomal protection proteins are predominantly found in 
Gram-positive bacteria which account for the majority of bacteria found in bovine faeces 
(Roberts 2005; Shanks et al., 2011), possibly explaining the greater relative abundance of these 
genes. 
Tetracyclines are usually fed at low concentrations to feedlot cattle for the control of liver 
abscesses and other bacterial diseases. All conventional feedlots sampled in this study used 
chlortetracycline in their production practices (Appendix 1 Table S4.2.) and at the time of 
sampling, most cattle were being administered chlortetracycline in their diet. This could account 
for the greater relative abundance of tet genes in faecal composite samples, as administration of 
tetracycline increases the abundance of tet genes in cattle faeces (Alexander et al., 2011). There 
was no difference between conventional and natural production systems for tet(M), tet(Q) and 
tet(W). However, tet(O) was more predominant in faeces collected from the conventional as 
compared to the natural production system, suggesting that in-feed chlortetracycline may 
preferentially select for certain tet genes. Tetracycline resistance genes in DNA isolated from the 
catch basin, sewage and creek samples were in low relative abundance compared to faecal 
samples. Tetracyclines have a high sorption to soil compared to other antibiotics making them 
less mobile (Chee-Sanford et al., 2009) and less likely to be transported in water runoff into the 
catch basin or nearby waterways. Their lower mobility in water could also account for the lower 
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presence of tet genes in urban wastewater. Consequently, selection pressure in the catch basin, 
sewage treatment and creek samples for tetracycline resistance would be lower and may explain 
the lower tet abundance in these environments.   
Ribosomal methylation is the most widespread mechanism of macrolide resistance and is 
encoded for by the erm genes, erm(A), erm(B), erm(C) and erm(F). Drug efflux is another 
common resistance mechanism, encoded for by mef(A) (Leclercq, 2002). Of the macrolide 
resistance genes assessed, differences were observed among samples for all genes, with the 
exception of erm(F). The genes conferring resistance to macrolides are mostly associated with 
Gram-positive bacteria, with the host range varying among genes (Roberts, 2004). The nature of 
the bacterial microbiome within samples is likely to influence both the density and types of 
resistance determinants present, factors that may explain why the abundance of erm(A) and 
erm(C) is much lower than erm(B) and mef(A) even though all determinants code for macrolide 
resistance. As with tetracycline, administration of macrolides to cattle has also been 
demonstrated to increase the abundance of macrolide resistance genes in cattle faeces (Alexander 
et al., 2011). While macrolides (tylosin, tulathromycin and tilmicosin) were used at all 
conventional feedlots, only one out of the three conventional pens sampled from feedlot D were 
being administered macrolides at the time of sampling. This may explain why no difference was 
observed in the relative abundance of macrolide resistance genes in cattle faeces collected from 
conventional versus natural production systems for erm(A), erm(B) and mef(A).  
The macrolide resistance gene mef(A) was the dominant gene within faecal samples. Its 
greater relative abundance in cattle faeces could be due to its common presence in enteric 
bacteria (Roberts, 2004) or a reflection of its co-selection along with other ARGs. Many 
tetracycline resistance genes can be linked with macrolide resistance genes on mobile genetic 
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elements, resulting in co-selection. For example, erm(F) is often linked with tet(Q) on a 
conjugative transposon described in Bacteroides spp. (Chung et al., 1999), erm(B) with tet(M) 
on the Tn1545 conjugative transposon described in Enterococcus spp. (De Leener et al., 2004) 
and mef(A) with tet(O) on a conjugative transposon described in Streptococcus pyogenes 
(Giovanetti et al., 2003). The erm(B) gene was more abundant in sewage influent than in other 
samples. This gene has been identified in a number of bacterial species, including Enterococcus 
and Escherichia (Roberts et al., 1999). Macrolides, such as erythromycin, are extensively used in 
human medicine (World Health Organization 2012) and may be influencing the relative 
abundance of erm(B) in the sewage influent sample. As observed with previous ARGs, the 
relative abundance of macrolide resistance genes was low in the creek sample. 
The fluoroquinolone resistant genes qnrS and oqxB were only detected in the sewage 
influent and effluent treatment samples, which may reflect the use of fluoroquinolones in human 
medicine. There was a noticeable decrease in the relative abundance of oqxB when comparing 
sewage influent to effluent. The sewage treatment process has been shown to reduce the number 
of bacteria resistant to tetracycline and sulfonamides, although numbers of resistant bacteria in 
the effluent still remained high (Gao et al., 2012). In this study, it appears the sewage treatment 
process resulted in a decline in fluoroquinolone resistant bacteria, as indicated by a reduction of 
resistance genes detected. However, the fact that fluoroquinolone resistance genes were detected 
in the effluent sample even after sewage treatment indicates that these resistance genes still 
entered the environment. The fluoroquinolone genes assessed in this study are predominantly 
plasmid-mediated suggesting they could easily be transferred to other bacteria (Hata et al., 2005; 
Hansen et al., 2007; Norman et al., 2008). Similar to the fluoroquinolone resistance genes, the β-
lactamase resistance genes were predominantly found in sewage samples. The blaTEM1 resistance 
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gene, which confers resistance to ampicillin, penicillin and first-generation cephalosporins (Rupp 
and Fey, 2003), was primarily detected in sewage samples, but low levels were also detected in 
the faecal and catch basin samples. Our results support those of Agga et al. (2015) describing a 
greater abundance of fluoroquinolone and β-lactamase resistance genes in sewage treatment 
samples compared to cattle faecal samples. The association between fluoroquinolone and β-
lactamase resistance genes, in particular qnrS and blaTEM1 could possibly indicate co-selection of 
these ARGs in sewage samples (Hata et al., 2005).  
Although the relative abundance of ARGs can be influenced by the use of antibiotics, 
there is a growing body of literature highlighting the relationship between antibiotic use and 
ARGs is complex and not necessarily linear. Jindal et al. (2006) demonstrated a high level of 
tylosin resistance persisted on swine farms years after antimicrobial use ceased. ARGs can also 
be detected in pristine environments not exposed to antibiotics and where the corresponding 
antibiotic residues are absent (D’Costa et al., 2011; Durso et al., 2012). Furthermore, the 
abundance of ARGs can be influenced by the bacterial community composition with ARGs more 
common in some bacterial species than in others. For example, the macrolide resistance genes 
erm(A) and erm(C) are typically associated with staphylococci whilst erm(B) is mostly found in 
streptococci and enterococci (Leclercq, 2002; Roberts et al., 1999). Other studies have also 
demonstrated links between the ARG profile and the bacterial taxonomic profile (Durso et al., 
2012; Forsberg et al., 2014). Bacterial composition and diversity amongst sample types was not 
examined in this study but it is likely to have influenced the distribution and abundance of 
ARGs. 
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4.6. Conclusion 
The results from this study demonstrate clear differences in the relative abundance of 
ARGs among feedlot and human related samples. Although samples were only collected at one 
point in time, it is clear that sulfonamide, fluoroquinolone and β-lactam resistance genes 
predominate in urban wastewater, whilst tetracycline resistance genes were more prevalent in 
cattle faeces. These differences appear to reflect differences in antibiotic use in cattle versus 
humans, however other factors such as co-selection of ARGs and differences in bacterial 
community diversity and distribution may also be playing a role. In conclusion, antibiotic 
resistance is a complex issue with multiple factors influencing the selection and persistence of 
ARGs.  
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Chapter 5 
 
 
Effect of in-feed administration and withdrawal of tylosin phosphate on 
antibiotic resistance in enterococci isolated from feedlot steers2 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
2This chapter was published in full: Beukers, A.G., Zaheer, R., Cook, S.R., Stanford, K., Chaves, 
A.V., Ward, M.P., and McAllister, T.A. (2015). Effect of in-feed administration and 
withdrawal of tylosin phosphate on antibiotic resistance in enterococci isolated from 
feedlot steers. Front. Microbiol. 6:483. 
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5.1. Abstract 
Tylosin phosphate is a macrolide commonly administered to cattle in North America for the 
control of liver abscesses. This study investigated the effect of in-feed administration of tylosin 
phosphate to cattle at subtherapeutic levels and its subsequent withdrawal on macrolide 
resistance using enterococci as an indicator bacterium. Faecal samples were collected from steers 
that received no antibiotics and steers administered tylosin phosphate (11 ppm) in-feed for 197 d 
and withdrawn 28 d before slaughter. Enterococcus species isolated from faecal samples were 
identified through sequencing the groES-EL intergenic spacer region and subject to antimicrobial 
susceptibility testing, identification of resistance determinants and pulsed-field gel 
electrophoresis profiling. Tylosin increased (P < 0.05) the proportion of eryR and tylR 
enterococci within the population. Just prior to its removal, the proportion of eryR and tylR 
resistant enterococci began decreasing and continued to decrease after tylosin was withdrawn 
from the diet until there was no difference (P > 0.05) between treatments on d 225. This suggests 
that antibiotic withdrawal prior to slaughter contributes to a reduction in the proportion of 
macrolide resistant enterococci entering the food chain. Among the 504 enterococci isolates 
characterised, Enterococcus hirae was found to predominate (n=431), followed by Enterococcus 
villorum (n=32), Enterococcus faecium (n=21), Enterococcus durans (n=7), Enterococcus 
casseliflavus (n=4), Enterococcus mundtii (n=4), Enterococcus gallinarum (n=3), Enterococcus 
faecalis (n=1), and Enterococcus thailandicus (n=1). The diversity of enterococci was greater in 
steers at arrival than at exit from the feedlot. Erythromycin resistant isolates harboured the 
erm(B) and/or msrC gene. Similar PFGE profiles of eryR E. hirae pre- and post-antibiotic 
treatment suggest that increased abundance of eryR enterococci after administration of tylosin 
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phosphate reflects selection for strains that were already present within the gastrointestinal tract 
of cattle at arrival. 
 
Key words: enterococci, antimicrobial resistance, subtherapeutic macrolides, beef cattle, tylosin, 
erythromycin 
 
5.2. Introduction 
Subtherapeutic administration of antibiotics in livestock feed has come under increasing 
scrutiny due to concerns that such a practice increases the emergence of antibiotic resistant 
bacteria (Aarestrup, 1999). This concern is particularly relevant for bacteria that reside in 
livestock and are associated with clinical infections in humans.  
Enterococci are commensal bacteria of the human and bovine gastrointestinal tract, but 
are also associated with nosocomial and community-acquired infections in humans (Franz et al., 
2011; Poh et al., 2006). Enterococcus faecalis and Enterococcus faecium are the two species 
most frequently associated with enterococcal infections in humans, being responsible for as 
much as a third of the nosocomial infections worldwide (Werner et al., 2008). Whereas in cattle, 
Enterococcus hirae, a species not commonly associated with human infections is predominately 
isolated from bovine faeces (Anderson et al., 2008; Jackson et al., 2010; Zaheer et al., 2013).  
In North America, tylosin phosphate is commonly included in cattle feed for the control 
of liver abscesses (Pagel and Gautier, 2012). Previous research has shown therapeutic and 
subtherapeutic administrations of macrolides to cattle increases the proportion of erythromycin 
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resistant enterococci in bovine faeces (Jacob et al., 2008; Zaheer et al., 2013). In 2005, the WHO 
identified macrolides as critically important antimicrobials for which management strategies are 
urgently required to reduce the prevalence of bacterial resistance (Collignon et al., 2009). 
Macrolides are part of the MLSB (macrolide-lincosamide-streptogramin B) superfamily with 
each antibiotic having slight structural differences, but resistance to one member of the family 
can cross-select for resistance to other drugs in the family. Consequently, if the inclusion of 
tylosin in feed leads to tylosin resistant enterococci in cattle it may also select for enterococci 
that are resistance to other macrolides such as erythromycin, an antibiotic important for the 
treatment of bacterial infections in humans (Desmolaize et al., 2011; Roberts, 2008). 
Enterococci resistant to macrolides commonly carry the resistance determinant erm(B), 
an rRNA methylase that confers cross-resistance to MLSB antibiotics, or msrC, a macrolide 
efflux pump (Portillo et al., 2000). Very little is known about the nature and resistance 
characteristics of enterococci isolated from feedlot cattle. If E. hirae is consistently found as the 
predominant species in cattle faeces, administering macrolides to cattle may not pose as 
significant risk because this species is not commonly associated with human infections. 
Furthermore, antibiotics are often withdrawn prior to slaughter to reduce the risk of residues 
contaminating meat. In this study, we hypothesized that withdrawal of tylosin prior to slaughter 
would be an effective method of reducing the risk of resistant enterococci entering the food 
chain. 
The objectives of this study were to determine the prevalence of macrolide resistant 
enterococci recovered from cattle continuously fed tylosin phosphate, and following its 
withdrawal. The recovered enterococci were characterised through species identification, 
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antimicrobial susceptibility testing, identification of resistance determinants and pulsed-field gel 
electrophoresis (PFGE) profiling.  
 
5.3. Materials and Methods 
5.3.1. Experimental design 
The enterococci isolates investigated in this study were a subset of those archived during 
a larger study. Full methodological details have been described previously (Alexander et al., 
2008; Sharma et al., 2008) and are summarised briefly below.  
British crossbred steers (150±20 kg) were randomly assigned to 10 pens (10 steers per 
pen) at the Lethbridge Research Centre feedlot (Lethbridge, Alberta, Canada). Steers were 
obtained from a single ranch (Deseret Ranches, Raymond, Alberta, Canada) and received no 
antibiotics prior to the beginning of the experiment.  
Five pens of cattle each were randomly assigned to one of two treatments: i) control, no 
antibiotics (denoted CON); ii) tylosin phosphate (Tylan®, Elanco Animal Health; treatment 
denoted T11) at 11 ppm in the diet. Tylosin was administered continuously for 197 d, starting on 
arrival at the feedlot and was withdrawn from the diet 28 d prior to slaughter (Figure 5.1.). To 
avoid cross contamination between diets, tylosin was mixed with 5 kg of supplement and 
manually spread over the surface of the feed during the morning feeding. Steers were fed once 
daily to ensure that all feed allotted to each pen was consumed. Steers in CON and T11 
treatments were housed in opposite sides of the feed alley to ensure that steers in different 
treatments did not have direct contact with one another. The animals involved in this study were 
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cared for according to the guidelines set out by the Canadian Council on Animal Care (Canadian 
Council on Animal Care, 2003).  
Steers were fed diets typical of the western Canadian feedlot industry during a growing 
and finishing period. For the growing period, a silage-based diet consisting of 70% barley silage, 
25% barley grain, and 5% supplement on a dry-matter (DM) basis was fed for the first 80 days 
(Figure 5.1.). Cattle were transitioned from the silage-based growing diet to a grain-based 
finishing diet (85% barley grain, 10% barley silage, and 5% supplement on a DM basis) over 21 
days and maintained on this diet for a further 124 days until slaughtered. A common watering 
bowl was shared between adjacent pens on the same treatment.  
 
Figure 5.1. Schematic representation of experiment timeline (Figure reproduced from Sharma et 
al., 2008). Numbers indicate day of feeding period. Periodic orange rectangles indicate points 
where faecal samples were collected from steers. A, B, D, E and I represent points where isolates 
were selected for assessing antibiotic susceptibility, PFGE profiles and identifying resistance 
determinants. Grey shaded area represents the period that tylosin was administered in the diet.   
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5.3.2. Sample collection and processing 
The study occurred from November 2004 to July 2005. Rectal faecal samples were 
collected from each steer upon arrival at the feedlot and monthly thereafter until slaughter 
(Figure 5.1.). Proportion of steers positive for macrolide resistant enterococci, CFU counts and 
the proportion of macrolide resistant enterococci in steers were estimated at all 9 sampling dates 
with enterococci isolates from 5 of these dates used for assessing antimicrobial susceptibility, 
identifying resistance determinants and PFGE profiles. The five sampling dates were selected to 
include isolates prior to administration of tylosin, during the growing and finishing feeding 
periods and post-withdrawal of tylosin from the diet.   
On each sampling date, faecal grab samples were collected and immediately transported 
to the lab within 1 h after collection. At the lab, faecal slurries were created by mixing faeces (10 
g) with 90 mL of 1 × phosphate-buffered saline in a stomacher bag (Fisher Scientific, Ottawa, 
Ontario, Canada) and using a Stomacher (2 min, 230 rpm, room temperature; Seward Ltd., 
Worthing, West Sussex, United Kingdom). Slurries were serially diluted 10-fold and 100 µL of 
the appropriate dilution plated in duplicate onto Bile-Esculin-Azide (BEA; BD, Franklin Lakes, 
New Jersey, USA) agar containing no antibiotics or onto BEA amended with erythromycin 
(8µg/mL; BEAE), or tylosin (32µg/mL; BEAT) to select for enterococci resistant to erythromycin 
or tylosin. The breakpoint for erythromycin was based on the Clinical and Laboratory Standards 
Institute (CLSI) guidelines whilst an arbitrary value, based on avoiding plate growth and the 
levels used by Davies and Roberts (1999), was selected for tylosin. Plates were incubated for 48 
h at 37°C and colonies from BEA, BEAE, and BEAT were enumerated. Two isolates from control 
plates and four isolates from antibiotic selective plates were streaked onto Trypticase soy agar 
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(TSA; BD), incubated for 24 h, transferred to 20% glycerol in brain heart infusion broth (BD) 
and stored at -80°C until processed.   
 
5.3.3. Characterisation of enterococci 
A total of 1029 presumptive enterococci isolates representing one isolate from each steer 
faecal sample were revived on the same media from which they were initially isolated (BEA, 
BEAE or BEAT; BD). Cultures were grown over 36 h at 37°C and two colonies were selected and 
suspended in 75 µL of TE (10 mM Tris, 1 mM EDTA, pH 8.0). Samples were heat lysed for 5 
min using a thermomixer set at 98°C with shaking at 1000 rpm, followed by centrifugation at 
10,000 × g for 5 min. The supernatant containing the genomic DNA was used as a source of 
template for all PCR reactions. Simultaneously, a subset of presumptive enterococci consisting 
of ~50% isolates of each category including treatment type, media type and sampling day were 
randomly selected for species identification. In this manner, 519 presumptive enterococci 
isolates were selected (Table 5.1.). All of the 1029 isolates were screened by PCR with 
Enterococcus specific groES-EL primers Ent-ES-211-233-F and Ent-EL-74-95-R (Zaheer et al., 
2012) for confirmation as Enterococcus spp. whereas the 519 selected isolates for species 
identification were further processed for sequencing of the groES-EL PCR product. 
Occasionally, the sequence results of the groES-EL PCR product varied from publically 
available databases. In order to characterise those Enterococcus spp. isolates correctly, 
multilocus sequencing including 16S rRNA, atpA, pheS and rpoA genes was used to identify 
species. Detailed methodology can be found in the Appendix 2 (Figure S5.1. and Table S5.1.). In 
cases where an isolate did not generate the groES-EL PCR product, i.e. was not an Enterococcus 
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spp., PCR amplification and sequencing of the 16S rRNA gene using primers 27F (5’-
AGAGTTTGATCMTGGCTCAG-3’) and 1492R (5’-TACGGYTACCTTGTTACGACTT-3’) 
was conducted for taxonomic identification. 
A subset of 171 isolates representing major species (~25% coverage) and all minor 
species were subject to antimicrobial susceptibility testing. These selected isolates were subject 
to PCR-based identification of resistance determinants and PFGE profiling. 
 
5.3.4. Antimicrobial susceptibility testing 
Disc susceptibility tests were conducted on 171 characterised enterococci isolates 
according to the CLSI documents M02-A11 and M100-S24 (Clinical and Laboratory Standards 
Institute, 2014a,b). The antimicrobials tested, suppliers and resistance breakpoints applied are 
listed in Table 5.2. Reference strains Staphylococcus aureus ATCC 25923® and E. faecalis 
ATCC 29212® were used as quality controls. Resulting zones of inhibition were read using the 
BioMic V3 imaging system (Giles Scientific, Inc., Santa Barbara, CA, USA) and classified as 
sensitive or resistant based on CLSI interpretive criteria (Clinical Laboratory Standards Institute, 
2014b), except for tigecycline which used EUCAST interpretive criteria (The European 
Committee on Antimicrobial Susceptibility Testing, (EUCAST), 2014). Neither EUCAST nor 
CLSI defined breakpoints exist for enterococci with tylosin, however the quality control range of 
tylosin discs (30 µg) has recently been acknowledged for S. aureus ATCC 25923® (Buß et al., 
2014). Tylosin minimum inhibitory concentration (MIC) were established for a sub-set of 
isolates containing erm(B) or msrC, both genes or neither gene according to CLSI documents 
M100-S24 and M07-A9, with results reported in the Appendix 2 (Figure S5.2.). Isolates 
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exhibiting a high MIC (≥128 µg/mL) to tylosin also contained the resistance determinant erm(B). 
Therefore, isolates harbouring the resistance determinant erm(B) were given the designation of 
resistant to tylosin.   
 
5.3.5. Identification of resistance determinants 
Of selected isolates, 125 isolates displaying intermediate or complete resistance to 
erythromycin were screened for the presence of macrolide resistance determinants. Isolates were 
first screened by PCR for the commonly found macrolide resistance determinants in enterococci, 
erm(B) and msrC (Portillo et al., 2000). For erm(B), PCR primers and reaction conditions were 
used as described by Chen et al. (2007). For msrC PCR, the forward and reverse primers, 
msrC_F1 (5’-TCGTTTTGTCATGAGACAAACAG-3’) and msrC_R1 (5’-
AAATTAGTCGGTTCATCTAACAG-3’), respectively were used. A 20 µL PCR reaction using 
2 µL of template DNA was prepared with the following reaction conditions: initial denaturation 
for 5 min at 95°C, followed by 35 cycles of denaturation for 30 s at 94°C, annealing for 30 s at 
53°C, extension for 30 s at 72°C with a final extension for 10 min at 72°C. The PCR reaction 
product (5 µL) was resolved on a 2% agarose gel, and visualized for the presence of a 191 bp 
PCR product. An environmental sample, showing positive amplification for msrC and verified 
by DNA sequencing, was used as a positive control. 
A subset of 40 isolates containing erm(B) or msrC or both genes and consisting of all 
identified species with a variety of PFGE profiles were further screened for the presence of other 
macrolide resistance determinants. These included erm(A), erm(C), erm(F), and erm(T) with 
primers and reaction conditions as described by Chen et al. (2007).  
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Isolates displaying intermediate or complete resistance to doxycycline were further 
screened for the tetracycline resistance determinants tet(B), tet(C), tet(L), and tet(M). A 20 µL 
PCR reaction using 2 µL of template DNA was prepared with products resolved on a 2% agarose 
gel. For tet(B), primers as described by Peak et al. (2007) were used with the following reaction 
conditions; initial denaturation for 5 min at 95°C, followed by 35 cycles of denaturation for 30 s 
at 94°C, annealing for 30 s at 60°C, extension for 30 s at 72°C and a final extension for 10 min at 
72°C. Primers and reaction conditions for tet(C), tet(L), and tet(M) were as described by Ng et 
al. (2001). The expected product size for tet(B), tet(C), tet(L), and tet(M) were 205, 418, 267, 
and 406 bp, respectively. 
For all PCR reactions, the commercially available HotStarTaq Plus Master Mix Kit 
(Qiagen Canada, Inc., Mississauga, ON, Canada) was used according to manufacturer’s 
instructions. Plasmids containing the corresponding gene fragments were used as positive 
controls (Alexander et al, 2009; Zaheer et al., 2013). 
 
5.3.6. PFGE 
One-hundred and seventy-one isolates were subject to PFGE profiling with SmaI 
restriction enzyme using a modified procedure of PulseNet USA (Centers for Disease Control 
and Prevention, 2012). Briefly, bacteria grown overnight on brain-heart infusion-agar (BHI-agar; 
BD) were harvested using sterile swabs and suspended in TE buffer to an OD of 1.85 at 610 nm. 
An aliquot (400 µL) of cell suspension was transferred to a 1.5 mL microfuge tube containing 
20 µL of lysozyme (50 mg/mL; Sigma-Aldrich, Co., St Louis, Mo, USA), gently mixed and 
incubated at 55°C for 45 min. An equal volume of 1.2% molten SeaKem Gold agarose (Lornza, 
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Rockland, Maine, USA) in TE buffer was added and the mixture dispensed in duplicate into re-
useable plug molds (Bio-Rad Laboratories, Hercules, CA, USA) and allowed to solidify at room 
temperature. Duplicate plugs were added to 2 mL microfuge tubes containing 1.8 mL cell lysis 
buffer [50mM Tris; 50mM EDTA; 1% sodium sarcosyl] and 9 µL of Proteinase K (20 mg/mL; 
Sigma-Aldrich, Co., St Louis, Mo, USA) and incubated for 2 h at 55°C with agitation (300 rpm). 
Plugs were washed twice in sterile, deionized H2O (1.8 mL) and three times in TE (1.8 mL) for 
10 min each using a thermomixer set at 50°C and 300 rpm. Restriction digestion and 
electrophoresis conditions were as described by Zaheer et al. ( 2013). Gels were photographed 
using an AlphaImager gel documentation system (Alpha Innotech Corp., St. Leandro, CA, USA) 
and banding patterns analysed with BioNumerics V6.6 software (Applied Maths Inc., Austin, 
TX, USA), using Dice coefficient and the unweighted pair group method (UPGMA). 
Optimisation and band tolerance were both set at 1%. Salmonella serotype Braenderup digested 
with XbaI was included in each gel as a control reference and for normalisation of band 
fragments. 
 
5.3.7. Data and statistical analysis 
Enumeration data were used to determine the proportion of steers positive for macrolide 
resistant enterococci and the proportion of macrolide resistant Enterococcus in the total 
population. For the purposes of enumeration, esculin hydrolysing colonies observed on BEA, 
BEAE and BEAT plates were assumed to be enterococci. 
Data were analysed using commercially available statistical analysis software (SAS 
Systems for Windows, version 9.3, SAS Institute Inc, Cary, NC, USA). Prior to analysis, 
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enumeration data were normalised through a log transformation. When enumeration data for the 
antibiotic selective media exceeded that of the non-selective media for each sampling point, it 
was assumed that 100% of the population was resistant to the respective antibiotic. The MIXED 
procedure of SAS was used to assess CFU counts over time and the proportion of macrolide 
resistant Enterococci in the total population. The CFU counts over time were analysed with 
media type, day and media type × day in the model as fixed effects while for the proportion of 
macrolide resistant enterococci in the total population, day, treatment and day × treatment 
interaction were included in the model as fixed effects. For both analyses, day was included as a 
repeated measure. Results were considered significant when P < 0.05. For most sampling days, 
50 samples were collected, but due to conflicts with other experiments in the feedlot facility, 
only 30 samples were collected on day 49, 141, 169, and 197.  
 
5.4. Results 
5.4.1. Prevalence of positive steers and CFU counts of macrolide resistant enterococci  
Upon arrival at the feedlot, 28 and 24% (CON and T11, respectively) of the steers were 
positive for eryR enterococci, whilst 44 and 38% (CON and T11, respectively) were positive for 
tylR enterococci, even though steers did not previously receive antibiotics (Figure 5.2.).  
For the control group, the counts of tylR enterococci were higher (P < 0.05) than the 
counts of eryR enterococci on d 0, 84, 113, 141, 169, 197, and 225 (Figure 5.2.A). Whilst for the 
tylosin treatment, the counts of tylR enterococci were higher (P < 0.05) than the counts of eryR 
enterococci for d 84, 113, and 225 (Figure 5.2.B). In general, the counts of eryR enterococci in 
the tylosin treatment group and counts of tylR enterococci in both treatment groups increased 
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over the sampling period as the cattle were transitioned from a silage-based growing diet to a 
grain-based finishing diet. The increased counts of macrolide resistant enterococci over the 
experiment were due to an increase in the proportion of macrolide resistant enterococci within 
the total population.  
 
Figure 5.2. Proportion of steers positive for eryR enterococci (Steers eryR) or tylR enterococci 
(Steers tylR) and Enterococcus counts (log CFUg-1) of, total population (CFU), eryR enterococci 
(CFU eryR) or tylR enterococci (CFU tylR) for CON (A) or T11 (B) treatments. Arrow indicates 
when antibiotics were withdrawn from the diet. An “*” indicates days for which there was a 
significant difference between treatments (P < 0.05). For each treatment (day 0, 14, 84, 113, and 
225 n=50; day 49, 141, 169, and 197 n=30).   
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5.4.2. Proportion of macrolide resistant enterococci in the total enterococci population 
No difference (P > 0.05) was observed between control and tylosin-fed steers on d 0, 14, 
49, and 84 for the proportion of eryR enterococci or d 0, 14, and 49 for the proportion of tylR 
enterococci (Figures 5.3.A,B, respectively). On d 113, 141, 169, and 197, the proportion of eryR 
enterococci was higher (P < 0.001) for steers fed tylosin compared to controls. The proportion of 
tylR enterococci, resistance was higher  (P < 0.001) for steers fed tylosin compared to controls on 
d 84, 113, 141, 169, and 197. After withdrawal of tylosin on d 197, the proportion of eryR or tylR 
enterococci decreased until there was no difference (P > 0.05) between tylosin-fed and control 
steers on d 225 (Figures 5.3.A,B, respectively).  
 
5.4.3. Characterisation of enterococci 
Of the 1029 isolates analysed, 95.2% were confirmed as enterococci by PCR. Of the 519 
isolates speciated, 504 were identified as E. hirae (n=431), Enterococcus villorum (n=32), E. 
faecium (n=21), Enterococcus durans (n=7), Enterococcus casseliflavus (n=4), Enterococcus 
mundtii (n=4), Enterococcus gallinarum (n=3), E. faecalis (n=1), and Enterococcus thailandicus 
(n=1). The remaining 15 non-enterococci were identified as Lactobacillus spp. (n=3), 
Aerococcus spp. (n=9), Streptococcus spp.	 (n=2), and Staphylococcus epidermids (n=1) as 
determined by 16S rRNA sequencing. All the species identified were represented by the 231 
isolates originally recovered from BEA, whereas only six species (E. hirae, E. villorum, E. 
faecium, E. durans, E. casseliflavus, and E. gallinarum) were isolated from BEAE and BEAT 
(Figure 5.4.). Variants of the groES-EL sequence for two isolates of E. faecium and single
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Figure 5.3. Proportion of erythromycin-resistant (A) or tylosin-resistant (B) faecal enterococci 
isolates for both treatments across all sampling days. Arrow indicates when antibiotics were 
withdrawn from the diet. Line styles distinguish the treatment. An “*” indicates days for which 
there was a significant difference between treatments (P < 0.05). For each treatment (day 0, 14, 
84, 113, and 225 n=50; day 49, 141, 169, and 197 n=30).  
isolates of E. thailandicus and E. villorum have been submitted to the NCBI database (Accession 
numbers KP993544, KP993545, KP993546, and KP993547, respectively). The diversity of 
enterococci tended to be greater in steers upon arrival than at exit from the feedlot. A greater 
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diversity of enterococci species were isolated from non-selective BEA compared with either 
BEAE or BEAT, with similar proportions of most species occurring in control and tylosin-fed 
steers. E. hirae was the predominant species isolated from both control and tylosin-fed steers 
across all sampling dates (Figure 5.4.).  
 
5.4.4. Antibiotic susceptibility testing 
A subset (n=171) of enterococci representing all of the isolated Enterococcus species 
were tested for antibiotic susceptibility (Table 5.3.). Resistance to ampicillin, gentamicin, 
linezolid, streptomycin or tigecycline was not detected in any of the isolates. Vancomycin 
resistance was also absent in all isolates except for one which displayed intermediate resistance. 
One isolate of E. casseliflavus exhibited ERY-TYL-Q-D-van resistance and one isolate of E. 
durans exhibited ERY-TYL-q-d (lower case denotes intermediate resistance and upper case 
complete resistance). One isolate of E. faecium was ERY-DOX-TYL-q-d resistant, with other 
single isolates exhibiting intermediate ery-nit, ery-lvx or dox-nit-lvx-q-d resistance. Two isolates 
of E. gallinarum showed ery-TYL resistance and a number of E. hirae isolates were resistant to 
ERY-TYL (n=27), ery-TYL (n=27), ERY-dox-TYL (n=8), or ERY-TYL-q-d (n=7). With one 
exception, all E. villorum isolates exhibited ERY-TYL (n=31) resistance.  
In general, isolates grown on BEAT also exhibited erythromycin resistance. An exception 
to this was three isolates of E. durans isolated on BEAT, which remained susceptible to 
erythromycin. 
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Figure 5.4. Species distribution of characterised isolates from (A) BEA (bile esculin azide agar), 
(B) BEAE (bile esculin azide agar amended with erythromycin [8µg/mL]) and (C) BEAT (bile 
esculin azide agar amended with tylosin [32µg/mL]). Prevalence was calculated by dividing the 
number of isolates for each species by the total number of isolates from each sample day and 
treatment. 
 
 
	
	
134	
5.4.5. Identification of resistance determinants 
Of the 125 enterococci isolates displaying intermediate or complete resistance to 
erythromycin, the erm(B) gene was detected in 106 isolates representing E. hirae, E. durans, E. 
faecium, E. villorum, E. gallinarum, and E. casseliflavus. Of the 19 erythromycin-resistant E. 
faecium isolates obtained all except one lacked erm(B), but all  were positive for msrC. The 
isolate identified as E. thailandicus displayed intermediate resistance to erythromycin, but was 
negative for all of the macrolide resistance determinants tested. None of the isolates tested 
positive for the other macrolide resistance determinants.    
A total of 10 isolates displayed intermediate or complete resistance to doxycycline. None 
of the isolates were positive for tet(B) or tet(C). All 10 isolates were positive for tet(M) and 9 
were positive for tet(L).  
 
5.4.6. PFGE 
The PFGE profiles of E. faecium, E. villorum and erythromycin resistant E. hirae are 
displayed in Figures 5.5.-5.7., respectively. E. faecium had at least 16 isolates from different 
steers with the same PFGE profile, suggesting the presence of a clonal population. Isolates from 
this clonal population were isolated only on day 0 (Figure 5.5.). The similarity (>95%) of PFGE 
profiles of E. villorum also suggested clonality (Figure 5.6.). Unlike E. faecium, these profiles 
appeared on day 14 of the trial and persisted until the end of the experiment. PFGE profiles of 
erythromycin resistant E. hirae produced 8 clusters with >85% similarity (Figure 5.7.).  
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Figure 5.5. Dendrogram of PFGE SmaI profiles from isolates identified as Enterococcus 
faecium. A “+” indicates PCR positive and “-” indicates PCR negative to the respective genes. A 
“blank” space indicates the gene was not screened for in the respective isolate. For the 
antibiogram, upper case denotes complete resistance and lower case denotes incomplete 
resistance. 
5.5. Discussion 
Enterococci are ubiquitous in nature and are frequently isolated from the gastrointestinal 
tract of mammals, including humans (Franz et al., 2011). Of the enterococci recovered from this 
study E. hirae was revealed to be the predominant species isolated, an observation consistent 
with previous studies (Anderson et al., 2008; Jackson et al., 2010; Zaheer et al., 2013).  
Enterococci have been described as a “drug resistance gene trafficker” due to the ease 
with which they can acquire and transfer resistance genes (Werner et al., 2013). They have 
emerged as a serious threat to human health, particularly due to the acquisition of vancomycin 
resistance, increasing the difficulty of successful treatment (Centers for Disease Control and 
Prevention, 2013). Of the 171 isolates examined for antibiotic resistance, only one isolate
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Figure 5.6. Dendrogram of PFGE SmaI profiles from isolates identified as Enterococcus 
villorum. A “+” indicates PCR positive and “-” indicates PCR negative to the respective genes. A 
“blank” space indicates the gene was not screened for in the respective isolate. For the 
antibiogram, upper case denotes complete resistance and lower case denotes incomplete 
resistance. 
displayed intermediate resistance to vancomycin. This isolate was identified as E. casseliflavus, 
an outcome that likely reflects the intrinsic resistance of E. casseliflavus and E. gallinarum to 
low levels of vancomcyin (Hollenbeck and Rice, 2012). This observation is encouraging, as the 
enterococci isolated from beef cattle do not appear to represent a significant source of 
vancomycin resistance.  
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Figure 5.7. Dendrogram of PFGE SmaI profiles from isolates identified as erythromycin 
resistant Enterococcus hirae. A “+” indicates PCR positive and “-” indicates PCR negative to the 
respective genes. A “blank” space indicates the gene was not screened for in the respective 
isolate. For the antibiogram, upper case denotes complete resistance and lower case denotes 
incomplete resistance.  
E. faecium and E. faecalis are the two species most commonly associated with 
nosocomial human infections (Ruoff et al., 1990; Sievert et al., 2013; Werner et al., 2008). These 
species have been isolated from cattle (Anderson et al., 2008; Jackson et al., 2010; Kuhn et al., 
2003), but they do not predominate, with our study suggesting that their prevalence declines after 
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cattle enter the feedlot. Although E. hirae, as well as other enterococcal species (i.e. 
Enterococcus avium, E. durans, E. casseliflavus, E. gallinarum, and Enterococcus raffinosus) 
can cause clinical infections in humans, they are rare and thought to be more opportunistic in 
nature than those caused by E. faecium and E. faecalis (Alfouzan et al., 2014; Ruoff et al., 1990). 
Presence of E. hirae predominantly in the bovine gastrointestinal tract suggests that cattle do not 
present a significant source of Enterococcus that could colonise and infect humans.  
In the absence of selection, the predominant resistance phenotype observed in the 
enterococci recovered from cattle was to erythromycin or tylosin, including isolates recovered 
pre- and post- antibiotic treatment. Despite no prior treatment with antimicrobials, steers 
harboured eryR (28 and 24%, CON and T11 respectively) and tylR (44 and 38%, CON and T11 
respectively) enterococci upon arrival at the feedlot (Figure 5.2.). This suggests that naturally 
occurring resistance determinants coding for macrolide resistance are already present and 
circulating in bovine gut enterococci populations. 
For some days, the counts of tylR enterococci were higher (P < 0.05) than eryR 
enterococci for both treatment groups (Figure 5.2.). It would be expected that similar counts 
would be obtained for both eryR and tylR enterococci as the same resistance mechanism confers 
resistance to both antibiotics (Desmolaize et al., 2011; Roberts, 2008). Enterococci with both 
intermediate and complete resistance to erythromycin were isolated from tylosin plates; whilst 
erythromycin plates only selected for enterococci with complete resistance to erythromycin, 
explaining some of the discrepancy seen between enumeration data for the two media. Isolates 
from tylosin media with intermediate resistance to erythromycin also carried the erm(B) gene. It 
appears that the MIC breakpoint for erythromycin may be too high, therefore missing 
enterococci with intermediate resistance which also carry a resistance determinant. Conversely, 
	
	
139	
the MIC breakpoint for tylosin may be too low thereby selecting for isolates that contain 
resistance determinants that may be compromised, resulting in an intermediate resistance 
phenotype. The fact that three isolates of E. durans from the tylosin media remained susceptible 
to erythromycin supports this theory. It is possible however, that these isolates carry a resistance 
determinant not screened for. It would be worthwhile to further explore the likely genetic 
differences between the resistance determinant(s) from complete and intermediate tylosin 
resistant isolates to identify the linkage between antimicrobial resistance (AMR) genotype and 
phenotype.  
As the trial progressed, the number of steers positive for macrolide resistant enterococci 
increased in both treatment groups. This increase, even in the control group may be a reflection 
of increased transmission between steers due to close proximity in the feedlot environment. 
Likewise, the changing population dynamics of enterococci in the gastrointestinal tract of cattle 
may also contribute to increased transmission. Increased shedding of macrolide resistant 
enterococci would increase the likelihood of cattle being exposed to macrolide resistant 
enterococci and thus also increase the detection of positive cattle. Similarly, an increase in the 
proportion of the population that are macrolide resistant would increase the chances of isolating 
macrolide resistant enterococci. For a steer to be considered positive in this study, isolation of a 
single macrolide resistant enterococci colony was required. In order to make an assessment of 
resistance development it is important to look at resistance as a proportion of the total 
enterococci population. 
The CFU counts of the overall enterococci population remained relatively constant over 
the experiment for both treatments (Figure 5.2.). This trend was also true for CFU counts of eryR 
enterococci in the control group (Figure 5.2.A), whilst the CFU counts of eryR enterococci in the 
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tylosin treatment group tended to increase during the period of tylosin administration before 
dropping off on d 197, presumably due to its withdrawal from the diet (Figure 5.2.B). This trend 
was also observed for the CFU counts of tylR enterococci for both treatments, with possible 
differences between eryR and tylR CFU being attributed to the selection of intermediate resistant 
enterococci on the tylosin media (Figure 5.2.). A delay between the increase of CFU counts and 
tylosin administration can be seen, with increases coinciding with the transition from a silage-
based diet to a grain-based diet. 
High-grain diets tend to increase the amount of starch available in the lower intestinal 
tract, changing the nutrient availability for bacterial growth (Callaway et al., 2009). Previous 
researchers have reported a 1 (Scott et al., 2000) to 3 log (Diez-Gonzalez et al., 1998) increase in 
Escherichia coli when cattle were transitioned from a forage- to a grain-based diet. Changes that 
occur in the gastrointestinal environment of cattle as a result of increased starch in the diet alter 
the composition of the microbiome (Shanks et al., 2011). It is possible that the transition to a 
grain-based diet created conditions ideal for proliferation of macrolide resistant enterococci. 
Although not seen with the CFU of eryR enterococci, the increase of tylR enterococci in both the 
control and tylosin treatment group suggest factors other than administration of tylosin may have 
been selecting for macrolide resistant enterococci.  
Increases in eryR enterococci in cattle as a result of the administration of tylosin has been 
previously documented (Jacob et al., 2008; Zaheer et al., 2013), but these authors did not study 
the effect of withdrawal of tylosin from the diet. As in previous studies, there was an increase in 
the proportion of eryR and tylR resistant enterococci isolated from cattle administered tylosin. 
The proportion of eryR and tylR resistant enterococci for the tylosin treatment began decreasing 
just prior to removal of tylosin from the diet and continued to decrease after its withdrawal, until 
	
	
141	
no difference (P > 0.05) was observed between treatments on d 225 (Figure 5.3.). It appears that 
withdrawal of tylosin phosphate prior to slaughter contributes to a reduction in the proportion of 
macrolide resistant enterococci entering the food chain. However, the possibility that other 
unknown factors such as stress, age and diet may also be influencing this decline cannot be 
eliminated. It would be interesting to investigate this phenomenon further to determine why this 
reduction is occurring prior to the withdrawal of tylosin from the diet.  
A decrease in species diversity was observed as the experiment progressed, with E. hirae 
being the predominant species identified. Transitioning of the diet from a forage- to a grain-
based diet alters the faecal microbiome of cattle (Shanks et al., 2011). Diet may be a contributing 
factor in the shift in species diversity seen in this study, but it is also possible that other factors, 
such as age, may also be influencing the faecal microbial community (Devriese et al., 1992).  
In this study, E. thailandicus and E. villorum were identified using multilocus sequencing 
of 16S rRNA, atpA, pheS, and rpoA genes after the discovery of groES-EL PCR products that 
varied from publically available databases (Appendix 2 Figure S.5.1.). To our knowledge, these 
species have not been previously isolated from cattle. E. thailandicus was first isolated in 2008 
from fermented sausage in Thailand (Tanasupawat et al., 2008) and has been found in swine 
faeces (Liu et al., 2013). E. villorum was first isolated in 2001 from piglets (Vancanneyt et. al., 
2001). Traditional methods of identifying Enterococcus species rely on biochemical tests which 
are unreliable for atypical species or species that have not been previously isolated (Deasy et al., 
2000; Jackson et al., 2004). Molecular techniques have the advantage of being able to 
differentiate between closely related enterococci species. 
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Erythromycin resistant enterococci possessed either erm(B) or msrC or both resistance 
genes. Isolates designated as tylosin resistant possessed erm(B). Other macrolide resistance 
determinants were absent in the subset of isolates screened and it is possible that isolates not 
screened may have contained macrolide resistance determinants other than erm(B) or msrC. 
Presence of at least one resistance determinant in these isolates however confirmed the 
association between resistance phenotype and genotype.  
Eight isolates of E. hirae and one isolate of E. faecium displayed complete resistance to 
erythromycin and either complete or intermediate resistance to doxycycline. These isolates were 
all positive for erm(B), tet(L), and tet(M). The resistance genes erm(B) and tet(M) are often 
associated with the transposon Tn1545 (Clewell et al., 1995; Rice, 1998). The transposon 
integrase gene (int gene) of Tn916/Tn1545 family of transposons has been previously detected in 
enterococci (De Leener et al., 2004). The identification of erm(B) and tet(M) in the same isolate 
in this study could possibly suggest the presence of mobile genetic elements. It would be 
worthwhile to investigate this further as many erm genes are often linked with other antibiotic 
resistance genes, tetracycline in particular (Roberts et al., 1999). Linkage of macrolide and other 
resistance genes is potentially problematic as administrating tylosin to cattle may not only select 
for macrolide resistance, but also for resistance to antibiotics such as tetracycline. Co-selection 
of tetracycline resistance upon the administration of tylosin has been suggested to occur within 
the faecal microbial communities of beef cattle (Chen et. al., 2008). Linkage of these genes on 
mobile genetic elements increases the potential for the transfer of genes conferring resistance to 
multiple antibiotics (Hegstad et al., 2010; Tremblay et al., 2012).  
Pulsed-field gel electrophoresis revealed a predominate cluster of E. faecium containing 
msrC and displaying a similar AMR profile of intermediate or complete resistance to 
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erythromycin. Sequencing of msrC revealed that all isolates within this cluster had identical 
sequences. However, there were sequence differences in the msrC gene among these isolates and 
isolates with unique PFGE profiles (Figure 5.5.). The four newly identified sequences have been 
submitted to the NCBI sequence database (Accession numbers KP775623, KP775624, 
KP775625, and KP775626).  
Similar PFGE profiles were seen pre- and post-antibiotic treatment for erythromycin 
resistant E. hirae, highlighting that administration of tylosin selected for erythromycin resistant 
enterococci already present in the bovine gastrointestinal tract. These same profiles were still 
present after d 225; 28 days after tylosin had been removed from the diet. This suggests that 
although administration of tylosin increased the proportion of macrolide resistant enterococci in 
beef cattle it does not appear to be promoting the transfer of resistance between isolates. Once 
the selection pressure is removed (withdrawal of tylosin), the proportion of macrolide resistant 
enterococci returned to levels seen before antibiotic treatment.   
 
5.6. Conclusion 
Few studies have investigated the role that administration of tylosin in the feed of beef 
cattle has on the development of macrolide resistance in enterococci. This study demonstrated 
that administering tylosin to cattle increases the proportion of macrolide resistant enterococci. 
Withdrawal of tylosin from the diet appears to contribute to the decline in macrolide resistant 
enterococci but may not be the only factor influencing this decline. Furthermore, transitioning 
cattle to a grain-based diet appears to alter the species population of enterococci to one in favour 
of E. hirae, a species not commonly associated with infection in humans. PFGE profiling of 
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erythromycin resistant E. hirae suggest that antibiotic administration selects resistant strains 
already present in the intestinal microbial population. 
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Tables 
Table 5.1. Distribution of isolates characterised in this study 
Treatmenta Media used for selectionb Sampling dayc Total 
  0 14 84 113 225  
CON BEA 24 20 25 25 23 119 
 BEAE 6 8 17 16 9 58 
 BEAT 9 9 19 22 19 79 
T11 BEA 24 20 25 25 25 122 
 BEAE 6 8 15 20 14 65 
 BEAT 8 7 24 25 22 86 
Total   77 72 125 133 112 519 
aSteers fed no antibiotics (control, CON) or tylosin phosphate (11 ppm; T11); administered 
continuously and withdrawn on day 197. 
 bIsolates were streaked onto bile esculin azide agar (BEA) containing no antibiotics, or amended 
with erythromycin (8µg/mL; BEAE) or with tylosin (32µg/mL; BEAT). 
cSampling days began at day 0 (arrival at feedlot) prior to antibiotic administration and continued 
until the end of the feeding trial; sample day 0 and 14 were during the silage-based diet, day 84 
during the transition diet and day 113 and 225 during the grain-based diet. 
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Table 5.2. Antibiotics, suppliers, disc content and breakpoints used for disc susceptibility testing 
Antibiotic Supplier Disc content (µg) Zone diameter (mm) breakpointsd 
   S I R 
Ampicillina BD 10 ≥17 - ≤16 
Doxycyclinea BD 30 ≥16 13-15 ≤12 
Erythromycina BD 15 ≥23 14-22 ≤13 
Gentamicina BD 120 ≥10 7-9 6 
Levofloxacina BD 5 ≥17 14-16 ≤13 
Linezolida BD 30 ≥23 21-22 ≤20 
Nitrofurantoina BD 300 ≥17 15-16 ≤14 
Quinupristin-dalfopristina BD 4.5/10.5 ≥19 16-18 ≤15 
Streptomycina BD 300 ≥10 7-9 6 
Tigecycline BD 15 ≥18 - <15 
Tylosinb Medox 30 n/a n/a n/a 
Vancomycina,c BD 30 ≥17 15-16 ≤14 
Ampicillina BD 10 ≥17 - ≤16 
aM100-S24: Performance standards for antimicrobial susceptibility testing; twenty-fourth informational supplement (CLSI, 2014b). 
bBreakpoint tables for interpretation of MICs and zone diameters. Version 4.0. (EUCAST, 2014). 
cVancomycin requires 24 hours incubation while for all other antibiotics 16-18 hours incubation is sufficient. 
dZone diameter value used to indicate susceptible (S), intermediate (I), resistant I and not available (n/a). 
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Table 5.3. Number of enterococci isolates (percentage of total speciesa) showing intermediate or complete resistance to antibiotics 
pooled across treatments, isolation media and sample date 
Enterococcus spp.  Antibioticb (No. isolates [%]) 
  AMP DOX ERY GEN LVX LZD NIT Q-D STR TGC TYLc VAN 
E. hirae (n=98) I n/a 8 (8.2) 27 (27.6) 0 0 0 0 7 (7.1) 0 n/a n/a 0 
 R 0 0 42 (42.9) 0 0 0 0 0 0 0 69 (70.4) 0 
E. villorum (n=32) I n/a 0 0 0 0 0 0 0 0 n/a n/a 0 
 R 0 0 31 (96.9) 0 0 0 0 0 0 0 31 (96.9) 0 
E. faecium (n=21) I n/a 1 (4.8) 5 (23.8) 0 2 (9.5) 0 2 (9.5) 2 (9.5) 0 n/a n/a 0 
 R 0 1 (4.8) 14 (66.7) 0 0 0 0 0 0 0 1 (4.8) 0 
E. durans (n=7) I n/a 0 0 0 0 0 0 1 (14.3) 0 n/a n/a 0 
 R 0 0 1 (14.3) 0 0 0 0 0 0 0 1 (14.3) 0 
E. casseliflavus (n=4) I n/a 0 0 0 0 0 0 0 0 n/a n/a 1 (25.0) 
 R 0 0 2 (50.0) 0 0 0 0 1 (25.0) 0 0 2 (50.0) 0 
E. mundtii (n=4) I n/a 0 0 0 0 0 0 0 0 n/a n/a 0 
 R 0 0 0 0 0 0 0 0 0 0 0 0 
E. gallinarum (n=3) I n/a 0 2 (66.7) 0 0 0 0 0 0 n/a n/a 0 
 R 0 0 0 0 0 0 0 0 0 0 2 (66.7) 0 
E. faecalis (n=1) I n/a 0 0 0 0 0 0 0 0 n/a n/a 0 
 R 0 0 0 0 0 0 0 1 (100.0) 0 0 0 0 
E. thailandicus (n=1) I n/a 0 1 (100.0) 0 0 0 0 0 0 n/a n/a 0 
  R 0 0 0 0 0 0 0 0 0 0 0 0 
aPercentages were calculated by dividing resistant isolates with the total number of isolates for individual species and rounded to the 
first decimal place. 
bAMP, ampicillin; DOX, doxycycline; ERY, erythromycin; GEN, gentamicin; LVX, levofloxacin; LZD, linezolid; NIT, 
nitrofurantoin; Q-D, quinupristin-dalfopristin; STR, streptomycin; TGC, tigecycline; TYL, tylosin; VAN, vancomycin. 
cResistance isolates were classified as those which carried the erm(B) resistance gene (see materials and methods for more 
information). 
R, complete resistance; I, intermediate resistance; n/a, no interpretive criteria for intermediate resistance. 
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Chapter 6 
 
 
Draft genome sequence of an Enterococcus thailandicus strain isolated from 
bovine faeces3 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
3This chapter was published in full: Beukers, A.G., Zaheer, R., Goji, N., Cook, S.R., Amoako, 
K.K., Chaves, A.V., Ward, M.P. and McAllister, T.A. (2016). Draft genome sequence of 
an Enterococcus thailandicus strain isolated from bovine feces. Genome Announc. 
4(4):e00576-16. 
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6.1. Abstract 
Here, we report the first draft genome sequence of Enterococcus thailandicus isolated from the 
faeces of feedlot cattle in Southern Alberta.  
 
6.2. Introduction and Results 
Enterococcus thailandicus was first isolated from fermented sausage in Thailand in 2008 
(Tanasupawat et al., 2008) and has been identified in the faeces of swine (Liu et al., 2013). We 
isolated E. thailandicus with an intermediate resistance to erythromycin from bovine faeces in 
Alberta, Canada in 2005 (Beukers et al, 2015). This isolate was originally identified through a 
previously unobserved variance in the groES-EL spacer region (Zaheer et al., 2012). The 
nonexistence/unavailability of E. thailandicus genome sequence in the database provided motive 
for selecting this isolate for whole-genome sequencing. The present genome sequence will help 
provide further insight and understanding of Enterococcus genera. 
Here, we report the first draft genome sequence of E. thailandicus. Genomic DNA was 
prepared as described by Klima et al. (2016). Indexed paired-end libraries were prepared using 
the Nextera XT DNA sample preparation kit (Illumina, Inc., CA) and paired-end (2 × 300 bp 
reads) sequenced on an Illumina MiSeq platform (Illumina) to yield a total of 1,169,142 reads. 
High quality reads were de novo assembled using SPAdes version 3.6.0 software (Bankevich et 
al., 2012).   
The draft genome of E. thailandicus has a total size of 2,603,691 bp with a GC content of 
36.7% and consists of 17 contigs ranging from 998 bp to 431,427 bp with an average coverage of 
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39× and an N50 length of 337,578 bp. Genome annotation was performed by use of the NCBI 
Prokaryotic Genome Annotation Pipeline (http://www.ncbi.nlm.nih.gov/genome/annotation_ 
prok/),	leading to the prediction of 2,397 protein-coding genes, 56 tRNAs, 1 transfer-messenger 
RNA (tmRNA), and 5 rRNA operons. At least four multidrug efflux pump proteins were 
annotated in the genome and may have contributed to the observed intermediate resistance to 
erythromycin (Beukers et al., 2015). A glycopeptide resistance protein with homology to VanZ 
was also identified in the genome. VanZ is known to confer low-level resistance to teicoplanin in 
Enterococcus faecium but not to vancomycin (Arthur et al., 1995).  No resistance determinants 
were identified using the Comprehensive Antibiotic Resistance Database (CARDs) (McArthur et 
al., 2013) or the ResFinder version 2.1 server (Zankari et al., 2012). No virulence factors were 
identified using the VirulenceFinder version 1.5 server (Joensen et al., 2014). Limitations of 
databases for both antibiotic resistance and virulence genes could have resulted in unknown 
resistance or virulence genes remaining unidentified. It is possible that E. thailandicus contains 
further novel antibiotic resistance or virulence genes with further studies required to elucidate 
this.  
The genome was ordered based on alignment against E. faecium T110 (Accession 
number CP006030.1) using progressive Mauve (Darling et al., 2010) and analysed for the 
presence of prophage using PHAST (Zhou et al., 2011). Three incomplete and one questionable 
prophage were predicted in the genome. Six confirmed clustered regularly interspaced short 
palindromic repeat (CRISPR) arrays were identified using CRISPRfinder (Grissa et al., 2007). 
Only one CRISPR array was linked to CRISPR-associated (cas) genes, consisting of cas9, cas2, 
cas1 and csn2 classifying this array as a type II-A system (Chylinski et al., 2014). Gene clusters 
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encoding for the production of a putative lantipeptide and a bacteriocin were predicted using the 
Antibiotics and Secondary Metabolite Analysis Shell (Medema et al., 2011).    
 
6.3. Conclusion 
The addition of the draft genome of E. thailandicus has expanded on the current 
Enterococcus genome database and will be a valuable addition in comparative genomic analysis 
studies to further understanding of the diversity of the genus Enterococcus. 
 
Nucleotide sequence accession number. This Whole Genome Shotgun project has been 
deposited in DDBJ/ENA/GenBank under the accession LWMN00000000. The version described 
in this paper is the first version LWMN01000000. 
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Chapter 7 
 
 
Comparative genomic analysis of Enterococcus spp. isolated from bovine 
faeces4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4 This chapter has been submitted and is under review: Beukers, A.G., Zaheer, R., Goji, N., 
Amoako, K.K., Chaves, A.V., Ward, M.P. and McAllister, T.A. Comparative genomic 
analysis of Enterococcus spp. isolated from bovine feces. BMC Microbiol. (Submitted). 
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7.1. Abstract 
Enterococcus is ubiquitous in nature and is a commensal of both the bovine and human 
gastrointestinal (GI) tract. It is also associated with clinical infections in humans. Subtherapeutic 
administration of antibiotics to cattle selects for antibiotic resistant enterococci in the bovine GI 
tract. Antibiotic resistance genes (ARGs) may be present in enterococci following antibiotic use 
in cattle. If located on mobile genetic elements (MGEs) their dissemination between 
Enterococcus species and to pathogenic bacteria may be promoted, reducing the efficacy of 
antibiotics. We present a comparative genomic analysis of twenty-one Enterococcus spp. 
including Enterococcus hirae (n=10), Enterococcus faecium (n=3), Enterococcus villorum (n=2), 
Enterococcus casseliflavus (n=2), Enterococcus faecalis (n=1), Enterococcus durans (n=1), 
Enterococcus gallinarum (n=1) and Enterococcus thailandicus (n=1) isolated from bovine 
faeces. The analysis revealed E. faecium and E. faecalis from bovine faeces share features with 
human clinical isolates, including virulence factors. The Tn917 transposon conferring macrolide-
lincosamide-streptogramin B resistance was identified in both E. faecium and E. hirae, 
suggesting dissemination of ARGs on MGEs may occur in the bovine GI tract. An E. faecium 
isolate was also identified with two integrative conjugative elements (ICEs) belonging to the 
Tn916 family of ICE, Tn916 and Tn5801, both conferring tetracycline resistance. This study 
confirms the presence of enterococci in the bovine GI tract possessing ARGs on MGEs, but the 
predominant species in cattle, E. hirae is not commonly associated with infections in humans. As 
the cost of genomic sequencing continues to decrease, further investigation of ICE using whole 
genome sequencing will help determine if there are linkages between enterococci isolates from 
bovine environmental and human clinical sources and whether bovine enterococci represent a 
source of dissemination and spread of antibiotic resistance.  
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Key words: bovine faeces, Enterococcus, comparative genomics  
 
7.2. Introduction 
The genus Enterococcus is ubiquitous in nature and can be found in a range of habitats, 
being associated with soil, plants, fresh and salt water, sewage and the gastrointestinal (GI) tract 
of animals (including mammals, birds, fish, reptiles and insects) and humans (Franz et al., 2011). 
Although typically a commensal of the human GI tract, enterococci are often associated with a 
variety of clinical infections including urinary tract infections, hepatobiliary sepsis, endocarditis, 
surgical wound infections, bacteraemia and neonatal sepsis (Agudelo Higuita and Huycke, 2014; 
Poh et al., 2006). Enterococcus faecalis and Enterococcus faecium are the two species 
responsible for the majority of healthcare-associated enterococcal infections (Sivert et al., 2013). 
Difficulties in treating enterococcal infections have emerged due to their ability to readily 
acquire resistance to many antibiotics, most notably to vancomycin. As a result, the ability to 
successfully treat clinical infections has been reduced (Arias and Murray, 2008).  
Antibiotic use in livestock production has been correlated with the emergence of 
antibiotic resistant bacteria. This was first recognised in the 1990s when use of the glycopeptide 
avoparcin as a subtherapeutic growth promotant led to the emergence of glycopeptide-resistant 
E. faecium in livestock and poultry (Bager et al., 1997). Consumption of meat products 
contaminated with resistant bacteria was suggested to lead to the transmission of glycopeptide-
resistant E. faecium to healthy, non-hospitalised humans. This association demonstrated 
transmission of resistant bacteria from animals to humans through the food chain (Klare et al., 
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1995; Schouten and Voss, 1997). Consequently, avoparacin was banned as a growth promotant 
in Europe in 1997 (European Commission, 1997). However, many antibiotics continue to be 
administered subtherapeutically to livestock in North America. For example, tylosin phosphate, a 
member of the macrolide family, is administered subtherapeutically to cattle to control liver 
abscesses. We recently demonstrated subtherapeutic administration of tylosin phosphate selected 
for macrolide resistant enterococci in the bovine GI tract (Beukers et al., 2015). Enterococci have 
the ability to transfer antibiotic resistance and virulence genes horizontally to other bacteria 
(Coburn et al., 2007). The creation of a reservoir of resistant enterococci in the bovine GI tract 
could promote the dissemination of antibiotic resistance genes (ARGs) to other bacteria, 
particularly if they are associated with mobile genetic elements (MGEs). 
Comparative genomic analysis can be used to identify genes coding for virulence, 
antibiotic resistance and gene mobility as well as elucidate the evolutionary relationship among 
bacteria. The number of complete or draft genome sequences available for E. faecalis and E. 
faecium is 446 and 436, respectively, comprising the bulk of enterococcal genome sequences 
available (http://www.ncbi.nlm.nih.gov/genome), as several comparative genomic studies of 
these species has been conducted (Palmer et al., 2012; Qin et al., 2012; Van Schaik et al., 2010). 
There are comparatively few draft genome sequences available for other Enterococcus spp. with 
only 11, 10, 6, 5, 2 and 1 genomes are available for Enterococcus casseliflavus, Enterococcus 
hirae, Enterococcus durans, Enterococcus gallinarum, Enterococcus villorum and Enterococcus 
thailandicus, respectively (http://www.ncbi.nlm.nih.gov/genome). Furthermore, there is a poor 
representation of genomic sequences available for enterococci isolated from non-human sources 
because the majority of enterococcal genomic sequences available originate from human clinical 
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infections (Palmer et al., 2014). Therefore, there is a need to expand the currently available 
dataset of enterococcal genomic sequences.  
Previously, we identified a number of enterococci from bovine faeces that carried at least 
one ARG, but only a few isolates carrying multiple ARGs (Beukers et al., 2015). We also 
identified E. hirae as the principle species of the bovine GI tract, with infrequent isolation of E. 
faecium and E. faecalis, the species associated with nosocomial infections in humans. In the 
current study, we selected twenty-one isolates of enterococci originating from bovine faeces for 
whole-genome sequencing and comparative genomic analysis. We hypothesised that E. faecium 
and E. faecalis would present more genes coding for virulence and antibiotic resistance than 
other Enterococcus spp. isolated from bovine faeces.  
 
7.3. Methods 
7.3.1. Isolate selection 
Twenty-one Enterococcus spp. isolated from bovine faeces including E. hirae (n=10), E. 
faecium (n=3), E. villorum (n=2), E. casseliflavus (n=2), E. faecalis (n=1), E. durans (n=1), E. 
gallinarum (n=1) and E. thailandicus (n=1) were selected for whole genome sequencing (Table 
7.1.). These were selected from an archive of isolates collected between 2004 and 2005, which 
were previously characterised by PFGE and antimicrobial susceptibility testing (Beukers et al., 
2015). At least one representative of each species isolated from bovine faeces was selected, and 
for E. hirae and E. faecium, selection was based on maximizing diversity as measured by PFGE 
profiles as well as selecting isolates that displayed unique antimicrobial resistance profiles. 
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7.3.2. DNA extraction and sequencing 
Genomic DNA was isolated using phenol:chloroform extraction. Enterococcus spp. were 
inoculated into 5 mL brain heart infusion (BHI; BD, Franklin Lakes, New Jersey, USA) broth 
and grown for 24 h in a shaking incubator (250 rpm; Excella E24 Incubator Shaker, New 
Brunswick Scientific) at 37°C. To increase cell yield, 150 µL aliquots were inoculated into 
duplicate tubes containing 6 mL BHI (BD) and grown over 24 h as described above. Cells were 
harvested by centrifugation at 10,000 × g for 5 min into a 2 mL microfuge tube and stored at -
20°C until genomic DNA was extracted. For extraction, the pellet was thawed on ice and 
resuspended in 1 mL of sterile 0.85% NaCl to remove residual growth media. The cells were 
repelleted by centrifugation (10,000 × g) for 1 min and the supernatant decanted. The washed 
cell pellet was resuspended in 665 µL of T10E25 (10 mM Tris-HCl pH 7.5; 25 mM EDTA) and 35 
µL of lysozyme (50 mg/mL; Sigma-Aldrich, Co., St. Louis, Mo, USA) was added. The tubes 
were incubated at 55°C for 60 min as a pre-lysis step. A 175 µL of 5M NaCl, 35 µL of proteinase 
K (10mg/mL; Sigma-Aldrich) and 44 µL of 20% SDS were added to the suspension and mixed 
by gentle inversion before being incubated at 65°C for 1-2 h until cell lysis was complete. The 
lysed cells were extracted once with phenol, once with phenol:chloroform:isoamylalcohol 
(25:24:1) and twice with chloroform. Ammonium acetate (10 M) was added to the mixture so as 
to achieve a final concentration of 0.5 M, followed by one volume of isopropanol to precipitate 
DNA. To encourage precipitation, the tubes were chilled on ice for 10 min before centrifuging at 
10,000 × g for 10 min. The supernatant was decanted and the DNA pellet washed with 70% 
ethanol and allowed to air dry before dissolving in 400 µL of TE (10 mM Tris-HCl; 1 mM 
EDTA). RNase A was added to achieve a final concentration of 30 µg/mL and the mixture was 
incubated for 20 min at 37°C. Duplicate solutions for each sample were pooled before 
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performing a second extraction, once with phenol:chloroform:isoamylalcohol and once with 
chloroform. Ammonium acetate (10 M) was added to the final aqueous solution to achieve a 
final concentration of 2 M followed by one volume of isopropanol and chilled on ice for 10 min 
to precipitate DNA. The DNA was pelleted by centrifugation, washed with 70% ethanol, air-
dried, dissolved in 100 µL of sterile deionized water and stored at -80°C until genomic library 
construction.  
Genomic library construction was performed using the Illumina Nextera XT DNA 
sample preparation kit (Illumina, Inc., CA, USA) following the manufacturer’s instructions and 
sequenced on an Illumina MiSeq platform (Illumina). High-quality reads were de novo 
assembled using SPAdes genome assembler version 3.6.0 software (Bankevich et al., 2012) and 
annotated using Prokka version 1.10 (Seemann, 2014). Multi-locus sequence typing (MLST) was 
performed using the MLST database (version 1.8) (Larsen et al., 2012). 
 
7.3.3. Comparative analysis  
Draft genome sequences of the 21 Enterococcus spp. were investigated for the presence 
of putative virulence genes and ARGs, mobile genetic elements (MGEs), bacteriophage, 
CRISPR-Cas and secondary metabolite biosynthetic gene clusters. Virulence genes were 
identified using VirulenceFinder (version 1.5) (Joensen et al., 2014), and ARGs using a 
combination of ResFinder (version 2.1) (Zankari et al., 2012) and the Comprehensive Antibiotic 
Resistance Database (CARDs) (McArthur et al., 2012). Results for ARGs were further verified 
using megaBLAST and hits were manually inspected. Genomes were investigated for integrative 
conjugative elements (ICEs) by homology searches using BLAST against 466 ICEs downloaded 
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from the ICEberg database (version 1.0) (Bi et al., 2012). To identify bacteriophage, the contigs 
of each draft genome were ordered based on alignment against a reference genome (see 
Appendix 3 Table S7.1.) using progressive Mauve (Darling et al., 2010), and then analysed for 
the presence of prophage using PHAST (Zhou et al., 2011). CRISPR-Cas were identified using 
the CRISPRdb (Grissa et al., 2007) and secondary metabolite biosynthetic gene clusters using 
the Antibiotics and Secondary Metabolite Analysis Shell (antiSMASH) (Medema et al., 2011). 
All alignments and BLAST searches were performed in Geneious version 9.0.4 (Biomatters, 
Ltd). Assignment of proteins into Clusters of Orthologous Groups (COGs) was performed using 
the Integrated Microbial Genomes (IMG) platform (Markowitz et al., 2012). Blast atlases were 
generated by GView Java package software (Petkau et al., 2010) using both alignment length and 
percent identity cut-off values at 80%. The GView server (Petkau et al., 2010) was used to 
perform pan-genome analysis of E. hirae. 
 
7.4. Results and Discussion 
7.4.1. Sequencing statistics 
A summary of the sequencing statistics for the 21 Enterococcus spp. genomes can be 
found in Table 7.1. The genomes ranged in size from 2.60−3.64 Mb with E. thailandicus 
exhibiting the smallest and E. casseliflavus the largest genome. There was considerable variation 
in the size of E. hirae genomes, suggesting large differences in the size of the chromosome 
between strains and/or the presence/absence of plasmids.  
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7.4.2. Phylogeny 
A phylogenetic tree was constructed based on analysis of single-nucleotide 
polymorphisms (SNPs) of the core genes of all 21 sequenced Enterococcus genomes, and using 
Enterococcus hirae ATCC 9790 as an outgroup (Figure 7.1.). The assembled tree was consistent 
with the PFGE profile dendrogram observed from our previous study (Beukers et al., 2015). As 
expected, clustering was observed for genomes of the same species further verifying the identity 
of each species based on previous groES-EL spacer speciation (Beukers et al., 2015).  
 
7.4.3. Clusters of orthologous groups (COGs) 
Clusters of Orthologous Groups (COGs) are broad functional categories used to assign 
proteins related by function (Tatusov et al., 2001). Functional categorization of proteins into 
different COGs (Appendix 3 Figure S7.1.) revealed variation in the functional profile among 
Enterococcus spp., but the percentage of COGs assigned to cell cycle control, cell division, 
chromosome partitioning; extracellular structures; and intracellular trafficking, secretion and 
vesicular transport were similar between species. The percentage of COGs assigned to cell 
motility was greatest for E. gallinarum and E. casseliflavus, two species of Enterococcus that are 
known to be motile (Palmer et al., 2012). The percentage of COGs for cell motility was low for 
all other enterococci species, which are known to be non-motile (Devriese et al., 1993). There 
was little difference in the functional profile between strains of the same species with the 
exception of the mobilome: prophages, transposons category, in which inter-species variation 
was observed. Two E. hirae strains (E. hirae 4 and E. hirae 9), two E. faecium strains (E. 
faecium 11 and E. faecium 12) and an E. villorum, E. faecalis and E. casseliflavus strain 
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Figure 7.1. Phylogenetic tree constructed based on analysis of single-nucleotide polymorphisms 
(SNPs) of the core genes of all 21 sequenced Enterococcus genomes isolated from bovine faeces 
using Enterococcus hirae ATCC9790 as an outgroup.  
(E. villorum 16, E. faecalis 17 and E. casseliflavus 20, respectively) had the greatest percentage 
of proteins assigned in this category with these proteins being most frequently associated with 
phage and transposases. 
Using the compare genomes function available in the IMG platform, we produced an 
abundance profile overview of the gene count for different COGs for all 21 Enterococcus spp. 
genomes. Van Schaik et al. (2010) performed a COG-based functional comparison between E. 
faecium and E. faecalis in an effort to identify characteristics that distinguished the two species. 
In their analysis, they identified differences in sugar metabolism for the pentose sugar arabinose. 
They found COGs responsible for metabolism (COG2160 and COG3957), uptake (COG4213 
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and COG4214) and degradation (COG3940) of arabinose to be present in E. faecium and absent 
in E. faecalis, attributing this to the inability of E. faecalis to metabolise arabinose (Deibel et al., 
1963). Genes for these COGs, with the exception of COG4214 in E. faecium 12, were present in 
the E. faecium strains examined in this study and absent in our E. faecalis strain. Genes for these 
COGs were also present in E. gallinarum and E. casseliflavus strains suggesting these species of 
Enterococcus also have the ability to metabolise arabinose. Ford et al. (1994) previously 
documented that strains of E. gallinarum and E. casseliflavus that they examined were able to 
metabolise arabinose but demonstrated poor growth compared to E. faecium. In the current 
study, E. hirae, E. villorum, E. durans and E. thailandicus all lacked genes for these COGs 
suggesting that they lacked the ability to metabolise arabinose, an outcome that has been 
biochemically confirmed by others (Devriese et al., 2002; Farrow and Collins, 1985; 
Tanasupawat et al., 2008). Arabinose is a subunit of the plant polysaccharide hemicellulose and 
therefore would be in abundance in the GI tract of cattle (Van Schaik et al., 2010). Despite E. 
faecium being able to utilise arabinose as an energy source, this trait does not appear to provide a 
competitive advantage for this species to proliferate in the GI tract of cattle, considering E. hirae 
is the predominant species identified (Beukers et al., 2015). 
Van Schaik et al. (2010) investigated other COGs involved in the metabolism of carbon 
sources from plants including COG4677, which is predicted to be involved in the metabolism of 
pectin, and COG3479, which is involved in the breakdown of coumaric acid and other 
components of lignocellulose. In our study, COG4677 was present in E. faecium, E. durans and 
E. casseliflavus and absent from E. hirae, E. thailandicus, E. villorum, E. faecalis and E. 
gallinarum, whilst COG3479 was present in E. hirae, E. faecium, E. villorum and E. durans and 
absent from E. faecalis, E. thailandicus, E. gallinarum and E. casseliflavus. These authors also 
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highlighted a number of COGs present in E. faecalis that were absent in E. faecium including 
COGs for the utilisation of ethanolamine as a carbon source. Ethanolamine is a phospholipid that 
can be found in the bovine GI tract (Bertin et al., 2011). In the current study, E. faecalis 
possessed COGs for the utilisation of ethanolamine, which were confirmed to be absent in E. 
faecium. Ethanolamine utilisation has been demonstrated for E. faecalis (Florencia Del Papa and 
Perego, 2008) but not for other Enterococcus species. In the current study, these COGs were also 
identified in E. gallinarum suggesting this Enterococcus species may also utilise ethanolamine as 
an energy source but to our knowledge has yet to be demonstrated biochemically. It is clear that 
different Enterococcus spp. have the ability to utilise various carbon sources allowing them to 
inhabit and survive in many diverse environments, including the GI tract of cattle. From this 
study, it was not apparent if E. hirae possessed specific traits for carbohydrate metabolism that 
may promote its abundance in the GI tract of cattle over other Enterococcus spp. 
Van Schaik et al. (2010) also investigated proteins involved in protection against 
oxidative stress. They identified the enzyme catalase (COG0753) was present in E. faecalis and 
absent in E. faecium. Examination of the different Enterococcus spp. in this study confirmed 
catalase to be specific for E. faecalis as it was absent from all other species. In the presence of 
heme, E. faecalis exhibits catalase activity (Frankenberg et al., 2002). Catalase production has 
been speculated to play a role in virulence in pathogenic bacteria including Staphylococcus 
aureus (Clements and Foster, 1999; Kanafani and Martin, 1985). E. faecalis can be exposed to 
oxidative stress as part of the host defence against invasion (Frankenberg et al., 2002). Catalase 
production may offer some protection against oxidation during invasion, contributing to the 
virulence of E. faecalis. Other mechanisms in E. faecium may play a role in the oxidative stress 
response, including the production of glutathione peroxidase (COG0386) (Van Schaik et al., 
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2010). With the exception of E. faecalis, this COG was present in all species of Enterococcus 
examined in this study, demonstrating the different strategies Enterococcus spp. use to combat 
oxidative stress. 
 
7.4.4. Multi-locus sequence typing (MLST) 
Multi-locus sequence typing (MLST) has been used to study the population structure and 
evolution of E. faecium and E. faecalis (Ruiz-Garbajosa et al., 2006; Willems et al., 2005). This 
technique involves sequencing and analysis of housekeeping genes and assignment of a sequence 
type (ST) (Homan et al., 2002; Ruiz-Garbajosa et al., 2006). In the current study E. faecium 11, 
E. faecium 12 and E. faecium 13 were classified as ST214, unknown and ST955, respectively, 
and E. faecalis 17 as ST242 (Table 7.1.). The lack of an assignment of a ST for E. faecium 12 
suggests there are STs that have yet to be defined within the MLST database. STs can be 
assigned to a clonal complex (CC) based on their similarity to a central alleic profile (PubMLST, 
2016). MLST analysis of the population structure of E. faecium has identified that the majority 
of strains associated with nosocomial infections belong to the Clonal Complex 17 (CC17) 
(Willems et al., 2005). For E. faecalis it appears that two complexes, CC2 and CC9, represent 
hospital-derived strains (Leavis et al., 2006; Ruiz-Garbajosa et al., 2006). The STs assigned to E. 
faecium and E. faecalis identified in the current study have been described previously (Boyd et 
al., 2015; Camargo et al., 2006; Sun et al., 2009) and are not associated with complexes of 
hospital-derived strains. There is currently no typing scheme available for other Enterococcus 
spp.  
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7.4.5. BLAST atlas 
A BLAST atlas was constructed for E. hirae and E. faecium strains using E. hirae ATCC 
9790 and E. faecium DO as reference strains, respectively (Figure 7.2.). Of the E. hirae strains, 
E. hirae 7 exhibited the highest relatedness to the reference strain. E. hirae 7 and E. hirae 8 also 
shared phage-related genes with the reference strain (Figure 7.2.a). There were few variable 
regions identified between strains of E. hirae, demonstrating similarity in gene content between 
strains. Likewise, the gene content between strains of E. faecium was also highly similar (Figure 
7.2.).  
 
7.4.6. Pan-genome analysis 
The pan-genome is comprised of three components: i) the core genome, describing genes shared 
across all strains; ii) the accessory or dispensable genome, describing genes that are present in 
one or more strains; and iii) unique genes, describing species-specific or strain-specific genes 
(Tettelin et al., 2005). We proceeded to carry out a pan-genome analysis of E. hirae genomes 
from this study to identify core and unique genes. A core genome consisting of 2,256 genes was 
identified for the 10 E. hirae strains (Figure 7.3.). The core genome of E. hirae from this study 
accounted for approximately 80% of each genome. Genes in the core genome are generally 
associated with the basic biology and maintenance of the organism (Medini et al., 2005; Tettelin 
et al., 2005). As expected, the core genome of the 10 E. hirae strains accounted for housekeeping 
genes essential for the basic biology of E. hirae such as carbohydrate transport and metabolism; 
translation, ribosomal structure and biogenesis; amino acid transport and metabolism; and 
transcription.  
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Figure 7.2. a) Blast atlas of Enterococcus hirae isolated from bovine faeces mapped against 
reference sequence Enterococcus hirae ATCC9790. Starting from the outer circle: E. hirae 10, 
E. hirae 9, E. hirae 8, E. hirae 7, E. hirae 6, E. hirae 5, E. hirae 4, E. hirae 3, E. hirae 2, E. hirae 
1. b) Blast atlas of Enterococcus faecium genomes isolated from bovine faeces mapped against 
reference sequence Enterococcus faecium DO. Starting from the outer circle: E. faecium 13, E. 
faecium 12, E. faecium 11. Blast atlases were generated by GView Java package software 
(Petkau et al. 2010) using both alignment length and percent identity cut-off values at 80%. 
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Figure 7.3. Venn diagram showing size of the core genome, pan-genome and number of strain 
unique CDS in 10 Enterococcus hirae genomes isolated from bovine faeces. Petals contain 
number of unique CDS per strain and core genes are presented in the centre. 
7.4.7. Virulence genes 
Virulence genes contribute to the pathogenicity of an organism. In this study, virulence 
genes were only detected in E. faecium and E. faecalis. All three E. faecium strains contained the 
efaA and acm genes, whilst E. faecalis contained a number of virulence genes including efaA, 
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ace, ebp pili genes, gelE and fsrB. The acm and ace genes described in E. faecium and E. 
faecalis, respectively, are important for facilitating cell wall adhesion to host tissues 
(Nallapareddy et al., 2003; Rich et al., 1999). The efaA gene found in both E. faecalis and E. 
faecium also plays a role in adherence to host tissues and is a virulence factor involved in 
endocarditis (Lowe et al., 1995; Singh et al., 1998). The ebp pili genes described in E. faecalis, 
comprising of ebpA, ebpB and ebpC, assist in adherence and biofilm formation (Nallapareddy et 
al., 2006). The gelE gene also found in E. faecalis encodes for gelatinase, which hydrolyses 
gelatin, collagen, casein and haemoglobin (Su et al., 1991). Its expression is regulated by the 
two-component fsr system, with both gelE and fsr genes important in biofilm formation 
(Hancock and Perego, 2004; Nakayama et al., 2006; Qin et al., 2000).  
In addition to these virulence genes, a number of bacterial sex pheromone genes were 
also present in E. faecalis including cad, camE, cCF10 and cOB1. Certain conjugative plasmids 
found in E. faecalis respond to the secretion of bacterial sex pheromone genes from plasmid-free 
enterococci, inducing their transfer (Clewell, 1993). Sex pheromone response plasmids have 
rarely been described in other Enterococcus spp. However, there have been a few reported for E. 
faecium (Handweger et al., 1990; Magi et al., 2003). The bacterial sex pheromones detected in 
the E. faecalis genome target the sex pheromone plasmids pAD1, pAM373, pCF10 and pOB1, 
respectively. Some of these plasmids encode features that can contribute to virulence such as 
pAD1 and pOB1, both encoding for a bacteriocin and hemolysin, and pCF10, encoding 
tetracycline resistance (Wirth, 1994). The pheromone cAD1 precursor lipoprotein cad gene was 
detected in all of the Enterococcus spp. isolates sequenced in this study, with amino acid 
identities 98%, 72%, 69%, 67%, 66%, 66%, 64% and 59% for E. faecalis, E. faecium, E. durans, 
E. thailandicus, E. hirae, E. villorum, E. gallinarum and E. casseliflavus respectively, as 
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compared to the cad gene in E. faecalis strain FA2-2 (GenBank accession no. AF421355.1). 
Presence of the cAD1 precursor lipoprotein in these Enterococcus spp. increases their potential 
of receiving the highly conjugative pheromone-responding plasmid pAD1. The 
hemolysin/bacteriocin (cytolysin) encoded by this plasmid has been shown to contribute to 
virulence in animal models (Clewell, 2007). Therefore acquisition of this plasmid by these 
Enterococcus spp. could increase their virulence. Further analysis is required to determine if this 
sex pheromone precursor is able to induce transfer of pAD1 to Enterococcus spp. other than E. 
faecalis. 
Virulence genes have mostly been characterised in E. faecalis and E. faecium, with little 
information available on the nature of these genes in other enterococcal species. A study 
investigating virulence traits for cytolysin, adhesins and hydrolytic enzymes described the 
presence of the whole cytolysin operon in E. durans and the presence of genes for cytolysin in E. 
hirae and E. gallinarum, isolated from cheese and milk. Other virulence genes were also 
commonly detected in E. durans, such as the esp gene which is important for adhesion (Semedo 
et al., 2003). With the exception of E. faecalis and E. faecium, virulence genes were not detected 
in the other Enterococcus isolates from the bovine GI tract sequenced in this study. The detection 
of virulence genes is not exclusive to human clinical enterococci. Studies have identified 
virulence genes in enterococci irrespective of their origin, such as from human and animal hosts, 
food and the environment (Iweriebor et al., 2015; Jimenez et al., 2013; Semedo et al., 2003). For 
E. faecalis and E. faecium, there is usually a greater incidence of virulence genes detected in E. 
faecalis than in E. faecium (Eaton and Gasson, 2001; Franz et al., 2001), an outcome that agrees 
with our study. 
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7.4.8. Antibiotic resistance genes 
Enterococci can exhibit resistance to a number of antibiotics, partly due to their innate 
resistance to many commonly used antibiotics such as penicillin, but also due to their ability to 
successfully acquire resistance through horizontal exchange of ARGs on MGEs (Kristich et al., 
2014). In this study we screened the 21 Enterococcus genomes against the ResFinder and 
CARDs databases for resistance genes (Table 7.2.).  
Genes conferring resistance to vancomycin were only found in the genomes of E. 
gallinarum and E. casseliflavus, where the vanC operon was present. The vanC operon is 
intrinsic to these species of Enterococcus and provides resistance to low concentrations of 
vancomycin (Leclercq et al., 1992; Navarro and Courvalin, 1994). Of the isolates examined in 
this study, only E. casseliflavus 20 displayed phenotypic resistance to vancomycin (Appendix 3 
Table S7.2.). The intrinsic resistance of E. casseliflavus and E. gallinarum can provide protection 
to concentrations of vancomycin as high as 32 µg/mL (Gold, 2001). For disc susceptibility 
testing, the concentration of vancomycin in the disc was 30 µg (Beukers et al., 2015). This 
concentration was sufficient to inhibit the growth of E. gallinarum 18 and E. casseliflavus 21 
despite the presence of the vanC operon in these isolates. However, vanC in E. casseliflavus 20 
provided adequate resistance to allow growth of this isolate in the presence of vancomycin. The 
lack of vancomycin resistance genes in Enterococcus isolated from bovine faeces is not 
surprising as avoparcin, a glycopeptide antimicrobial related to vancomycin, has not been used in 
cattle in North America (Health Canada, 2002).  
Resistance genes to macrolides were present in a number of Enterococcus genomes 
sequenced, a finding that coincides with the fact that cattle were administered tylosin phosphate 
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in their diets (Beukers et al., 2015). Erm(B) confers resistance to macrolide-lincosamide-
streptogramin B (MLSB) antibiotics and was found in isolates of E. hirae, E. faecium, E. 
villorum, E. gallinarum and E. casseliflavus. In contrast, msrC, a macrolide efflux pump, was 
only detected in E. faecium (Table 7.2.). This is consistent with Portillo et al. (2000) who 
described erm(B) as the predominant gene conferring resistance to erythromycin in Enterococcus 
spp. and msrC in E. faecium. The presence of these resistance genes corresponded with the 
phenotypic resistance observed in these isolates (Appendix 3 Table S7.2.). Interestingly, E. hirae 
6, E. durans 19 and E. casseliflavus 20 exhibited resistance to macrolides even though no 
resistance genes to macrolides matched those in either the ResFinder or CARDs databases.  
We previously reported that the E. thailandicus isolate sequenced in this study exhibited 
intermediate resistance to erythromycin (Appendix 3 Table S7.2.; Beukers et al., 2015; Beukers 
et al., 2016). Although there were no obvious macrolide resistance genes present, there were a 
number of genes identified as having multidrug efflux functions which may have contributed to 
the observed intermediate resistance to erythromycin (Beukers et al., 2016). There is also the 
possibility that this phenotype was as a result of an unknown gene that codes for erythromycin 
resistance.  
Genes conferring resistance to high concentrations of aminoglycosides were not detected 
in any of the genomes analysed. Susceptibility to high concentrations of aminoglycosides was 
confirmed by the lack of phenotypic resistance to gentamicin and streptomycin (Appendix Table 
S7.2.). Enterococci are intrinsically resistant to low concentrations of aminoglycosides which is 
conferred by the genes aac(6’)-Ii, aac(6’)-Iid and aac(6’)-Iih present in E. faecium, E. durans 
and E. hirae, respectively (Table 7.2.; Costa et al., 1993; Del Campo et al., 2005).  
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Genes coding for tetracycline resistance were detected in a number of genomes, including 
E. hirae, E. faecium and E. villorum (Table 7.2.). Tet(L) encodes for an efflux protein whilst 
tet(M) and tet(O) encode for ribosomal protection proteins (Roberts, 2005). Anderson et al. 
(2008) found tet(O) was the most prevalent gene encoding for tetracycline resistance in 
enterococci isolated from cattle, a finding that agrees with ours. Anderson et al. (2008) reported 
E. hirae as the predominant species isolated from cattle and tet(O) was only associated with E. 
hirae in the current study. Detection of tet(M) and tet(L) in other isolates is not unexpected as 
both genes are also frequently detected in enterococci from animals including poultry, pigs, dogs, 
cats, rabbits, badgers, wildcats and birds (Aarestrup et al., 2000; Poeta et al., 2005; Poeta et al., 
2006). Disc susceptibility testing revealed isolates containing tet(M) were resistant to 
doxycycline whilst those containing tet(L) or tet(O) were susceptible (Appendix 3 Table S7.2.). 
It is possible that isolates that are sensitive to doxycycline are susceptible to other members of 
the tetracycline family. In general, bacteria that are resistant to doxycycline are also resistant to 
other tetracyclines including tetracycline and oxytetracycline (Holzel et al., 2010; Roberts, 
2002).  
Only a few of the selected genomes contained ARGs to two or more antibiotics. Of 
particular interest was E. faecium 11, which contained at least 11 ARGs as inferred from the 
analysis of genome sequences (Table 7.2.), including those conferring aminoglycoside, MLSB, 
pleuromutilin, streptogramin A, tetracycline and streptothricin resistance.  
7.4.9. Mobile genetic elements 
Mobile genetic elements (MGEs) play an important role in horizontal gene transfer 
(HGT) of ARGs within and between bacteria from human and/or animal hosts (Bennett, 2008; 
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Burrus et al., 2002; Roberts and Mullany, 2011). MGEs include plasmids, transposable elements, 
prophages and various genomic islands such as integrative and conjugative elements (ICEs) 
(Wozniak and Waldor, 2010). A number of MGEs have been described in enterococci including 
transposons, plasmids and bacteriophage (Werner, 2013).  
The well-known Tn3-like transposon, Tn917, which is widely distributed in enterococci 
was identified in several of the sequenced genomes. Four E. hirae strains (E. hirae 1, E. hirae 2, 
E. hirae 3 and E. hirae 4) and one E. faecium strain (E. faecium 11) had high sequence homology 
(>95%) to the Tn917 transposon, previously described in E. faecalis (Shaw and Clewell, 1985). 
All of these strains exhibited erythromycin resistance (Appendix 3 Table S7.2.; Beukers et al., 
2015), conferred by the erm(B) resistance gene present in Tn917. Other distinguishing features 
of this transposon include a transposase (TnpA) and a resolvase (TnpR) involved in the 
replicative mode of transposition (Nicolas et al., 2014).  
The erm(B) gene was present in a number of other genomes including E. hirae 5, E. 
villorum 16, E. gallinarum 18 and E. casseliflavus 21. However, it did not align with the Tn917 
transposon. In E. hirae 5, the erm(B) gene was found on a contig associated with chromosomal 
genes. The tetracycline resistance gene tet(O) was also found in the vicinity of erm(B). Based on 
sequence information, erm(B) in the other three genomes appeared to plasmid mediated. In E. 
villorum 16, the erm(B) and tet(L) genes were found on contigs associated with a plasmid 
sequence from an E. faecium strain UW8175 (GenBank accession no. CP011830.1). In E. 
gallinarum 18 and E. casseliflavus 21, the erm(B) gene was found on contigs associated with the 
plasmid sequence of pRE25 from an E. faecalis (GenBank accession no. X92945.2).  
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The tetracycline resistance genes tet(L) and tet(M) found in E. hirae 1 were located on a 
contig which shared 21,418 identical bp with the 25,963 bp transposon Tn6248 of E. faecium 
strain E506 (GenBank accession no. KP834592). The genes responsible for transposition (tnpA) 
and insertion and excision of Tn6248 (tndX) were absent, as was the chloramphenicol 
acetyltransferase gene (cat). This same contig also appeared to be associated with a plasmid 
sequence in E. hirae strain R17 (GenBank accession no. CP015517.1), suggesting this remnant 
transposon may be on a plasmid. 
Integrative conjugative elements (ICEs) are self-transmissible elements that contain 
modules for their maintenance, dissemination and regulation (Burrus and Waldor, 2004). In 
major Gram-positive human pathogens (e.g. Enterococcus spp., Staphylococcus spp. and 
Streptococcus spp.), tetracycline resistance is known to arise from the acquisition of the Tn916-
family ICE carrying the tet(M) gene. The gene synteny in this family of ICE is well conserved, 
but there are differences in integrase (int) and excisionase (xis) gene sequences, insertion site 
specificity, and host range among family members (Ciric et al., 2013; Hegstad et al., 2010; 
Novais et al., 2012). The Tn916 ICE was originally identified as an 18-kb conjugative 
transposon in E. faecalis DS16 (Flannagan et al., 1994; Franke and Clewell, 1981). Variants of 
some Tn916-tet(M) members, including Tn916, Tn5397, Tn6000 or Tn5801, are widely spread 
among several genera within the Firmicutes, suggesting widespread dissemination of these 
elements. Many Tn916-like ICEs have a broad host range and are responsible for dissemination 
of tetracycline resistance through tet(M) in Gram-positive bacteria associated with humans and 
animals (Franke and Clewell, 1981; Rice, 1998; Roberts and Mullany, 2011). Recently, almost 
identical Tn5801-like genomic islands have been identified in different Gram-positive species of 
pet (Staphylococcus pseudintermedius) and human (E. faecalis, S. aureus, Staphylococcus 
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agalactiae) origin, suggesting a horizontal transfer of these elements (De Vries et al., 2016). In 
our study, two ICEs belonging to the Tn916-family were identified in E. faecium 11. These ICEs 
exhibited homology to Tn916 and Tn5801, each harbouring a tet(M) variant, and appeared to be 
located within the chromosome. In Group B Streptococcus, the vast majority of Tn916 and 
Tn5801 are inserted into the core genome (Da Cunha et al., 2014). Once inserted in the genome, 
it is thought that Tn916 and Tn5801 are retained, as they impose a minimal impact to the 
biological fitness of the host bacteria (Celli and Trieu-Cuot, 1998; Da Cunha et al., 2014; 
Roberts and Mullany, 2011).  
A gene cluster aadE–sat4–aphA-3 encoding resistance to streptomycin, streptothricin and 
kanamycin, previously described in E. faecium (Werner et al., 2001) was also found in E. 
faecium 11 associated with plasmid related contigs. This gene cluster has also been described in 
Tn5405 within S. aureus (Derbise et al., 1997) and Tn1545 from Streptococcus pneumoniae 
(Palmieri et al., 2012), suggesting that it is widespread among Gram-positive bacteria.   
 
7.4.10. Bacteriophage 
Bacteriophage mediated transduction of antibiotic resistance has been demonstrated in 
enterococci (Mazaheri Nezhad Fard et al., 2011), and potential virulence determinants have been 
identified in phage associated with E. faecalis (Yasmin et al., 2010). Phage found in enterococci 
usually belong to the Podoviridae, Siphoviridae or Myoviridae, but others including Inoviridae, 
Leviviridae, Guttaviridae and Fuselloviridae have also been reported (Duerkop et al., 2014; 
Mazaheri Nezhad Fard et al., 2010).   
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All Enterococcus genomes sequenced contained at least one putative phage, ranging in 
size from 8.0 to 70.3 kb (Table 7.3.). A total of 37 intact prophages were identified across the 21 
sequenced genomes. E. hirae and E. faecium contained one to three intact prophages, whereas E. 
faecalis and E. gallinarum each contained two intact prophages and E. durans contained one 
intact prophage. E. villorum and E. casseliflavus contained up to four intact prophages whilst no 
intact prophages were detected in E. thailandicus. The intact prophages detected were from the 
Siphoviridae, Myoviridae or Podoviridae families, with prophage from the Siphoviridae family 
being most prevalent across all species examined (Table 7.3.). Prophages of the Phycodnaviridae 
family was identified in E. faecium and E. villorum. Its status was intact for only one of the E. 
faecium strains whilst it was questionable or incomplete in the others (Table 7.3.). To our 
knowledge, phage from the Phycodnaviridae family have yet to be described in enterococci 
species. However, their presence in the rumen microbiome has been reported following 
metagenomic analysis (Berg Miller et al., 2012). 
 
7.4.11. CRISPR-Cas 
Clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-
associated (Cas) genes are a type of adaptive immune response described in bacteria against 
invading genetic elements such as phage and plasmids (Makarova et al., 2015). A CRISPR locus 
includes a CRISPR array flanked by various cas genes, with the array comprised of short direct 
repeats alternating with short variable DNA sequences called ‘spacers’ (Makarova et al., 2015). 
Three types of CRISPR-Cas systems have been described, distinguished by the presence of 
different Cas genes namely cas3 for type I, cas9 for type II and cas10 for type III (Makarova et 
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al., 2011). Recently, two additional types have been proposed to this classification system that 
includes type IV and type V (Makarova et al., 2015). CRISPR-Cas systems typically described in 
enterococci are of the type II variety. However, a recent report identified a type I system in 
Enterococcus cecorum (Borst et al. 2015; Katyal et al., 2013).  
All E. hirae strains contained CRISPR arrays, except for E. hirae 8. CRISPR arrays were 
also detected in E. thailandicus, E. villorum and E. durans (Appendix 3 Table S7.3.). The 
CRISPR arrays from these genomes were flanked by Cas genes, consisting of cas9, cas1, cas2 
and csn2 with the exception of E. villorum which lacked the csn2 gene. CRISPR arrays flanked 
by these four Cas genes are classified as a type II-A system and are predicted to be functional, 
indicated by the presence of the core Cas genes cas1 and cas2 (Chylinski et al., 2014; Makarova 
et al., 2011). Following the same nomenclature, the CRISPR-Cas system identified in E. villorum 
would also be classified as a type-II system, but its subtype is unclear. 
Multiple CRISPR arrays can often be detected in bacterial genomes. However, not all 
CRISPR arrays may be accompanied by Cas genes. It is predicted that these arrays lie dormant 
or that Cas genes from other similar arrays may be sufficient for their activity (Bhaya et al., 
2011). Orphan CRISPR arrays (without Cas genes) (Katyal et al., 2013) were identified by the 
CRISPRdb in a number of genomes, including two E. hirae strains and in E. thailandicus, E. 
faecalis and E. durans (Appendix 3 Table S7.3.). No functional CRISPR arrays were detected for 
E. faecium, E. faecalis, E. gallinarum or E. casseliflavus. 
Comparison of CRISPR arrays flanked by Cas genes revealed unique arrays between 
Enterococcus species, but some arrays were shared between strains of the same species (Figure 
7.4.). Amongst the nine E. hirae strains, only four unique arrays were present. The arrays 
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identified in E. villorum were identical for both strains. The largest array was identified in E. 
thailandicus. Arrays identified in the sequenced Enterococcus genomes contained between three 
and ten direct repeat (DR) sequences, alternating with spacer sequences (Appendix 3 Table 
S7.4.). A total of 26 unique spacer sequences associated with functional CRISPR arrays and an 
additional 38 unique spacers were associated with orphan CRISPR arrays were identified 
(Appendix 3 Table S7.5.). 
In enterococci, it is hypothesised that the absence of CRISPR-Cas systems is associated 
with increased antibiotic resistance in isolates of E. faecium and E. faecalis (Palmer and 
Gilmore, 2010). In this study, E. faecium 11 lacked CRISPR-Cas and harboured several 
antibiotic resistance genes, reflecting this association (Table 7.2.; Appendix 3 Table S7.3.). 
Palmer and Gilmore (2010) detected identities between CRISPR spacer sequences and sequences 
of known pheromone-responsive plasmids and phage, suggesting CRISPR-Cas systems provided 
defence against these invading genetic elements. The authors hypothesised that the absence of 
CRISPR-Cas systems resulted in a compromised genome defence, enabling the acquisition of 
ARGs on MGEs. Palmer and Gilmore (2010) did not detect spacer sequences with identities to 
transposons and hypothesised CRISPR-Cas systems may not provide defence against 
transposons. Several E. hirae strains in the current study contained functional CRISPR-Cas 
systems and the erm(B) resistance gene on a Tn3-like transposon, supporting this theory. 
Functional CRISPR arrays and intact prophage were identified in most of the genomes 
sequenced in this study, with the exception of E. thailandicus. It is not surprising that these 
genomes contained prophage, as bacteriophage have developed strategies to avoid CRISPR 
regulation through the development of anti-CRISPR systems to enable integration into the 
genome (Sorek et al., 2008). In the case of E. thailandicus, spacers identified in CRISPR arrays
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Figure 7.4. Schematic of CRISPR-Cas systems identified in whole genome sequence analysis of 21 Enterococcus spp. genomes. a) 
Functional CRISPR array spacer and direct repeat organization. Diamonds represent direct repeats interspaced with numbers 
representing spacers. Spacer numbers correlate with sequences displayed in Appendix 3 Table S7.5. b) Orphan CRISPR array spacer 
and direct repeat organization. Diamonds represent direct repeats interspaced with numbers representing spacers. Spacer numbers 
correlate with sequences displayed in Appendix 3 Table S7.5. c) Numbered direct repeats. Numbers correlate with sequences 
displayed in Appendix 3 Table S7.4. 
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aligned to incomplete prophage sequences with 100% sequence similarity and may possibly 
explain the lack of intact prophage in this genome. Spacer 60 aligned with both regions 3 and 4 
of E. thailandicus prophage whilst spacer 12 aligned with region 4. None of the remaining 
spacers identified in CRISPR arrays had any sequence similarity to identified prophage. 
 
7.4.12. Secondary metabolites 
Bacteriocins are ribosomally synthesised antimicrobial peptides produced by Gram-
positive and Gram-negative bacteria that have antimicrobial activity against closely related 
bacteria (Yang et al., 2014). In Gram-positive bacteria, they are classified into three major 
classes. Class I consists of the heat stable, modified peptides or lantibiotics, Class II describes the 
heat stable, unmodified non-lantibioitics and Class III consists of large proteins that are heat 
unstable (Nes et al., 2014; Yang et al., 2014). It is believed the production of bacteriocins by 
bacteria provides a competitive advantage to their survival in certain ecological niches (Eijsink et 
al., 2002).  
Putative lantibiotics were identified in E. hirae, E. thailandicus and E. gallinarum whilst 
none were predicted in E. faecium, E. villorum, E. faecalis, E. durans or E. casseliflavus. 
Putative class II bacteriocins were identified in seven E. hirae strains (E. hirae 3, E. hirae 4, E. 
hirae 5, E. hirae 6, E. hirae 8, E. hirae 9, E. hirae 10), two E. faecium strains (E. faecium 11, E. 
faecium 13), E. thailandicus, E. villorum, and E. durans. A putative bacteriocin identified in E. 
faecium 11 and E. faecium 13 had an amino acid identity of 99% to Enterocin A (Genbank 
accession no. AAF44686.1). Enterocin A was first described in an E. faecium strain isolated 
from fermented Spanish sausage (Aymerich et al., 1996). Enterocin A inhibits a broad spectrum 
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of Gram-positive bacteria including species of Clostridium, Propionibacterium, Listeria and 
Staphylococcus (Casaus et al., 1997). 
Until recently, terpenes were mainly considered secondary metabolites associated with 
plants and fungi, and were described in prokaryotes in only a few instances. These compounds 
serve a number of purposes including acting as antibiotics, hormones, flavour or odour 
constituents and pigments (Yamada et al., 2012). Since the advent of genomic sequencing, a 
number of presumptive terpene synthase genes have been discovered in bacteria (Yamada et al., 
2015). Putative terpenes were identified in all E. hirae, E. villorum, E. gallinarum, E. durans and 
E. casseliflavus genomes sequenced in this study. None were predicted in E. faecium, E. 
thailandicus and E. faecalis genomes. The role of terpenes in enterococci remains unclear. 
 
 7.5. Conclusion 
This study has provided valuable insight about genetic differences observed between 
Enterococcus spp. isolated from bovine faeces. We hypothesised that enterococci originating 
from bovine faeces would lack genes coding for virulence, but would contain MGEs that could 
promote the dissemination of ARGs. We confirmed the majority of Enterococcus spp. isolated 
from bovine faeces lacked virulence traits. The virulence traits that were identified were 
primarily associated with E. faecium and E. faecalis. As E. faecium and E. faecalis are not the 
predominant species of the bovine GI tract, the risk of transmission to humans through 
contamination of food products is likely low. Of most concern perhaps is dissemination of ARGs 
on MGEs. We identified that both E. faecium and E. hirae contained the Tn917 transposon 
conferring MLSB resistance suggesting that transfer of ARGs may occur in the bovine GI tract 
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between Enterococcus spp. We also identified two ICE of the Tn916 family that conferred 
tetracycline resistance in one isolate of E. faecium. As only a small number of isolates were 
examined in this study it is possible that other enterococci may be present in the bovine GI tract 
that possess ICE with ARGs. As the cost of genomic sequencing continues to decline, further 
investigation of ICE using whole genome sequencing will help determine if there are linkages 
between enterococci isolates from bovine, the surrounding environment and human clinical 
sources.  
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Tables 
Table 7.1. Genome characteristics of Enterococcus spp. isolated from bovine faeces 
aST: sequence type
Strain No. contigs Size (bp) %GC Genes CDSs STa 
E. hirae 1 32 2926392 36.7 2785 2712 - 
E. hirae 2 29 2850950 36.7 2678 2631 - 
E. hirae 3 81 3088947 36.6 2977 2906 - 
E. hirae 4 28 3042973 36.7 2825 2753 - 
E. hirae 5 28 2869170 36.8 2741 2670 - 
E. hirae 6 62 2966815 36.6 2848 2777 - 
E. hirae 7 235 2766361 37.0 2602 2535 - 
E. hirae 8 47 2922437 36.7 2801 2730 - 
E. hirae 9 47 3178271 36.6 2971 2899 - 
E. hirae 10 71 3018341 36.6 2885 2814 - 
E. faecium 11 111 2783595 37.9 2719 2648 214 
E. faecium 12 182 2712126 38.3 2665 2597 Unknown 
E. faecium 13 28 2772865 37.7 2659 2591 955 
E. thailandicus 14 17 2603791 36.7 2495 2430 - 
E. villorum 15 42 2994157 34.9 2834 2765 - 
E. villorum 16 159 3056754 34.9 2907 2837 - 
E. faecalis 17 34 2913318 37.3 2788 2729 242 
E. gallinarum 18 41 3381991 40.5 3259 3197 - 
E. durans 19 43 2931269 37.9 2723 2657 - 
E. casseliflavus 20 85 3483586 42.6 3355 3295 - 
E. casseliflavus 21 50 3639801 42.2 3436 3375 - 
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 Table 7.2. Antibiotic resistance gene profile of Enterococcus spp. isolated from bovine faeces. Values represent % pairwise identity 
aIntrinsic to E. faecalis, bvanC operon consists of vanC, vanR-C, vanS-C, vanXY-C and is intrinsic to E.gallinarum and E. casseliflavus; GenBank 
accession numbers for resistance genes: aph(3’)-III (M26832.1), aac(6’)-Ii (L12710.1), aac(6’)-Iid (AJ584701.2), aac(6’)-Iih (AJ584700.2), ant(9)-Ia 
(JQ861959.1), adeC (CP003583.1), erm(B) (U86375.1), msrC (AY004350.1), lsa(A) (AY225127.1), lsa(E) (JX560992.1), lnu(B) (AJ238249.1), tet(L) 
(M29725.1), tet(M) (EU182585.1), tet(O) (Y07780.1), tet(32) (AJ295238.3), sat4 (U01945.1), vanC operon E. gallinarum (AF162694.1), vanC operon 
E. casseliflavus (EU151753.1) 
Resistance gene aph(3’)
-III 
aac(6’)
-Ii 
aac(6’)
-Iid 
aac(6’)
-Iih 
ant(9) 
-Ia 
adeC erm(B) msrC lsa(A)a lsa(E) lnu(B)  tet(L) tet(M) tet(O) sat4 vanC 
operonb 
Strain                 
E. hirae 1    99.5   100     100 96.5    
E. hirae 2    99.5   100          
E. hirae 3    100   100       93.0   
E. hirae 4    98.9   100       100   
E. hirae 5    100   99.5       91.4   
E. hirae 6    100             
E. hirae 7    99.5             
E. hirae 8    100             
E. hirae 9    98.9          96.9   
E. hirae 10    100          92.8   
E. faecium 11 100 100   100 99.9 100 98.9  98.9 99.9 100 95.1  99.0  
E. faecium 12  100    92.9  95.4         
E. faecium 13  99.8    99.8  99.3         
E. thailandicus 14                 
E. villorum 15                 
E. villorum 16       99.6     100     
E. faecalis 17         99.5        
E. gallinarum 18       98.6         present 
E. durans 19   100              
E. casseliflavus 20                present 
E. casseliflavus 21       98.6         present 
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 Table 7.3. Putative prophage detected in Enterococcus spp. isolated from bovine faeces 
Strain Region Length 
(kb) 
Status #CDS Putative phage GC% Phage family 
E. hirae 1 1 44.7 Intact 59 PHAGE_Entero_vB_IME197_NC_028671 35.4 Siphoviridae 
 2 49.6 Intact 54 PHAGE_Entero_phiEf11_NC_013696 33.7 Siphoviridae 
 3 26.1 Incomplete 32 PHAGE_Lactob_prophage_Lj965_NC_005355 31.0 Siphoviridae 
 4 8.0 Incomplete 9 PHAGE_Entero_EF62phi_NC_017732 33.3 Unclassified phage 
E. hirae 2 1 46.5 Intact 60 PHAGE_Entero_vB_IME197_NC_028671 35.5 Siphoviridae 
 2 52.5 Intact 61 PHAGE_Entero_phiEf11_NC_013696 33.8 Siphoviridae 
 3 26.3 Incomplete 32 PHAGE_Lactob_prophage_Lj965_NC_005355 31.0 Siphoviridae 
 4 11.2 Incomplete 17 PHAGE_Entero_EF62phi_NC_017732 33.1 Unclassified phage 
E. hirae 3 1 33.5 Intact 44 PHAGE_Lactoc_bIL285_NC_002666(14) 33.8 Siphoviridae 
 2 15.5 Incomplete 22 PHAGE_Entero_phiEf11_NC_013696(4) 34.7 Siphoviridae 
 3 14.7 Incomplete 20 PHAGE_Lister_A006_NC_009815(3) 31.8 Siphoviridae 
E. hirae 4 1 11.8 Incomplete 20 PHAGE_Entero_vB_IME197_NC_028671(3) 33.0 Siphoviridae 
 2 36.8 Intact 45 PHAGE_Entero_phiFL1A_NC_013646(7) 32.9 Siphoviridae 
 3 70.3 Intact 96 PHAGE_Bacill_phBC6A52_NC_004821(11) 36.5 Podoviridae 
E. hirae 5 1 31.7 Intact 47 PHAGE_Entero_phiFL2A_NC_013643(7) 33.7 Siphoviridae 
 2 17.6 Incomplete 18 PHAGE_Entero_vB_IME197_NC_028671(4) 31.6 Siphoviridae 
 3 40.6 Intact 51 PHAGE_Bacill_phBC6A52_NC_004821(13) 35.6 Podoviridae 
E. hirae 6 1 25.5 Questionable 40 PHAGE_Lactoc_bIL285_NC_002666(13) 33.8 Siphoviridae 
 2 21.2 Questionable 32 PHAGE_Entero_IME_EFm1_NC_024356(3) 33.5 Siphoviridae 
 3 17.5 Intact 24 PHAGE_Clostr_phi_CD119_NC_007917(2) 33.3 Myoviridae 
E. hirae 7 1 22.1 Incomplete 25 PHAGE_Entero_phiFL3A_NC_013648(6) 35.3 Siphoviridae 
 2 34.2 Intact 46 PHAGE_Lister_2389_NC_003291(15) 35.4 Siphoviridae 
 3 17.0 Incomplete 21 PHAGE_Entero_vB_IME197_NC_028671(3) 36.1 Siphoviridae 
 4 13.1 Incomplete 17 PHAGE_Lactoc_bIL285_NC_002666(13) 33.2 Siphoviridae 
E. hirae 8 1 37.6 Intact 51 PHAGE_Lactoc_bIL285_NC_002666(15) 34.5 Siphoviridae 
 2 40.5 Intact 55 PHAGE_Lister_2389_NC_003291(16) 34.6 Siphoviridae 
 3 25.4 Incomplete 18 PHAGE_Entero_phiEf11_NC_013696(4) 33.4 Siphoviridae 
 4 8.0 Incomplete 8 PHAGE_Clostr_c_st_NC_007581(2) 40.1 Myoviridae 
E. hirae 9 1 37.8 Intact 57 PHAGE_Entero_vB_IME197_NC_028671(7) 37.1 Siphoviridae 
 2 37.2 Intact 45 PHAGE_Entero_phiFL1A_NC_013646(8) 33 Siphoviridae 
 3 42.4 Intact 53 PHAGE_Bacill_phBC6A52_NC_004821(11) 35.4 Podoviridae 
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 Table 7.3. Continued 
Strain Region Length 
(kb) 
Status #CDS Putative phage GC% Phage family 
E. hirae 10 1 36 Intact 45 PHAGE_Lactoc_bIL285_NC_002666(14) 33.6 Siphoviridae 
 2 20.9 Questionable 32 PHAGE_Entero_IME_EFm1_NC_024356(3) 33.5 Siphoviridae 
E. faecium 11 1 39.7 Intact 56 PHAGE_Lactoc_TP901_1_NC_002747(14) 36.2 Siphoviridae 
 2 38.2 Intact 55 PHAGE_Entero_phiFL1A_NC_013646(10) 34.9 Siphoviridae 
 3 30.8 Intact 22 PHAGE_Ectoca_siliculosus_virus_1_NC_002687(
4) 
35.5 Phycodnaviridae 
 4 35.6 Questionable 16 PHAGE_Staphy_SPBeta_like_NC_029119(2) 34.8 Siphoviridae 
E. faecium 12 1 43.8 Intact 52 PHAGE_Lacto_phigle_NC_004305(10) 36.4 Siphoviridae 
 2 18.6 Incomplete 16 PHAGE_Bacter_Sitara_NC_028854(3) 35 Siphoviridae 
 3 32.9 Questionable 33 PHAGE_Aureoc_anophagefferens_virus_MM_201
4_NC_024697(3) 
37.3 Phycodnaviridae 
E. faecium 13 1 35.9 Intact 48 PHAGE_Bacill_BCJA1c_NC_006557(11) 35.8 Siphoviridae 
E. thailandicus 14 1 26.9 Incomplete 31 PHAGE_Lactoc_bIL285_NC_002666(4) 35.8 Siphoviridae 
 2 17.6 Incomplete 17 PHAGE_Lactoc_ul36_NC_004066(6) 36.2 Siphoviridae 
 3 24.2 Questionable 25 PHAGE_Lister_B025_NC_009812(8) 37.2 Siphoviridae 
 4 28.5 Incomplete 27 PHAGE_Clostr_phiCD27_NC_011398(3) 36.3 Myoviridae 
E. villorum 15 1 32.2 Incomplete 23 PHAGE_Staphy_PT1028_NC_007045(2) 34 Unclassified 
dsDNA phage 
 2 11.4 Incomplete 11 PHAGE_Ectoca_siliculosus_virus_1_NC_002687(
4) 
34.1 Phycodnaviridae 
 3 17.7 Incomplete 25 PHAGE_Lactoc_bIL286_NC_002667(2) 33.5 Siphoviridae 
 4 45.6 Intact 51 PHAGE_Entero_phiFL3A_NC_013648(6) 32.9 Siphoviridae 
 5 52.8 Intact 51 PHAGE_Strept_SM1_NC_004996(15) 34.4 Siphoviridae 
 6 30.1 Incomplete 30 PHAGE_Entero_EFC_1_NC_025453(4) 34.9 Siphoviridae 
 7 41.2 Intact 50 PHAGE_Lactoc_bIL285_NC_002666(14) 36.1 Siphoviridae 
E. villorum 16 1 32.2 Incomplete 23 PHAGE_Staphy_PT1028_NC_007045(2) 34 Unclassified 
dsDNA phage 
 2 11.4 Incomplete 11 PHAGE_Ectoca_siliculosus_virus_1_NC_002687(
4) 
34.1 Phycodnaviridae 
 3 17.7 Incomplete 24 PHAGE_Lactoc_bIL286_NC_002667(2) 33.6 Siphoviridae 
 4 38.4 Intact 46 PHAGE_Entero_phiFL3A_NC_013648(6) 32.9 Siphoviridae 
 5 51.7 Intact 53 PHAGE_Strept_SM1_NC_004996(15) 34.5 Siphoviridae 
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Table 7.3. Continued 
Strain Region Length 
(kb) 
Status #CDS Putative phage GC% Phage family 
E. villorum 16 6 29.4 Intact 33 PHAGE_Lactoc_bIL285_NC_002666(13) 34.9 Siphoviridae 
 7 31.8 Incomplete 22 PHAGE_Aureoc_anophagefferens_virus_MM_201
4_NC_024697(2) 
35.4 Phycodnaviridae 
 8 25.4 Incomplete 11 PHAGE_Staphy_SPBeta_like_NC_029119(2) 36 Siphoviridae 
 9 25.6 Intact 40 PHAGE_Staphy_SPBeta_like_NC_029119(2) 36.3 Siphoviridae 
E. faecalis 17 1 42.2 Intact 56 PHAGE_Entero_phiEf11_NC_013696(20) 36 Siphoviridae 
 2 37 Intact 47 PHAGE_Strept_phi3396_NC_009018(6) 35.2 Siphoviridae 
 3 17.7 Incomplete 19 PHAGE_Entero_vB_IME197_NC_028671(7) 38.8 Siphoviridae 
E. gallinarum 18 1 44 Intact 55 PHAGE_Paenib_HB10c2_NC_028758(5) 38.1 Siphoviridae 
 2 28.9 Intact 41 PHAGE_Bacill_BCJA1c_NC_006557(8) 38 Siphoviridae 
E. durans 19 1 56.7 Intact 63 PHAGE_Lactoc_TP901_1_NC_002747(11) 36.4 Siphoviridae 
E. casseliflavus 20 1 40.7 Intact 51 PHAGE_Entero_EFC_1_NC_025453(10) 39.7 Siphoviridae 
 2 38.8 Intact 41 PHAGE_Entero_phiFL3A_NC_013648(5) 40 Siphoviridae 
 3 35.2 Intact 27 PHAGE_Bacter_Sitara_NC_028854(4) 39 Siphoviridae 
E. casseliflavus 21 1 26.9 Incomplete 40 PHAGE_Lister_LP_037_NC_021787(3) 37 Siphoviridae 
 2 27.6 Incomplete 21 PHAGE_Entero_phiFL3A_NC_013648(4) 38.8 Siphoviridae 
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Chapter 8 – General Discussion 
8.1. General Discussion  
Antibiotics have been used for more than 60 years in the management of infectious 
diseases in humans and livestock (Veterinary Medicines Directorate, 2009). The inappropriate 
use of antibiotics in human medicine and in livestock production has contributed to the 
emergence of antibiotic resistance. Antibiotic resistance threatens the effectiveness of antibiotics 
in the treatment of infectious diseases and represents one of the most challenging public health 
issues in today’s society.   
It is estimated that over half of the antibiotics produced each year are used in livestock 
production, with the majority of antibiotics administered subtherapeutically (Schmieder and 
Edwards, 2012). Subtherapeutic refers to the use of antibiotics at low concentrations in livestock 
feed or water to prevent disease and improve production efficiency. It has been increasingly 
recognised that this practice is correlated with the emergence of resistant bacteria. The use of the 
glycopeptide avoparcin and emergence of glycopeptide-resistant Enterococcus faecium was the 
first example demonstrating a transmission route of antibiotic resistant bacteria from animals to 
humans (Witte, 2000). Avoparcin was once widely used in Australia and the European Union, 
but the discovery of an association between avoparcin use and vancomycin resistance eventually 
resulted in a global ban of avoparcin use in livestock (Casewell et al., 2003; NRA, 2001). 
Avoparcin was never approved for use in North America (Health Canada, 2002). However, many 
other antibiotics are still used in livestock production, leading to the possibility of transmission 
of antibiotic resistant bacteria from animals to humans. 
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The World Health Organization (WHO) has recognised macrolides as a critically 
important antibiotic (World Health Organization, 2012). Macrolides are commonly administered 
to cattle in feedlots for the control of bovine respiratory disease (BRD) and liver abscesses. 
Macrolides are also used in human medicine and erythromycin is the macrolide antibiotic of 
choice. The same genes confer resistance to macrolides in cattle production and human medicine 
leading to concern for the potential spread of macrolide resistant bacteria from cattle to humans.  
Enterococci are a commensal of the gastrointestinal tract of both animals and humans 
(Franz et al., 2011). They are also associated with nosocomial infections in humans (Agudelo 
Higuita and Huycke, 2014; Poh et al., 2006). Transmission of resistant enterococci from animals 
to humans has been demonstrated, highlighting the zoonotic potential of enterococci. 
Vancomycin-resistant E. faecium strains sharing identical pulsed-field gel electrophoresis 
(PFGE) profiles were reported isolated from a turkey farmer and his turkeys (Van den Bogaard, 
1997). In another study, vancomycin-resistant E. hirae strains with identical PFGE profiles were 
isolated from a broiler farmer and his broilers (Van den Bogaard, 2002). This suggests 
transmission of macrolide resistant enterococci from animals to humans could also occur. The 
zoonotic potential of enterococci, association with nosocomial infections in humans, role as an 
indicator bacteria, and habitation in the normal gut flora of both animals and humans highlights 
them as a suitable candidate to study macrolide resistance in beef cattle.  
As such, this thesis assessed the potential contribution of antimicrobial use in beef cattle 
production on antimicrobial resistance by examining differences in the relative abundance of key 
resistance genes in the resistome of cattle and urban environments using real-time, quantitative 
PCR. Tylosin phosphate is a commonly used macrolide administered at subtherapeutic levels in 
the diet of feedlot cattle for the control of liver abscesses. Enterococci were used as an indicator 
	
	
219	
bacterium to investigate the effects of in-feed administration and withdrawal of tylosin phosphate 
on macrolide resistance. This study identified a number of enterococci that harboured antibiotic 
resistance genes (ARGs), which were selected for genomic sequencing and further study using 
comparative genomics. 
Real-time, quantitative PCR (qPCR) has been used in many studies to quantify ARGs in 
various environments, including in livestock and poultry faeces (He et al., 2014; Mu et al., 2014; 
Zhu et al., 2013), livestock lagoons (McKinney et al., 2010), and wastewater from urban 
environments (Marti et al., 2013; Negreanu et al., 2012). Studies such as these have highlighted 
correlations between antibiotic use and the elevated abundance of ARGs.  
It can be argued shotgun metagenomic approaches are slowly replacing molecular 
techniques such as qPCR in the study of antibiotic resistance (Schmieder and Edwards, 2012). 
Metagenomic approaches are not limited by the number of resistance genes that can be screened 
and have the ability to discover novel ARGs, unlike qPCR which is restricted to the study of 
known resistance genes. Despite its advantages over qPCR, shotgun metagenomics requires 
complex analysis with high computational power and expertise in bioinformatics (Schmieder and 
Edwards, 2012). Thus, qPCR is still a useful tool that can provide an approximation of the 
abundance of ARGs in the environment in order to assess how antibiotic use may be influencing 
the relative abundance of targeted ARGs within the resistome (Berendonk et al., 2015).  
As such, Chapter 4 explored the use of qPCR to determine the resistance gene profile of 
Canadian beef feedlots and urban environments by quantifying ARGs across five antibiotic 
classes including the sulfonamides, tetracyclines, macrolides, fluoroquinolones and β-lactams. 
The relative abundance of ARGs in feedlot cattle faeces was compared to those in feedlot catch 
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basins, a surrounding waterway and municipal wastewater treatment plants in Alberta to 
determine how differences in antibiotic use may contribute to different resistance gene profiles. 
An aspect of the study was collection of data related to antibiotic use from the feedlots sampled, 
allowing links between antibiotic use and the resistance gene profile to be proposed.  
The abundance profiles of the resistance genes quantified in Chapter 4 differed across the 
environments examined, with sulfonamide, fluoroquinolone and β-lactam resistance genes 
predominating in urban wastewater whilst tetracycline resistance genes were prevalent in cattle 
faecal composite samples. The differences in the resistance profiles observed appeared to reflect 
differences in antibiotic use in cattle versus humans, suggesting the selective pressure of 
antibiotic use on resistance development. Co-localisation of resistance genes on mobile genetic 
elements can lead to the co-selection of resistance genes (Chung et al., 1999; De Leener et al., 
2004; Giovanetti et al., 2003). This would also influence the abundance profile observed. 
Furthermore, bacterial composition and diversity can also influence the resistance gene profile, 
as some ARGs are more common in some bacterial species than in others (Durso et al., 2012; 
Forsberg et al., 2014). Therefore, there are multiple factors that can influence the selection and 
persistence of ARGs, highlighting the complex nature of antibiotic resistance development. 
Whilst quantifying ARGs can provide a general overview of the resistome in different 
environments, it is unable to provide an understanding of what may be occurring at a 
microbiological level. Diverse bacterial populations in the gastrointestinal (GI) tract of cattle and 
the use of multiple antibiotics in the feedlot can make it difficult to produce a clear idea of the 
direct impact of antibiotic use on resistance development, and how best we can manage the use 
of antibiotics in production so as to not reduce their efficacy. Indicator bacteria are therefore 
used as a tool to interpret the direct impact of antibiotic use on bacterial populations.  
	
	
221	
Escherichia coli has been used as an indicator bacterium to interpret resistance 
development to tetracyclines and sulfonamides (Alexander et al., 2008; Sharma et al., 2008). 
However, this bacterium cannot be used to study macrolide resistance due to its innate resistance 
(Mao and Putterman, 1968). The results of Chapter 4 highlighted the presence of macrolide 
resistance genes in composite faecal samples from cattle despite macrolides not being 
administered at the time of sampling and provided an indication of the relative abundance of 
macrolide resistance genes in the entire bacterial population. The importance of macrolides in 
both animal husbandry and human medicine prompted investigation of how macrolide use in the 
cattle feedlot industry impacts macrolide resistance. To investigate this, enterococci were 
selected as an indicator bacterium.   
Previous studies have demonstrated therapeutic and subtherapeutic administration of 
macrolides to cattle increases the proportion of erythromycin-resistant (eryR) enterococci in 
bovine faeces (Jacob et al., 2008; Zaheer et al., 2013). Prior to slaughter, a withdrawal period is 
employed to prevent residual antibiotics contaminating meat for consumption. The duration of 
withdrawal differs depending on the antibiotics used (Compendium of Veterinary Products, 
1999). For in-feed macrolides there is no defined withdrawal period. There is limited knowledge 
regarding how the withdrawal of macrolides prior to slaughter may impact the proportion of eryR 
enterococci in bovine faeces. It is expected once antibiotic selective pressure is removed, the 
proportion of resistance will decrease. If this is the case, antibiotic withdrawal could be an 
effective control strategy to minimise the potential spread of eryR enterococci through the food 
chain. 
As such, my second study (Chapter 5) aimed to analyse the effect of in-feed 
administration of tylosin phosphate to cattle at subtherapeutic levels and its subsequent 
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withdrawal on macrolide resistance using enterococci as an indicator bacterium. It was 
demonstrated that administering tylosin phosphate to cattle at subtherapeutic levels increased the 
proportion of both eryR and tylosin-resistant (tylR) enterococci within the total enterococci 
population, consistent with observations in previous studies (Jacob et al., 2008; Zaheer et al., 
2013). Just prior to its withdrawal, the proportion of eryR and tylR enterococci began to decrease 
and continued to decrease after tylosin was withdrawn, until there was no difference between the 
control (administered no antibiotics) and the tylosin phosphate treated groups (administered 
tylosin phosphate at 11 ppm in the diet). The observed decrease in resistance just prior to the 
withdrawal of tylosin phosphate from the diet was unexpected. It was predicted that the 
proportion of eryR and tylR enterococci would decrease after tylosin phosphate was withdrawn 
from the diet and not before. Stress, age and diet were suggested as potential confounding factors 
of this observed early decrease in resistance. The difference between control and tylosin 
phosphate groups was non-existence after tylosin phosphate was removed from the diet, 
suggesting that this practice has some merit in reducing antibiotic resistance.   
Enterococcus hirae has been identified as a predominant species present in the GI tract of 
cattle (Anderson et al., 2008; Jackson et al., 2010; Zaheer et al., 2013), whilst in humans 
Enterococcus faecium and Enterococcus faecalis dominate (Chenoweth and Schaberg, 1990; 
Noble, 1978). A consistant disparity between the species of Enterococcus isolated from cattle 
and humans may suggest no direct link between the use of macrolides in beef cattle production 
and the occurrence of eryR pathogenic enterococci isolated from humans.  
In Chapter 5, the species distribution of enterococci in the GI tract of cattle was 
investigated. E. hirae was confirmed as the predominant species present, consistent with 
observations in previous studies (Anderson et al., 2008; Jackson et al., 2010; Zaheer et al., 2013). 
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The species diversity of enterococci changed throughout the study, with a greater diversity of 
enterococci in steers at arrival than at exit from the feedlot. Isolates of E. faecium and E. faecalis, 
the two species most commonly associated with nosocomial infections in humans (Ruoff et al., 
1990; Sievert et al., 2013; Werner et al., 2008), were isolated at the beginning of the feeding 
period but were rarely recovered at the end of the experiment. Transitioning of the diet from a 
forage- to a grain-based diet has been demonstrated to alter the faecal microbiome of cattle 
(Shanks et al., 2011) and may have created conditions favourable for E. hirae to flourish, whilst 
being detrimental for E. faecium and E. faecalis. The increasing age of the cattle may have also 
contributed to the decline in species diversity during the feeding period (Devriese et al., 1992). 
The species of Enterococcus that dominates the GI tract of cattle is clearly different to the 
species commonly associated with infections in humans. Even though both E. faecium and E. 
faecalis can be isolated from the GI tract of cattle, it appears production practices may be 
reducing their abundance as cattle reach slaughter. 
Despite E. hirae being the predominant species present in the GI tract of cattle, this 
species still has the potential to contain and transfer ARGs. Very little is known about the nature 
and resistance characteristics of enterococci isolated from feedlot cattle. Chapter 5 further 
investigated the underlying genetic mechanisms conferring resistance to erythromycin in 
enterococci isolated from bovine faeces, identifying either erm(B) or msrC or both resistance 
genes responsible for the observed phenotype. Similar PFGE profiles of eryR E. hirae pre- and 
post-antibiotic treatment suggested that administration of tylosin phosphate selected for eryR 
enterococci already present in the bovine GI tract. 
A number of isolates from Chapter 5 possessed multiple ARGs, including isolates of E. 
faecium and E. hirae. This, combined with a lack of genomic sequencing information on 
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enterococci, excluding E. faecium and E. faecalis, and from sources other than clinical infections 
prompted selection of twenty-one Enterococcus isolates for whole-genome sequencing and 
comparative genomic analysis. Chapter 6 and 7 addressed the results from this analysis. 
In Chapter 6, a genome note highlighted the key features of the draft genome of an 
Enterococcus thailandicus isolate from bovine faeces following whole-genome sequencing. E. 
thailandicus was first described following isolation from fermented sausage in Thailand in 2008 
(Tanasupawat et al., 2008). The identification of E. thailandicus in cattle faeces was a unique 
finding, as this species had yet to be recognised in the bovine GI tract. Its detection can be 
credited with improvements in characterisation methods towards more molecular based 
techniques and further verified the suitability of the groES-EL spacer region for Enterococcus 
speciation (Zaheer et al, 2012).  
Chapter 7 delved deeper into the genus Enterococcus by performing a comparative 
genomic analysis of twenty-one isolates of Enterococcus isolated from bovine faeces, and 
comprising E. hirae (n=10), E. faecium (n=3), Enterococcus villorum (n=2), Enterococcus 
casseliflavus (n=2), E. faecalis (n=1), Enterococcus durans (n=1), Enterococcus gallinarum 
(n=1) and E. thailandicus (n=1). The analysis examined the presence of putative virulence and 
ARGs, mobile genetic elements (MGEs), bacteriophage, CRISPR-Cas and secondary metabolite 
biosynthetic gene clusters. The pertinent findings from this study identified virulence genes in E. 
faecium and E. faecalis genomes that corresponded with those found in human clinical isolates, 
and the identification of MGEs, including the Tn917 transposon containing the erm(B) resistance 
gene in E. faecium and E. hirae genomes, and two integrative conjugative elements (ICEs) of the 
Tn916 family both containing the tet(M) resistance gene in an E. faecium genome.  
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The identification of virulence genes in E. faecium and E. faecalis isolated from bovine 
faeces is not surprising. Many virulence genes also play a role in the general survival and 
colonisation of enterococci in various environments. However, their presence does suggest the 
potential for them to colonise humans if transmitted from bovine faeces through the food chain. 
The likelihood of this occurring is likely low considering E. hirae is the predominant species 
present in the bovine GI tract. Virulence factors were not detected in E. hirae isolated from 
bovine faeces. However, there was a pheromone cAD1 precursor lipoprotein cad gene detected 
in E. hirae with amino acid identity of 66% to the previously functionally characterised cad gene 
in E. faecalis (GenBank accession no. AF421355.1). This sex pheromone induces the transfer of 
the highly-conjugative, pheromone-responding plasmid pAD1 encoding for a bacteriocin and 
hemolysin (Wirth, 1994). It is underdetermined if the precursor identified in E. hirae is able to 
induce transfer of pAD1.  
A number of MGEs were identified in Enterococcus spp. isolated from bovine faeces 
carrying ARGs. The Tn917 transposon carrying erm(B) was identified in both E. faecium and E. 
hirae genomes suggesting transfer of resistance genes on MGEs may occur in the bovine GI tract 
between different Enterococcus spp. Furthermore, the identification of two ICE of the Tn916 
family, Tn916 and Tn5801, both carrying tet(M) and conferring resistance to tetracycline in E. 
faecium, indicates ICE are also present in enterococci in the bovine gut. The Tn916 family of 
ICE is known to have a wide host range, having been detected in Proteobacteria, Actinobacteria 
and Firmicutes (Roberts and Mullany, 2009). Several other families of ICE have also been 
identified in enterococci (Werner et al., 2013). Only a small number of isolates were investigated 
for this study, therefore it is possible other enterococci present in the bovine gut may contain ICE 
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carrying multiple ARGs. The prevalence of enterococcal ICEs in the bovine gastrointestinal tract 
has yet to be fully investigated.  
ICEs are capable of acquiring multiple ARGs, which can lead to shared antibiotic 
resistance as a result of a single genetic transfer event. For example, an ICE identified in 
Pasteurella multiocida conferred resistance to twelve antimicrobials (Michael et al., 2012). The 
ability of ICE to carry multiple ARGs enabling rapid dissemination of antibiotic resistance is 
concerning and has implications for both animal and human health by reducing the efficacy of 
antibiotics. However, in this study the number of multi-drug resistant enterococci was low, 
despite the inclusion of tylosin phosphate in the diet of feedlot cattle.  
 
8.2. Future Directions 
Following on from the work carried out in Chapter 4, it would be beneficial to carry out a 
metagenomic study of the resistome of urban and cattle environments to enable a more 
comprehensive study of the resistance genes present. As highlighted earlier, qPCR is limited to 
the inclusion of known resistance genes. Furthermore, the labour involved increases with number 
of resistance genes investigated. A metagenomic study could help expand the knowledge gained 
from Chapter 4 to give a more complete view of the resistome. Further work could also include 
measuring residual antibiotics in the environments investigated to allow correlations between the 
resistance genes identified and the presence of antibiotic residues. Characterisation of the 
bacterial community composition would also allow links between the resistance genes detected 
and bacteria present to be made. Finally, a longitudinal study would be of value to provide 
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insight towards seasonal variation that may occur in the resistome of urban and cattle 
environments.  
The number of closed genomes available for the genus Enterococcus is limited. There is 
an imbalance in the availability of Enterococcus spp. genomes for analysis, with E. faecium and 
E. faecalis genomes from clinical infections comprising the majority. Furthermore, the source of 
isolates is also biased with a poor representation of strains isolated from healthy humans and 
non-human sources and from locations excluding Europe and North America. As the cost of 
genomic sequencing continues to decrease it would be of value to perform further genomic 
sequencing projects that includes a more diverse range of Enterococcus spp. from different 
origins. In doing so, genetic linkages may be able to be established to determine if there are 
connections between enterococci isolated from animal and human clinical sources and what role 
enterococci plays in the dissemination and spread of antibiotic resistance. 
While the detection of multidrug resistant enterococci from bovine faeces of cattle 
administered tylosin phosphate were low, the identification of MGEs such as ICE carrying ARGs 
indicates potential for resistance genes to spread between organisms. Two ICE were detected in a 
single genome of an E. faecium isolate in Chapter 7, therefore other enterococci may be present 
in the bovine gut harbouring ICE with resistance genes. Further studies are warranted to 
investigate the distribution of enterococcal ICE in the bovine GI tract and to determine their 
prevalence. Furthermore, studies investigating the ability of enterococcal ICE present in the 
bovine GI tract to be transferred to other organisms should also be carried out. Transfer of Tn916 
conferring tetracycline resistance among strains of E. faecalis colonising the intestines of 
gnotobiotic rats and transfer of Tn1545 conferring kanamycin, erythromycin and tetracycline 
resistance between E. faecalis and Listeria monocytogenes has been demonstrated (Bahl et al., 
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2004; Doucet-Populaire et al., 1991). It is therefore plausible enterococcal ICE found in the 
bovine GI tract may be transferred to other organisms and potentially human pathogens if 
enterococci containing ICE are disseminated along the food chain.  
Although macrolide resistance in enterococci decreased following the withdrawal of 
macrolides from cattle feed, this is not a reason to become complacent with the use of macrolides 
in cattle production. Implementation of management practices by farmers that reduce the 
likelihood of disease spread and decrease the dependence on antibiotics for disease control is 
becoming increasingly important. For example, investigating alternatives to macrolides for the 
control of BRD and liver abscesses such as vaccines and use of plant bioactives (Amachawadi 
and Nagaraja, 2016; Fulton, 2009). Essential oils have been investigated for the control of liver 
abscesses with varied results. In vitro studies have shown essential oils, limonene and thymol at 
concentrations of 20 or 100 µg/mL and 100 µg/mL, respectively inhibit the growth of 
Fusobacterium necrophorum (Elwakeel et al., 2013). In an in vivo study, the inclusion of 
CRINA, a commercially available mixture of limonene and thymol in the diet of finishing 
feedlot cattle appeared to reduce the incidence of liver abscesses, but the decline was not 
statistically significant (Meyer et al., 2009). Both BRD and liver abscesses are polymicrobial, 
making vaccine development difficult. A number of vaccines are available for BRD control. 
However, an effacious vaccine for liver abscesses has yet to be developed (Amachawadi and 
Nagaraja, 2016).  
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8.3. Concluding Remarks 
As the worldwide population continues to grow and the income of low- and middle-
income countries rises, the global demand for animal protein will increase leading to increased 
intensification of food animal production and greater use of antibiotics in agriculture (Center for 
Disease Dynamics, Economics and Policy, 2015). It is predicted the worldwide consumption of 
antibiotics by livestock will increase from 63,200 tons in 2010 to 105,600 tons by 2030, unless 
steps are taken to reduce the need for antibiotics in agriculture (Van Boeckel et al., 2015).  
This thesis demonstrated the selective pressure of antibiotics, in particular increased 
macrolide resistant enterococci following the use of tylosin phosphate in cattle production. The 
full effects of withdrawing tylosin phosphate from the diet were unclear as the prevalence of 
macrolide resistant enterococci began to decrease just prior to its withdrawal. Despite this 
unexpected result, changes to antibiotic use in animal agriculture are important with many 
authoritarian figures endorsing this. 
In May 2015, the World Health Assembly endorsed the Global Action Plan on 
Antimicrobial Resistance, where it is expected within the next two years all countries will adopt 
their own national strategies in line with the global plan to address antibiotic resistance (World 
Health Organization, 2015). In terms of antibiotic use in agriculture, this involves removing the 
use of antibiotics as antibiotic growth promoters and reducing use of antibiotics in animal 
production by optimising production through other means such as improving farm hygiene and 
using vaccines (Center for Disease Dynamics, Economics and Policy, 2015).  
Several countries including the European Union Member States, Mexico, South Korea 
and New Zealand have already enforced bans on antibiotic growth promoters for livestock 
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production (Center for Disease Dynamics, Economics and Policy, 2015). Presently, there is no 
ban on the use of antibiotics for growth promotion in the United States or Canada. However, in 
2013 the FDA released voluntary guidelines for the withdrawal of medically important 
antibiotics as growth promoters and in 2014 the Canadian government released similar 
guidelines (Health Canada, 2014; U.S. Food and Drug Administration, 2013). Australia has had 
one of the most conservative approaches towards antimicrobial use in livestock production and 
has many initiatives in place to address antimicrobial resistance including many regulatory 
restrictions on the prescription and use of antibiotics (Australian Commission on Safety and 
Quality in Health Care, 2013). Australia is also the only country in the world that has a 
regulatory measure in place to ban the use of fluoroquinolones in food producing animals 
(Australian Government, 2015).  
One of the major problems of assessing the impact of antibiotic use in agriculture is the 
limited reliable information on global use. Further, there is limited global information on 
antibiotic resistance in food animals. Apart from Europe, there have been few instances where 
the effect of reduced antibiotic use in agriculture on antibiotic resistance has been studied. The 
ban of avoparcin by the European Union in 1997 provided some insight, with studies comparing 
resistance prevalence in humans and poultry, indicating a decrease in vancomycin-resistant 
enterococci (Aarestrup et al., 2001; Klare et al., 1999; Van den Bogaard et al., 2000). It is 
expected these same trends will be observed as other countries implement similar regulations.  
Until these changes take effect, continued surveillance is essential in order to monitor the 
progress of antibiotic stewardship within all areas of antibiotic use, not just agriculture. There is 
no doubt antibiotic resistance is a complex issue. Using indicator organisms such as enterococci 
can aid in understanding the complex relationship between antibiotic use and resistance 
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development and assist in monitoring progress. However, only time will tell if reduced antibiotic 
use will have beneficial outcomes for reducing antibiotic resistance over the long term. 
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Appendix 1 
Table S4.1. Summary of samples collected 
Sample Type and ID Type of Production Average Number of Cattle per 
pen/catch basin 
Feedlot faecal composite   
 A (n=3) Conventional 237 
 B (n=3) Conventional 200 
 C (n=3) Conventional 371 
 DC (n=3) Conventional 251 
 DN (n=3) Natural 232 
Catch basin   
 CB (n=5) n/a 13673 
Sewage treatment   
 Influent (n=2) n/a n/a 
 Effluent (n=2) n/a n/a 
Surface water   
 Ephemeral creek (n=2) n/a n/a 
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Table S4.2. Summary of antibiotics used at sampled feedlots 
Feedlot Antibiotic family Antibiotic  Route 
A Tetracycline Chlortetracycline In Feed 
 Oxytetracycline Parenteral 
 Ionophore Monensin In Feed 
 Lasalocid In Feed 
 Macrolide Tylosin In Feed/parenteral 
 Tulathromycin Parenteral 
 Phenicol Florfenicol Parenteral 
 Cephalosporin Ceftiofur Parenteral 
 Fluoroquinolone Enrofloxacin Parenteral 
 Potentiated sulfonamide Sulfadoxine Parenteral 
 Sulfonamide combination Sulfanilamide, sulfathiozole, 
sulfamethazine 
Oral Administration  
    
B, C, Dc Tetracycline Chlortetracycline In Feed 
 Oxytetracycline Parenteral 
 Ionophore Monensin In Feed 
 Lasalocid In Feed 
 Macrolide Tylosin In Feed/parenteral 
 Tulathromycin Parenteral 
 Tilmicosin Parenteral 
 Phenicol Florfenicol Parenteral 
 Cephalosporin Ceftiofur Parenteral 
 Fluroquinolone Enrofloxacin Parenteral 
 Potentiated sulfonamide Sulfadoxine Parenteral 
  
Sulfonamide combination Sulfanilamide, sulfathiozole, 
sulfamethazine 
Oral Administration 
DC conventional pens at feedlot D
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Table S4.3. Primers used in real-time, quantitative PCR analysis 
Gene Primer 
pair 
Sequence (5’-3’) Ann. 
Temp. 
(°C) 
Amplicon 
size (bp) 
No. 
cycles 
Slope Intercept 
point 
Eff. 
(%) 
R2 Reference 
16S-
rRNA 
F CTCCTACGGGAGGCAGCAGT 60 156 30 -3.4 35.2 97.4 0.999 This study 
R TTACCGCGGCTGCTGGCAC 
sul1 F CGCACCGGAAACATCGCTGCAC 55 162 40 -3.6 42.7 88.3 1.000 Negreanu et al. 
2012 R TGAAGTTCCGCCGCAAGGCTCG 
sul2 F TCCGGTGGAGGCCGGTATCTGG 60 190 40 -3.7 43.0 85.6 0.998 Negreanu et al. 
2012 R CGGGAATGCCATCTGCCTTGAG 
tet(A) F GCTACATCCTGCTTGCCTTC 64 210 35 -3.4 38.9 96.3 0.999 Ng et al. 2001 
R CATAGATCGCCGTGAAGAGG 
tet(B) F ACACTCAGTATTCCAAGCCTTTG 60 205 40 -3.6 40.8 90.2 0.999 Peak et al. 
2007 R GATAGACATCACTCCCTGTAATGC 
tet(M) F TGGACAAAGGTACAACGAGGACGG 64 224 35 -3.5 36.4 94.4 0.998 This study 
R ACGAGTTTGTGCTTGTACGCCA 
tet(O) F ACGGARAGTTTATTGTATACC 53 171 40 -3.4 40.1 95.5 0.999 Aminov et al. 
2001 R TGGCGTATCTATAATGTTGAC 
tet(Q) F AGAATCTGCTGTTTGCCAGTG 64 167 35 -3.7 42.4 86.8 0.998 Aminov et al. 
2001 R CGGAGTGTCAATGATATTGCA 
tet(W) F GAGAGCCTGCTATATGCCAGC 64 168 35 -3.7 38.4 86.0 0.997 Aminov et al. 
2001 R GGGCGTATCCACAATGTTAAC 
erm(A) F CCTTCTCAACGATAAGATAGC 55 207 35 -3.4 37.6 97.2 0.998 This study 
R ATGGAGGCTTATGTCAAGTG 
erm(B) F TTCAATTCCCTAACAAACAGAG 55 161 40 -3.6 45.5 88.5 0.994 This study 
R TGTTCGGTGAATATCCAAGG 
erm(C) F GAGGTGTAATTTCGTAACTGCC 55 189 35 -3.7 38.6 85.0 0.997 This study 
R TTGCGTATTATATCCGTACTTATG 
erm(F) F GCCCGAAATGTTCAAGTTGTCGGTTG 55 164 35 -3.6 38.7 90.3 0.998 This study 
R TGAAGGACAATGGAACCTCCCAGA 
mef(A) F GGAGCTACCTGTCTGGATGG 60 179 40 -3.3 36.3 100.3 1.000 Szczepanowski 
et al. 2009 R CAACCGCCGGACTAACAATA 
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Table S4.3. Continued 
Gene Primer 
pair 
Sequence (5’-3’) Ann. 
Temp. 
(°C) 
Amplicon 
size (bp) 
No. 
cycles 
Slope Intercept 
point 
Eff. 
(%) 
R2 Reference 
qnrS F ATGCAAGTTTCCAACAATGC 60 240 35 -3.5 37.9 91.5 0.998 Marti et al. 
2013 R CTATCCAGCGATTTTCAAACA 
oqxB F TCCTGATCTCCATTAACGCCCA 64 131 35 -3.4 38.4 96.0 1.000 Kim et al. 
2009 R ACCGGAACCCATCTCGATGC 
blaSHV F CGCTTTCCCATGATGAGCACCTTT 64 110 35 -3.5 38.7 94.7 0.999 Xi et al. 2009 
R TCCTGCTGGCGATAGTGGATCTTT 
blaTEM1 F TTGGGTGCACGACTGGGT 64 504 35 -3.8 36.7 84.8 0.997 Wu et al. 
2011 R TAATTGTTGCCGGGAAGC 
blaCTX-M F CTATGGCACCACCAACGATA 60 103 35 -3.6 36.9 90.4 0.999 Marti et al. 
2013 R ACGGCTTTCTGCCTTAGGTT 
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Appendix 2 
A.2.1. Verification of species identity of isolates with unique groES-EL intergenic spacer regions 
Of the isolates examined for speciation, 36 of these presented unique groES-EL intergenic spacer 
regions not currently deposited in the NCBI database. Of these 36, 5 unique sequences were present 
(Figure S5.1.). Genetic methods using 16S rRNA, atpA, pheS and rpoA gene sequencing were used 
to further verify the identity of these Enterococcus species. The genes atpA, pheS and rpoA were 
selected as good candidates for Enterococcus species identification due to their high discriminatory 
power (Naser et al., 2005a; Naser et al., 2005b). The sequences of the primers used for amplification 
and sequencing of 16S rRNA, atpA, pheS and rpoA genes are listed in Table S5.1. Different primer 
combinations were used to amplify atpA, pheS and rpoA based on the species each isolate was 
speculated to be following 16S rRNA amplification and sequence analysis. For Enterococcus 
thailandicus, the primer combinations atpA E. thai; rpoA specific and pheS specific were used, for 
Enterococcus villorum, atpA E. vill; rpoA specific and pheS specific were used, for Enterococcus 
faecium, atpA all; rpoA specific and pheS specific were used and for Enterococcus casseliflavus 
atpA E. cass, rpoA specific and pheS E. cass were used. These primers were designed using atpA, 
pheS and rpoA partial gene sequences of enterococci species publicly available. For each gene, a 50 
µL reaction using 5 µL of DNA template was set up using a final primer concentration of 500 nM, 
except for atpA all and rpoA all where 1000 nM was used. PCR products were purified using 
commercial kits and sequenced using both the forward and reverse primers. The reaction conditions 
were as follows; initial denaturation for 5 min at 95°C, followed by either 35 or 40 cycles of 
denaturation for 30 s at 94°C, annealing at temperature specified in table for 30 s, extension at 72°C 
with time specified in table and with a final extension for 10 min at 72°C. Sequence results were 
BLAST against the non-redundant database to further confirm species identification. 
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Table S5.1. Primers for 16S rRNA, atpA, pheS, and rpoA amplification and sequencing 
Primer name  Primer sequence (5’-3’)  Expected 
product 
size (bp) 
 Annealing 
temperature 
(°C) 
 Number of 
cycles 
 Extension 
time 
 Reference 
27F  AGAGTTTGATCCTGGCTCAG  ~1400  58  35  1 m 30 s  Zaheer et 
al., 2013 1492R  GGTTACCTTGTTACGACTT          
             
atpA all F  GGDYTWGAAAAYGCVATGAGTG  1070  49  40  1 m  This study 
atpA all R  CCRAAYTGNGTRAADGCTTC           
             
atpA E. thai F  GAATGCATGAGTGGTGAGTTGC  1054  59  35  1 m 30 s  This study 
atpA E. thai R  GCGTAAATGCTTCAAGTTCACGG           
             
atpA E. vill F  CGTGCACATGGGTTAGAAAACGC  1098  59  35  1 m 30 s  This study 
atpA E. vill R  TGTCGCAGCATCTAAATCAGAACC           
             
atpA E. cass F  ACGGTTCTTATGGGATGGCA  945  58  35  1 m  This study 
atpA E. cass R  TCTGTGCAGAACCACCAACC           
             
pheS specific F  CGDACVATGGAAAAACATG  337  51  35  40 s  This study 
pheS specific R  CWGCNCCTAARATYTCRATC           
             
pheS E. cass F  GAAGTGCTGATTCGGACCCA  415  58  35  40 s   This study 
pheS E. cass R  CGATCCCTGACATTTCTAAGACG           
             
rpoA all F  CGTCGTATYYTDYTDTCTTC  485  48.9  40  40 s  This study 
rpoA all R  CCRTCWGTCCADATYTCC           
             
rpoA specific F  GGTGTACTGCATGAATTCTC  548  54  35  40 s  This study 
rpoA specific R   CTTTYTCVACCATGATTTCAGC                 
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Figure S5.1. Alignment of groES-EL spacer region of Enterococcus species with unique spacer regions isolated from this study 
deposited in the NCBI database (Accession numbers KP993544, KP993545, KP993546 and KP993547). Enterococcus casseliflavus 
(F1129F 46) displays a ‘variant’ spacer region that has been reported previously (Tsai et al., 2005 and Zaheer et al., 2012). ATCC 
strains 19434, 8043 and 25788 were included as comparison. Stop codon of groES (TAA) and start codon of groEL (ATG) are 
underlined. Species were verified by sequencing and blast analysis of 16S rRNA, atpA, pheS and rpoA.   
Consensus 
Sequence Logo 
Identity 
 
ATCC 19434 Enterococcus faecium 
E. faecium (F1213D 01) 
E. faecium* (F1129D 148) 
ATCC 8043 Enterococcus hirae 
Enterococcus villorum (F0321D 152) 
Enterococcus thailandicus (F0711D 46) 
ATCC 25788 Enterococcus 
casseliflavus 
Enterococcus casseliflavus (F1129F 46) 
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Figure S5.2. Scattergram of MICs versus zone diameters for tylosin. Isolates in bold were confirmed by PCR to have the resistance 
determinant erm(B) and those that are underlined to have the resistance determinant msrC. 
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Appendix 3 
 
Figure S7.1. Organisation of protein coding genes by Clusters of Orthologous Groups (COGs) category
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Table S7.1. Reference sequences for contig ordering using progressive Mauve 
Strain Reference genome name 
GenBank 
accession 
number for 
reference 
genomes 
E. hirae 1 Enterococcus hirae ATCC 9790, complete genome CP003504.1 
E. hirae 2 Enterococcus hirae ATCC 9790, complete genome CP003504.1 
E. hirae 3 Enterococcus hirae ATCC 9790, complete genome CP003504.1 
E. hirae 4 Enterococcus hirae ATCC 9790, complete genome CP003504.1 
E. hirae 5 Enterococcus hirae ATCC 9790, complete genome CP003504.1 
E. hirae 6 Enterococcus hirae ATCC 9790, complete genome CP003504.1 
E. hirae 7 Enterococcus hirae ATCC 9790, complete genome CP003504.1 
E. hirae 8 Enterococcus hirae ATCC 9790, complete genome CP003504.1 
E. hirae 9 Enterococcus hirae ATCC 9790, complete genome CP003504.1 
E. hirae 10 Enterococcus hirae ATCC 9790, complete genome CP003504.1 
E. faecium 11 Enterococcus faecium Aus0085, complete genome CP006620.1 
E. faecium 12 Enterococcus faecium Aus0085, complete genome CP006620.1 
E. faecium 13 Enterococcus faecium Aus0085, complete genome CP006620.1 
E. thailandicus 14 Enterococcus faecium T110, complete genome CP006030.1 
E. villorum 15 Enterococcus hirae ATCC 9790, complete genome CP003504.1 
E. villorum 16 Enterococcus hirae ATCC 9790, complete genome CP003504.1 
E. faecalis 17 Enterococcus faecalis 62, complete genome CP002491.1 
E. gallinarum 18 Enterococcus gallinarum strain FDAARGOS_163, complete genome CP014067.1 
E. durans 19 Enterococcus durans strain KLDS6.0930, complete genome CP012366.1 
E. casseliflavus 20 Enterococcus casseliflavus EC20, complete genome CP004856.1 
E. casseliflavus 21 Enterococcus casseliflavus EC20, complete genome CP004856.1 
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Table S7.2. Raw antibiogram data from disc susceptibility testing conducted previously (Beukers et al., 2015) 
Strain AMP DOX ERY GEN LVX LZD NIT Q-D STR TGC TYL VAN 
E. hirae 1 25 14 10 21 23 24 22 19 17 24 6 21 
E. hirae 2 26 28 8 22 27 27 19 22 21 23 6 20 
E. hirae 3 30 22 12 23 28 27 23 18 21 23 8 21 
E. hirae 4 32 16 10 21 23 28 19 20 20 24 7 20 
E. hirae 5 32 20 20 22 26 28 19 26 21 24 6 21 
E. hirae 6 30 22 14 21 28 27 24 19 18 23 6 21 
E. hirae 7 27 27 24 20 23 24 17 25 19 24 20 21 
E. hirae 8 31 28 29 21 23 28 25 21 21 21 21 20 
E. hirae 9 31 19 24 22 26 24 24 23 20 25 19 21 
E. hirae 10 32 22 27 21 27 25 21 22 20 25 24 23 
E. faecium 11 32 11 9 27 19 27 21 18 13 26 10 23 
E. faecium 12 26 26 14 28 21 27 19 22 27 23 20 20 
E. faecium 13 23 28 18 22 16 26 20 21 21 25 20 20 
E. thailandicus 14 26 28 18 22 18 27 20 20 20 23 21 20 
E. villorum 15 38 28 25 28 28 32 30 29 28 28 22 27 
E. villorum 16 40 20 6 24 26 28 28 24 20 27 6 25 
E. faecalis 17 23 21 23 19 22 24 23 13 17 20 17 21 
E. gallinarum 18 26 28 19 24 21 27 24 21 19 25 11 21 
E. durans 19 30 26 13 23 23 25 23 16 20 22 6 23 
E. casseliflavus 20 25 27 6 24 17 25 20 14 23 21 7 16 
E. casseliflavus 21 26 29 12 23 19 26 25 20 24 24 12 21 
AMP, ampicillin; DOX, doxycycline; ERY, erythromycin; GEN, gentamicin; LVX, levofloxacin; LZD, linezolid; NIT, nitrofurantoin; 
Q-D, quinupristin-dalfopristin; STR, streptomycin; TGC, tigecycline; TYL, tylosin; VAN, vancomycin.  
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Table S7.3. Presence and absence of CRISPR arrays and intact prophage in Enterococcus spp. 
isolated from bovine faeces 
Strain Functional 
CRISPR 
Type Orphan 
CRISPR 
Intact 
prophage 
E. hirae 1 Yes Type II-A - Yes 
E. hirae 2 Yes Type II-A - Yes 
E. hirae 3 Yes Type II-A - Yes 
E. hirae 4 Yes Type II-A Yes (1) Yes 
E. hirae 5 Yes Type II-A - Yes 
E. hirae 6 Yes Type II-A - Yes 
E. hirae 7 Yes Type II-A - Yes 
E. hirae 8 No - - Yes 
E. hirae 9 Yes Type II-A Yes (1) Yes 
E. hirae 10 Yes Type II-A - Yes 
E. faecium 11 No - - Yes 
E. faecium 12 No - - Yes 
E. faecium 13 No - - Yes 
E. thailandicus 14 Yes Type II-A Yes (5) No 
E. villorum 15 Yes Type II - Yes 
E. villorum 16 Yes Type II - Yes 
E. faecalis 17 No - Yes (1) Yes 
E. gallinarum 18 No - - Yes 
E. durans 19 Yes Type II-A Yes (1) Yes 
E. casseliflavus 20 No - - Yes 
E. casseliflavus 21 No - - No 
	
	
257	
Table S7.4. Direct repeat sequences of CRISPR arrays found in Enterococcus spp. isolated from 
bovine faeces 
Direct 
repeat Sequence  
Direct 
repeat Sequence 
1 ATCTTCATTCATTCAAAACAA
CATAACTCTAAAGC 
 16 TTACCGTTACTGAATCTTTA
AGAGTACAAAAAC 
2 TTTTGGAAACATTCAAAACAA
CATAGCTCTAAAAC 
 17 GTTTTAGAGCTATGTTGTTTT
GAATGCTTCCAAAAC 
3 TTTTGGAAGCATTCAAAACAA
CATAGCTCTAAAAC 
 18 GTTTTAGAGCTATGTTGTTTT
GAATGTTTCTGAACT 
4 GTTTTAGAGCTATGTTGTTTTG
AATGCTTCCAAAA 
 19 GTGATAGTTTGTTTTTTAAC
AACATGGCTCTAAAAC 
5 GTTTTAGAGCTATGTTGTTTTG
AATGTTTCCAAAA 
 20 GTTTTGGTACCATTCTAAAC
AACATGACTCTAAAAC 
6 GTTTTAGTTTTGTGTTATTTTG
AGTGCTGACCTCA 
 21 GTTTTAGAGCTATGTTGTTTT
GAATGCTTCCAA 
7 GTTTTAGAGTTGTGTTATTTTG
AGTGCTGACCTCA 
 22 GTTTTAGAGCTATGTTGTTTT
GAATGTTTCCAA 
8 GCATCTTCATTCATTCAAAAC
AACATAACTCTAAAGC 
 23 GTTTTAGAGCTATGTTGTTT
AGAATGCTTCCAAAAC 
9 CATTTTGGAAACATTCAAAAC
AACATAGCTCTAAAAC 
 24 GTTTTAAAGCTATGTTGTTT
AGAATGCTTCCAAAAC 
10 TGTTTTGGAAGCATTCAAAAC
AACATAGCTCTAAAAC 
 25 GTTTTAGAACTATGTTGTTT
AAAATGCCTCCAACAC 
11 GTTTTGGAAGCATTCAAAACA
ACATAGCTCTAAAAC 
 26 GTTTTAGAGCTATGCTGTTT
TGAATGCTTCCAAAAC 
12 GTTTTGGAAGCATTCGAAACA
ACATAGCTCTAAAAC 
 27 GTTTTAGAGCTATGCTGTTT
TGAATGCTTACTTTTG 
13 GTTTTGGAAGCGTTCAAAACA
ACATAGCTCTAAAAC 
 28 TTTAGCCAGTCATTCAAAAC
AGCATAGCTCTAAAAC 
14 TAAGGCTTATTTGAACTTTAA
GAGTATAAAAAC 
 29 GTTTTGGAAGCATTCAAAAC
AGCATAGCTCTAAAAC 
15 TTACTGTTACTGAATCTTTAA
GAGTACAAAAAC 
 30 GTTTTAGAGCTATGCTGTTT
TGAATGCTGACCAAAT 
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Table S7.5. Spacer sequences of CRISPR arrays found in Enterococcus spp. isolated from 
bovine faeces 
Spacer Sequence  Spacer Sequence 
1 TACCTCTTATCATAGTTGATG
AGGTCAGCACTCAAAATAAC
AC 
 
AAAACTAAAACAGCGATCGA
GTAAAGCACAACGCTTCTACA 
 33 GAAAGGTGTCCGAACAGTG
TCCGCAAGGCT 
2 TACCTCTTATCATAGTTGATG
AGGTCAGCACTCAAAATAAC
ACAACTCTAAAACAGCGATC
GAGTAAAGCACAACGCTTCTA 
 34 AACCTGTTTGTGATTATTTA
TTAAATTATAGTA 
3 AACGACGACGAGTGGTTAGA
GCTTGCGAAAG 
 35 AACTTTGTGGTACTGAATA
TGTCAGTTTGCTAA 
4 CAACCGCATTACCTTCAGAAG
AATTTGCATT 
 36 AACTATTGTCATGGCTGGC
GCGAATGGCGGTTT 
5 CTAAGGGTTCAACGCAGTACA
CATTGAGTTT 
 37 ACATTAGACTAATAAACAA
TGCTATGGTCA 
6 CATCTAAGCGGTAAGTGCTTA
GTAGCTTCAA 
 38 CTTTATCTTATATATTTAGT
ATACTTTAAA 
7 CTTTCGCAAGCTCTAACCACT
CGTCGTCGTT 
 39 TATTGTTTTTGCCTGACAAC
GTACCCAATA 
8 TGTAGAAGCGTTGTGCTTTAC
TCGATCGCT 
 40 AGTGATAGACAAAGAAGA
ATACACGAACAA 
9 TTGAAGCTACTAAGCACTTAC
CGCTTAGA 
 41 GCACAAAAGGCGAAGAAC
GTCAAGACCCAA 
10 AATGCAAATTCTTCTGAAGGT
AATGCGGT 
 42 CCTGTGAACCGTCCAGAAA
ATGTGCCGTCT 
11 AATTTTTATAATCCTTTGGAA
TTTCAAAAT 
 43 AGTCTACATGATAGGTAAT
ACTTTAAATTC 
12 GTGCATAACAATTAAGTCAGT
GAAAATTGA 
 44 TAAAGATGTAACAGCTAAT
TTAGTTGCGTA 
13 AGTACCATGACAATGCCTTCA
TGGCTTTAC 
 45 AATAGGGGTTCGACTCCTC
TACGACCTGTT 
14 TACTCAAAATATTTTTCAATT
TTGTTTTTG 
 46 ACTTGTGATAGTGATGTTA
GGATCGTGTAT 
15 ACTAAGCTTTTCAAATGATTC
AATCCTTTT 
 47 CGGTCATACTTTAGCATTA
CAAGGCAAATT 
16 AGTTGAAATACTTGATTATCT
CGTAGATGA 
 48 TGTGAAAGTTCGTGTGCTA
ATTCTGATCGG 
17 ACACCACCGCCAAGTTCGACA
ATTACCGAA 
 49 TTGTTTCATGCTATTCACCG
CCTTTATAGT 
18 GAGGATATTTTACATTTTAAA
TTATCCACG 
 50 TAGCAAGATTGCTCAACCT
AAGTCCTGATC 
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Table S7.5. Continued 
Spacer Sequence  Spacer Sequence 
19 ACTTTTATTGAATCATACACA
CTAAACACA 
 51 GTAGTAGTCAAAAGCTCTT
TCCCAATTTTC 
20 CAGGTTAAAATCTTAACATTG
AGACCCATAATC 
 52 AATTCTGCTAGGCGTGCCA
CCATGTCTGTT 
21 AGAGCTAGAAACATTGATAC
AGAGCTGATCGTT 
 53 TGGGACTTGATTTTACCCA
CTTGTTAGCTA 
22 AGATTGATTATGATGATGCAT
TTGACTTGT 
 54 ATTAGCTAACTTAATTAGT
CGTTGTACATT 
23 TCATATGATTAATCTCCTTTAT
GATATTGT 
 55 AGTCGTATTAAAGAAAAGC
GACTATAGGCT 
24 ATTTAGAAAAAAAATAATTA
ATCGAGATCA 
 56 TTAAAGAAAATGCTTCGTG
GTCGTGGCTAT 
25 AAATGGTTAGTGAAATCATTG
AACTAACAA 
 57 ACAAATTGTTGTGCGTAGT
GAATCATATTT 
26 TCTTTCGCATGATTGATTCTG
CCTCCTCTT 
 58 GATAAAGAGAGTGGTCAA
GTGAAGGTCACT 
27 AAATACATGGAAACAAAAGC
GCCAGAATCT 
 59 TTAGAGCTTTTGAATGAAA
TTCATTTTGAT 
28 GTAAAAAGTTATGGGATCACT
TCCATAAAG 
 60 TGCACGGAATTGATTACTA
TGATGTCTCTA 
29 TAAAATCAAAGATTTACTTTT
CAAAAGGTA 
 61 TATCCACACGACCAAAGTA
ATACCCTAAAT 
30 AGCTGCTCTTGAAGAAGCTGA
GTATACACC 
 62 ATTTTTATAAACACTATCAT
TGTATACATA 
31 TCATCATAGTATCGTAAAACT
CTTTCTGGT 
 63 TCGTCTGGTTTATACATATA
TGGATAAGTT 
32 TTATTGCTTCACCTATTGGAA
TTGTAATTG 
 64 AACAAGACACTTTAAACGG
CTATGTAAATA 
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